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Abstract  
 
Following the results from a pilot study indicating the interaction of endosomal            
maturation proteins MON1B and CCZ1 with the uncharacterised protein         
‘WDR98/RMC1’, this potentially new protein complex was investigated further.         
Literature research and bioinformatics revealed the highly evolutionarily conserved         
nature of WDR98 and also its unique C-terminal ‘MIC’ domain (the N-terminal            
containing the common protein binding platform domain WD40).        
Immunoprecipitation methods were used to confirm the, then novel, interaction of           
WDR98 with MON1B and CCZ1 individually. Furthermore, it was discovered that the            
WD40 domain is alone capable of eliciting binding between these proteins. Though            
reported elsewhere that WDR98 was able to bind to RAB5 and RAB7 in a              
whole-lysate context, we are confident that WDR98 is unable to bind to either RAB              
in isolation ​in vitro​. Immunofluorescence was utilised to localise WDR98 to           
endosomes both early (RAB5) and late (RAB7) and lysosomes (LGP120),          
specifically those most active around the nuclear periphery. WDR98 was not seen to             
localise to autophagosomes (LC3). Both the WD40 and MIC domains also localised            
to lysosomes individually. This, along with recent literature, indicates an important           
role for WDR98 in protein trafficking, specifically endosomal maturation and          
lysosome biology. In addition, its potential role in disease and the emerging            
disease-contribution of the lysosome, particularly concerning cancer, renders this         
protein an exciting discovery, with potential as a target for future investigations.  
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 Chapter 1: Introduction 
 
1.1 Lysosomes 
 
Lysosomes use hydrolytic enzymes to break down many biological molecules,          
including those from the endocytic, phagocytic and autophagic pathways (Luzio ​et           
al. ​2007). They are involved in a variety of cellular processes, not solely             
degradative, and contribute to cellular homeostasis regulation. As such, lysosomal          
dysfunction often contributes to disease pathogenesis, including that of lysosomal          
storage diseases, neurodegeneration and certain cancers (Appelqvist ​et al. 2013).          
The lysosomal membrane has a uniquely high carbohydrate content owing to the            
presence of heavily glycosylated proteins, the most abundant being         
lysosome-associated membrane protein (LAMP)-1 and -2 (Appelqvist ​et al. ​2013).          
Lysosomal membrane proteins mediate many crucial functions, including luminal         
acidification, transport of small molecules and/or macromolecules, and potentially         
lysosomal interactions and fusions (Eskelinen 2006).  
 
There are several routes of transport to the lysosome, including autophagy,           
endocytosis and phagocytosis (Figure 1).  
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Figure 1: Routes to the Lysosome 
Routes of transport to the lysosome: phagocytosis, endocytosis and autophagy. Figure           
adapted from Xu et al. (2018). 
 
Phagocytosis and endocytosis work to bring molecules external to the cell inside,            
and traffic these through the generation of vesicles (phagosomes and endosomes)           
before fusion with the lysosome (Richards and Endres 2017). Autophagy initiates           
the formation of a partial membrane - a phagophore - which begins to engulf              
particular intracellular molecules that have been marked for degradation. This          
matures to an autophagosome before lysosomal fusion (Eskelinen and Saftig 2009).  
 
Autophagy is required to maintain homeostasis and proteomic function by protein           
degradation and turnover of organelles. There are three types of autophagy,           
distinguishable by their cargo delivery mechanisms (Kaushik ​et al. 2011).          
Macroautophagy eradicates damaged organelles or proteins by sequestering        
regions of the cytosol into double-membraned autophagosomes which fuse with the           
lysosome (Figure 1) (Kaushik & Cuervo 2012). Microautophagy encases proteins for           
13 
 degradation inside vesicles via invagination of the lysosomal membrane, which is a            
more direct engulfment of cytoplasmic material into the lysosome (Cuervo & Wong            
2014). Chaperone-mediated autophagy (CMA) is distinct in that it selects individual,           
soluble proteins from a selective subset, and transports these directly to the            
lysosomal membrane where they translocate across into the lumen (Kaushik ​et al.            
2011).  
 
1.2 Endosomal Maturation 
 
RAB proteins are small GTPases required for membrane fusion. RAB5 is known to             
function in early endocytic fusion events, and RAB7 in late endosomes, both acting             
in a coordinated fashion. MON1 has been seen to actively recruit RAB7 to             
endosomes, and it has been proposed that MON1 mediates the switch between            
early and late endosomal transition (Figure 2) (Poteryaev ​et al. 2010). Knockdown            
of MON1 caused early endosomes to accumulate as RAB5 remained trapped on the             
membranes, unable to exchange for RAB7, which was rectified following MON1           
overexpression rescue (Poteryaev ​et al. 2010). MON1 and CCZ1 are proteins           
identified via gene knockouts to be required for almost all membrane-trafficking           
pathways, including autophagy, as measured by defective mutants (Wang ​et al.           
2002). The MON1-CCZ1 complex has recently been acknowledged as the only           
known RAB7 guanine nucleotide exchange factor (GEF) and similarly to Poteryaev           
et al. (2010), Yasuda ​et al. (2016) found that CCZ1 knockdown prevented RAB7             
activation on late endosomal membranes. This data is also backed up by Hegedus             
et al. (2016), who also identified that the MON1-CCZ1-RAB7 complex is required for             
autophagosome-lysosome fusion as MON1 and CCZ1 mutants exhibited a         
reduction in acidic (active) lysosomes. P62 also accumulated, suggesting a loss of            
autophagic flux.  
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Figure 2: The Interactions of MON1 and CCZ1 with Rab5 and Rab7 
RAB5 recruits MON1-CCZ1, which displaces the GDP dissociation inhibitor (GDI) from           
RAB7, required to initiate endosome maturation. Figure adapted from Kinchen and           
Ravichandran​ (​2010). 
 
1.3 WDR98 Identification  
 
Data from a large scale immunoprecipitation with mass spectrometry analysis (IP           
LC-MS/MS) pilot study, conducted by the Pryor lab, found novel protein           
‘C18orf8/WDR98/RMC1’, referred to hereafter as ‘WDR98’, appearing to bind to          
MON1 and CCZ1. Following subsequent literature searching, it was determined that           
this was a protein worth pursuing.  
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 1.4 WDR98 in Literature  
 
WDR98 has previously been identified in liquid chromatography (LC) mass          
spectrometry (MS) screens of lysosomal homogenate from human plancental tissue          
(Schroder ​et al. 2007) and it was predicted to be membrane-associated. It has also              
been identified as a RAB5 binding partner through affinity chromatography MS using            
Drosophila ​Rabs (Gillingham ​et al. 2014) and with a role in autophagy regulation             
following a genome-wide siRNA screen - knockdown of WDR98 resulted in an            
increase in autophagic flux (Lipinski ​et al. 2010). WDR98 has also been reported to              
bind FYCO1, a protein involved in autophagic vesicle transport, which in turn binds             
MON1B, CCZ1 and RAB7 (Behrends ​et al.​ 2010).  
 
WDR98 is predicted to have an N-terminal WD40 domain, a common protein            
domain with a β-propeller structure and a unique C-terminal MIC α-helical domain of             
unidentified function (Figure 3).  
 
 
Figure 3: WDR98 Protein Domains  
WDR98 is predicted domain structureThe area between the WD40 and MIC domains has yet              
to be defined in terms of its structure.  
 
HHPred (Soding ​et al. 2005) identifies the MIC domain to have a high degree of               
structural similarity to the N-terminal domain of clathrin heavy chain (92.60%) and            
vacuolar sorting proteins VPS11 (91.64%), VPS41 (91.11%) and VPS18 (90.86%).          
These three particular VPS proteins have all been shown to interact with MON1B in              
Homo sapiens​ ​(Poteryaev et al. 2010)​. 
 
1.5 Lysosomes and WDR98 in Disease  
 
RAS activation due to missense mutations enables the acquisition of oncogenicity           
and has been cited as a regulator of RAB5 with the ability to upregulate              
RAB5-dependent endocytosis (Balaji ​et al. 2012). This can be beneficial to cancer            
16 
 cells in numerous ways, including the endocytosis and subsequent lysosomal          
degradation of E-cadherin, occludin and claudin, facilitating the destruction of          
adherens and tight junctions, which in turn promotes epithelial-mesenchymal         
transition and eventually metastasis (Mellman and Yarden 2013). Lysosomal         
proteins have also been implicated in cancer, including the overexpression and           
presence of LAMP-1 and -2 in the epithelium of metastatic colorectal tissue            
according to immunohistochemistry analysis (Furuta ​et al. 2001) and increased          
activation of vacuolar ATPase - promoting an acidic tumour microenvironment and           
destruction of the extracellular matrix, also enabling tumour progression (Hernandez          
et al. ​2012). The lysosome is an emerging cancer therapeutic target and this has              
been identified as a possible strategy to overcoming cancer drug resistance (Piao            
and Amaravadi 2016).  
 
WDR98 also has disease relevance, as various research groups have linked it to             
cancer (Delgado ​et al. 2014, Jones ​et al. 2016) with overexpression in a range of               
cancers, including thyroid, non-small cell lung, colorectal, melanoma and pancreatic          
(Kimmelman ​et al. 2008, Doebele ​et al. 2017). Delgado ​et al. (2014) classified             
WDR98 as an oncogenic open reading frame and found homozygous mutations in a             
range of tumours. Jones ​et al. (2016) used multiplex targeted mass spectrometry to             
identify WDR98 as a potential plasma-based protein marker for colorectal cancer           
detection. Doebele ​et al. (2017) discovered WDR98-NTRK1 (TrkA receptor tyrosine          
kinase, which has important roles in nervous system development and regulates cell            
proliferation, differentiation and apoptosis and neuronal survival) fusion genes in a           
wide range of cancers. They argue this could be used as a biomarker to identify               
suitable chemotherapeutic treatments and predict response, for example, to RTK          
inhibitors. Kimmelman ​et al. (2008) observed genetic anomalies in the 18q11           
amplicon (a 2Mb span containing WDR98) across multiple tumour types. They           
knocked down WDR98 in cells cultured from pancreatic ductal adenocarcinomas          
and observed reduced colony formation ​in vitro. ​Kimmelman ​et al. argued for the             
need to characterise this gene given its likelihood as a ‘putative PDAC oncogene’. 
 
Considering the context of WDR98 - its likely function in the endosomal-lysosomal            
system, interaction with essential proteins of this pathway and localisation to the            
lysosome - it is plausible to explore the possibility of WDR98 as another cancer drug               
target.  
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1.6 Model Systems  
 
The primary model systems used throughout this study are normal rat kidney (NRK)             
cells. These were chosen due to their diploid nature and thin, flat appearance             
allowing detailed lysosome visualisation via immunofluorescence microscopy.       
Additional HeLa cell lines were occasionally used, including a previously-produced          
MYC-MON1B inducible expression line and newly-produced pcDNA5       
MYC-GFP-humanWDR98 line in an attempt to achieve a stable cell line expressing            
GFP-tagged WDR98. Some preliminary work was undertaken in ​Drosophila         
melanogaster and ​Xenopus laevis which is not reported here due to a lack of              
biological replicates.  
 
1.7 Aims and Objectives  
 
Given that WDR98 reportedly binds to essential components of the          
endosomal-lysosomal pathway and has a potential role in        
lysosomal/autophagosomal biology, there is great cause for investigating its         
function, magnified by its possible association with cancer. Therefore the aims of            
this project are to characterise the novel protein ‘WDR98’ and to probe its function in               
the wider context of lysosome biology.  
 
In order to achieve this, the following experimental objectives have been defined: 
 
1. To produce a variety of constructs to enable characterisation of WDR98,           
including GFP-WDR98 and GST-WDR98 (Chapter 3)  
2. To produce an antibody to WDR98 (Chapter 3)  
3. To assess the protein-protein interactions in which WDR98 participates         
(Chapter 4)  
4. To assess where WDR98 localises in the cell (Chapter 5)  
 
A range of techniques were used to these ends, including yeast 2 hybrid,             
immunoprecipitations, pulldowns and immunofluorescence. Concurrently, similar      
work was being carried out by labs in Harvard (Pontano Vaites ​et al. 2017) and               
Stanford (Tsui ​et al. 2019) universities, and many of our results corroborate with             
18 
 their data. The novelty of our work comprises that surrounding the WDR98            
individual domain data, which has yet to be published by any group.  
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 Chapter 2: Materials and Methods  
 
2.1 Materials  
 
2.1.1 Antibodies 
 
Details of antibodies used are listed in Table 1.  
 
Table 1. Details of Antibodies 
W.B; western blot, IF; immunofluorescence, IgG; immunoglobulin G, AF; Alexa Fluor, HRP;            
horseradish peroxidase.  
 
Primary Antibodies 
 
Cat. No. Source Target Host Species W.B Dilution IF Dilution 
sc-28365 Santa Cruz Biotech APP Mouse 1 : 100 - 
sc-28365 Santa Cruz Biotech Beta-Amyloid Mouse 1 : 100 - 
sc-514290 Santa Cruz Biotech CCZ1 Mouse 1 : 500 1 : 100 
ab137276 Abcam C18orf8 Rabbit 1 : 200 - 
ab78596 Abcam C18orf8 Goat 1 : 1000 - 
20111-1-AP Proteintech C18orf8 Rabbit 1 : 1000 - 
sc-390305 Santa Cruz Biotech C18orf8 Mouse 1 : 100 - 
PA521004 Invitrogen  AFP Mouse - 1 : 200 
- Pryor Lab GFP Rabbit 1 : 500 1 : 200 
- Pryor Lab GST Rabbit 1 : 500 - 
sc-133225 Santa Cruz Biotech HDAC5 Mouse 1 : 100 - 
2366 Cell Signaling HIS Mouse 1 : 200 - 
sc-101494 Santa Cruz Biotech HSP90 Mouse 1 :100 - 
LC3-5F10 Nanotools LC3 Rabbit - 1 : 100 
Gift Cambridge LGP120 Mouse - 1 : 200 
- Pryor Lab MYC Mouse 1 : 200 1 : 100 
20 
 3547 Cell Signaling RAB5 Rabbit - 1 : 100 
9367 Cell Signaling RAB7 Rabbit - 1 : 100 
ab134064 Abcam STUB1 Rabbit 1 : 10000 - 
A Eurogentec WDR98 Rabbit 1 : 500 1 : 100 
B Eurogentec WDR98 Rabbit 1 : 500 1 : 100 
 
Secondary Antibodies 
Cat. No. Source Antigen Label W.B Dilution IF Dilution 
A11056 Life Technologies α-Goat IgG AF 546 - 1 : 300 
A150113 Life Technologies α-Mouse IgG AF 488 - 1 : 300 
A21424 Life Technologies α-Mouse IgG AF 555 - 1 : 300 
A21429 Life Technologies α-Rabbit IgG AF 555 - 1 : 300 
A9169 Sigma Aldrich α-Rabbit IgG HRP 1 : 8000 - 
AP186P Sigma Aldrich α-Goat IgG HRP 1 : 8000 - 
AP130P Sigma Aldrich α-Mouse IgG HRP 1 : 8000 - 
 
2.2 Methodology 
 
Note: room temperature (RT) ranged from 17 - 23 °C. 
 
2.2.1 General Polymerase Chain Reaction (PCR) 
 
All PCRs were performed in a Bio-Rad PTC-200 DNA engine cycler. Optimised            
PCR parameters are displayed in Table 2.  
 
 
 
 
 
 
 
 
21 
 Table 2. PCR Reaction Parameters 
Three different enzymes with individual protocols were utilised: HiFi premix (Clontech), Pfu            
(Promega), Phusion (Thermo Fisher). The reagents required and temperature parameters          
for the reactions are detailed in the Table below.  
 
 HiFi Pfu Phusion 
Water to 20 µl to 50 µl to 25 µl 
Buffer - 5 µl 4 µl 
dNTPs (10 mM) 1 µl 0.5 µl 1 µl 
Primers (10 µM) 1 µl each 2.5 µl each 1 µl each 
DMSO 2.5 µl - 0.6 µl 
DNA Template variable variable variable 
Polymerase 12.5 µl premix 0.5 µl 0.2 µl 
    
 HiFi Pfu Phusion 
Initial 
Denaturation 98°C 10 sec 95°C 2 min 98°C 30 sec 
Denaturation 98°C 10 sec 95 °C 45 sec 98°C 10 sec 
Annealing 
Tm - 5°C 15    
sec 
Tm - 5°C 30    
sec 
Tm - 5°C 30    
sec 
Extension 72°C 1 min/kb 72°C 2 min/kb 72°C 15 sec/kb 
Cycles 30 30 30 
Final Extension 72°C 10 min 72°C 10 min 72°C 10 min 
Final Hold 4°C 4°C 4°C 
 
2.2.2 QuickChange PCR  
 
Primers were designed to insert desired codon into target region of gene, one being              
the reverse complement of the other. PCR mastermix was prepared as follows: 37.5             
µl ddH​2​O, 5 µl 10X Pfu buffer + MgCl​2​, 0.5 µl 10 mM dNTPs, 2.5 µl 10 µM primers,                   
0.5 µl Pfu and DNA template at variable amounts. A control PCR was run for each                
set of primers without the Pfu enzyme present to check for amplification. The             
reaction parameters were as follows: 95 °C for 2 minutes, 95 °C for 45 seconds, Tm                
- 5 °C 30 seconds, 72 °C 2 minutes per kb (11 total cycles), 72 °C for 10 minutes,                   
kept at 4 °C.  
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 2.2.3 DNA Electrophoresis and Purification 
 
Agarose gels were made by dissolving 60 g agarose in 75 ml TAE buffer (40 mM                
Tris, 20 mM acetic acid, 0.5 mM EDTA, pH 8 in 1 L ddH​2​O) in a microwave and                  
returning the volume to 75 ml using ddH​2​O. SYBR Safe (Invitrogen) was added at              
1:10,000 and mixed. DNA was electrophoresed at 60 V for 1 hour and visualised              
using a blue lightbox. Images captured via Syngene gel imager and UGenius            
software.  
 
 
DNA was purified from gel slices using the Qiagen Gel Purification kit as per              
manufacturer’s instructions with the following modifications: 600 µl Buffer QC used           
to dissolve the gel slice with 200 µl isopropanol added following dissolution.  
 
2.2.4 DNA Restriction Digests  
 
Restriction digests were performed using 4 µl 10X KGB buffer (1 M glutamic acid,              
250 mM Tris acetate pH 7.6, 100 mM magnesium acetate, 0.5 mg/ml bovine serum              
albumin, 5 mM β-mercaptoethanol), 4 µl vector (~ 1 µg), 2 µl appropriate restriction              
enzyme and 30 µl ddH​2​O incubated at 37 °C for 45 minutes. Digested products and               
undigested controls were analysed by DNA electrophoresis and DNA gel-purified. 
 
2.2.5 Bacterial Transformation and DNA Extractions 
 
DNA was inserted into the vector by combining 2 µl InFusion Enzyme Mix (5X)              
(Takara), ~ 100 ng vector DNA and ~ 50 ng insert DNA. The mixture was vortexed                
and incubated at 50 ºC for 15 minutes. 2 µl InFusion reaction mixture was added to                
50 µl stellar competent cells (Takara) and incubated on ice for 10 minutes, heat              
shocked at 42 ºC for 1 minute and incubated on ice for 2 minutes. 250 µl SOC                 
media (Takara) was added and cells recovered at 37 ºC for 1 hour with shaking.               
Cells were centrifuged at 3500 rpm (​Rotor FA-45-18-11​) for 2 minutes, resuspended            
in the media meniscus and plated onto an antibiotic-selective plate.  
 
Plasmid Minipreps from Bacteria:  
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 DNA plasmids were extracted from 5 ml overnight cultures containing the relevant            
antibiotic using the Qiagen MiniPrep kit as per the manufacturer's instructions.  
 
Plasmid Midipreps from Bacteria: 
DNA plasmids were extracted from 50 ml overnight cultures containing the relevant            
antibiotic using the Qiagen MidiPrep kit as per the manufacturer’s instructions.  
 
Wizard Minipreps from NRK Cells: 
1 x T25 flask NRK cells were lysed and DNA extracted using the Promega Wizard               
Miniprep kit as per the manufacturer’s instructions. 
 
DNA samples were sent to either Source Bioscience or Eurofins GATC for            
sequencing analysis and prepared according to the company’s instructions.  
 
2.2.6 Recombinant Protein Production 
 
E. coli (BL21 DE3 pLysS) were transformed with plasmids encoding either GST- or             
HIS​6​-tagged proteins as appropriate. Bacteria were grown in 2 x 600 ml of LB or               
2TY broth as follows: 7.5 ml of LB (plus the appropriate selective antibiotics) was              
inoculated with a single bacterial colony and grown overnight at 37 ºC with shaking.              
The next day, starter cultures were diluted 1:500 into a total volume of 600 ml LB or                 
2TY broth, and grown at 37 ºC until an OD​600 of 0.6 - 2.0 was obtained. Protein                 
production was induced with IPTG to a final concentration of 0.2 mM, and cultures              
grown for a further 4 h. The bacteria were pelleted at ​2,645 x g for 15 minutes at 4                   
ºC. The cell pellet was resuspended in 10 ml of bacterial lysis buffer (1 % (v/v)                
Triton X-100, 1 mg/ml lysozyme, 2 mM MgCl​2​, 1 U/ml DNAse, in PBS) with protease               
inhibitors (Roche), and frozen at -20 ºC overnight. The cell pellet was defrosted on              
ice and centrifuged at ​47,800 x g in a Sorvall SS34 rotor for 20 minutes at 4 ºC. For                   
GST fusion proteins, the supernatant was incubated with 1 ml (packed volume) of             
glutathione sepharose (GE healthcare) for 1 h at 4 ºC with gentle rotation. The              
sepharose beads were then collected and washed with 3 x 20 ml of wash buffer (1                
% (v/v) Triton X-100 in PBS). GST/GST-fusion proteins were eluted with 20 ml             
elution buffer (50 mM Tris, pH 8.0, 10 mM reduced glutathione). These fractions             
were then analysed by SDS-PAGE. The eluted proteins were then pooled and            
dialysed extensively into PBS at 4 ºC for 2 days and stored at -20 ºC until needed.                 
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 For the purification of HIS​6​-tagged proteins, cell pellets were processed as above.            
The soluble supernatant was incubated with 134 µl (packed volume) of HIS-Select            
resin (Sigma) for 1-2 h at 4 ºC with gentle rotation. The beads were washed with 3 x                  
20 ml wash buffer (10 mM imidazole, 0.3 M NaCl, 50 mM Na​2​HPO​4​, pH8.0).              
Proteins were eluted with 20 ml elution buffer (250 mM imidazole, 0.3 M NaCl, 50               
mM Na​2​HPO​4​, pH 8.0) and 1 ml fractions collected. Fractions were analysed by             
SDS-PAGE. The eluted proteins were then pooled and dialysed extensively into           
PBS at 4 ºC for 2 days and stored at -20 ºC until needed.  
 
2.2.7 Mammalian Cell Culture  
 
All cells were cultured in Dulbecco’s modified eagle’s medium (DMEM)          
supplemented with 10 % (v/v) FBS, 2 mM glutamine and 1 % (v/v)             
penicillin-streptomycin (10 U/ml and 10 μg/ml respectively) in a humidified 5 % CO​2             
atmosphere at 37 ºC, unless otherwise stated. Flp-In HeLa cells were a kind gift              
from Prof. M. Lowe (University of Manchester) and isogenic cell lines expressing            
either GFP or GFP-WDR98 protein were made by cloning genes into           
pcDNA5/FRT/TO and transfecting cells with this vector along with pOG44.          
Transfected Flp-In HeLa cells were selected with 50 µg/ml Hygromycin B (Roche)            
and protein expression was induced with 1 µg/ml doxycycline for 24h. 
 
2.2.8 Mammalian Cell Transfection 
 
Transfection reagents were combined with DNA in the ratios 20 µl X-tremeGENE            
HP (Sigma Aldrich) to 10 µg DNA made up to 1 ml total with OptiMEM (Gibco) to 1                  
µg DNA and incubated at RT for 20 minutes then added to cells that were split the                 
day prior to obtain confluency of 80-90%.  
 
2.2.9 CRISPR/Cas9 knockouts  
 
An NRK CRISPR/Cas9 knockout protocol was optimised to the following:          
DharmaFect solution (DFS) was produced with 10 µl DharmaFect (Dharmacon) and           
490 µl Dulbecco’s serum-free media (SFM) (Gibco), incubated at room temperature           
(RT) for 5 minutes. The transfection mixture contained: 210 µl SFM, 3 x 5 µl crRNA                
with distinct targeting sites (Dharmacon), 15 µl trRNA (Dharmacon), 3 µg Cas9            
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 plasmid (Dharmacon) and 300 µl DFS, incubated at RT for 20 minutes before being              
added to cells containing 2.4 ml DMEM per well of a 6-well plate and cells at ~60%                 
confluency, passaged the day prior.  
 
Cells were incubated overnight at 37 °C in 5% CO​2 before seeding into larger dishes               
for selection of single colonies. The following day puromycin was added to a final              
concentration of 50 µg/ml. Once single colonies were established, cells were           
washed with PBS and colonies isolated with sterile pipette tips following           
trypsinisation. These were then transferred to a 24-well plate containing DMEM and            
puromycin and cultured for analyses.  
 
2.2.10 Detergent Soluble Lysates 
 
Tissue culture cells were washed with Dulbecco’s phosphate buffered saline (PBS)           
(Sigma) and scraped into ice-cold cell lysis buffer (150 mM NaCl, 20 mM Tris-HCl              
pH 8.0, 2 mM EDTA, 0.5% (v/v) NP-40 with EDTA-free protease inhibitors (Roche)).             
The lysate was incubated at 4°C, 15 minutes and centrifuged at 16,000 x g, 10               
minutes at 4 °C.  
 
2.2.11 Protein Quantification Assay 
 
BSA protein stock solution was prepared at 2 mg/ml. 100 µl BSA solution was              
diluted 1:1 with 0.2 M NaOH and used to set up a standard curve in duplicate with                 
BSA 1 mg/ml ranging from 0 - 10 µl and 0.1 M NaOH ranging from 10 - 0 µl in order                     
to make the total volume 10 µl per well of a 96 well plate. Protein samples to                 
measure were diluted in water, if necessary, at increasing ratios and 5 µl each              
sample added to 5 µl 0.2 M NaOH in duplicate. BCA reagent and CuSO​4 were               
combined in the ratio 50:1 and 200 µl this reagent was added to all wells requiring                
quantification. Plates were incubated at 37 °C for 30 minutes. Absorbancce           
measurements were taken at 560 nm using a Thermo Multiscan GO plate reader to              
produce a standard curve and subsequently calculate the protein concentration of           
the sample(s).  
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 2.2.12 Antibody Coupling 
 
Amino-link beads (Pierce) were centrifuged and washed 3 x 500 µl PBS. 1 µg GFP               
nanobody was covalently coupled to 1 µl packed volume Amino-link beads via            
addition of 3 µl 5 M NaCNBH​4 per 200 µl total volume. The suspension was mixed                
by rotating at 4 °C for 2 hours, beads were pelleted and washed 3 x 500 µl 1 M Tris                    
pH 8.0. 500 µl 1 M Tris and 3 µl 5 M NaCNBH​4 was added per 200 µl total volume.                    
The suspension was mixed by rotating at 4 °C for 15 minutes and washed 3 x 500 µl                  
PBS, followed by 6 x 1 M NaCl and 6 x 500 µl PBS. Beads were stored at 4 °C as a                      
50% packed bead slurry in PBS.  
 
2.2.13 Immunoprecipitation 
 
Transfected cells and untransfected controls were washed with ice cold PBS and            
lysates were produced. Protein quantification assay was used to estimate protein           
concentration which was normalised across samples. 8 µl bead slurry was added            
per 100 µg lysate and the suspension was rotated at 4 °C for 2 hours. Beads were                 
washed 5 x 500 µl lysis buffer using Spin-X 0.45 µm cellulose acetate 8163 filter               
cups (Corning Costar), and centrifuged at 3000 rpm for 1 minute (​Rotor            
FA-45-18-11​). 100 µl IgG elution buffer (Pierce) was added and beads centrifuged            
at 3000 rpm for 1 minute (​Rotor FA-45-18-11​). 100 µl IgG elution buffer was again               
added and incubated at RT for 10 minutes before centrifugation at 3000 rpm for 1               
minute (​Rotor FA-45-18-11​). Samples were concentrated for 45 minutes using a           
vacuum pump.  
 
2.2.14 RAB Nucleotide Loading 
 
RAB proteins were diluted to 1 mg/ml in exchange buffer (20 mM Tris-HCl pH 7.5, 1                
mM EDTA, 250 mM (NH​4​)​2​SO​4​, 1 mM dithiothreitol, 0.05 mM NP-40) and the             
solution adjusted to 5 mM EDTA and 250 mM (NH​4​)​2​SO​4​. Each 1 ml solution was               
incubated with 33 units alkaline phosphatase beads with mixing by rotation for 15             
minutes at RT. 250 µM GMPPNP and 33 units alkaline phosphatase beads were             
added to each solution and incubated with mixing by rotation for 30 minutes at RT.               
Beads were washed 2 x 500 µl exchange buffer using Spin-X 0.45 µm cellulose              
acetate 8163 filter cups (Corning Costar), and centrifuged at 3000 rpm for 1 minute              
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 (​Rotor FA-45-18-11​). Flow throughs were pooled and divided equally into 3 tubes            
per Rab. Each tube was made up to 2 ml with exchange buffer and GMPPNP / GDP                 
/ GTP was added to 500 µM. Solutions were concentrated using Amicon Ultra             
Centrifugal Tubes at 3000 rpm for 30 minutes at 4°C (​Rotor FA-45-18-11​). 2 ml              
loading buffer (20 mM Tris-HCl pH 7.5, 5 mM MgCl​2​, 1 mM EDTA, 50 mM NaCl, 1                 
mM dithiothreitol, 0.05 mM NP-40) was added to each tube with 200 µM nucleotide.              
Solutions were concentrated using Amicon Ultra Centrifugal Tubes at 3000 rpm for            
30 minutes at 4 °C (​Rotor FA-45-18-11​) and the final step repeated. Each solution              
was then made up to 1 ml with loading buffer and stored at -80 °C.  
 
2.2.15 Pulldowns 
 
6 µg bait protein was combined with 6 µg prey protein and incubated in 500 µl                
pulldown buffer for 1 hour with mixing by rotation at 4 °C. Glutathione sepharose              
was washed 3 x 500 µl pulldown buffer and 20 µl unpacked pellet added to solutions                
and incubated for 1 hour with mixing by rotation at 4 °C. Beads were washed 3 x                 
500 µl pulldown buffer using Spin-X 0.45 µm cellulose acetate 8163 filter cups             
(Corning Costar), and centrifuged at 3000 rpm for 1 minute (​Rotor FA-45-18-11​). 40             
µl 95 °C Laemmli sample buffer (3X stock: 188 mM Tris pH 6.8, 6% (w/v) SDS, 30%                 
(v/v) glycerol, 0.03% (w/v) Bromophenol blue, ​10% (v/v) β-mercaptoethanol) was          
added to the beads and incubated at 95 °C for 5 minutes. Samples were analysed               
using SDS-PAGE and western blotting. Pulldown buffers consisted of loading buffer           
with slightly different compositions, including 50 mM Tris-HCl pH 7.5 / pH 6, 150-300              
mM NaCl, 1-2% (v/v) NP-40, 1-2% (v/v) Tween-20, 1-2% (w/v) PEG 4000. 
 
2.2.16 PLATE Transformation of Yeast 
 
Transformed bacterial stocks were plated onto selective agar plates and cultured           
overnight at 37 °C. Single colonies were selected to Miniprep. Yeast strains were             
grown overnight in 5 ml YPD (yeast extract peptone dextrose, 1% (w/v) yeast             
extract, 2% (w/v) peptone, 2% (w/v) dextrose) in 50 ml tubes at 30 °C with agitation.                
Cultures were divided into 500 µl aliquots, centrifuged at 6,000 rpm (​Rotor            
FA-45-18-11​), for 1 minute and the supernatant removed. Pellets were resuspended           
with 20 µl ice-cold salmon sperm ssDNA and 20 µl of miniprep plasmid DNA.              
Following incubation at RT for 15 minutes, 250 µl PLATE solution (1 ml 10X TE, 1                
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 ml 1M LiOAc, 8 ml 50% (w/v) PEG 4000) was added to the yeast and the yeast                 
were further incubated overnight at 30 °C without agitation. Cells were heat-shocked            
at 42 °C, 15 minutes before centrifuging at 6,000 rpm (​Rotor FA-45-18-11​), for 1              
minute and removing PLATE solution. 400 µl YPD was added and incubated at 30              
°C for 1-4 hours. The yeast were then pelleted by centrifugation at 6,000 rpm (​Rotor               
FA-45-18-11​), for 1 minute then resuspended in 200 µl ddH​2​O and 100 µl plated              
onto selective plates (pGAD vectors onto SD-leu agar and pGBDU onto SD-ura            
agar) and incubated at 30 °C until transformants could be picked.  
 
2.2.17 Yeast 2 Hybrid 
 
Yeast were plated out onto selective SD-leu/-ura plates and incubated at 30 °C for              
48 hours. Yeast were replica plated onto YPD plates using sterile velvets so that              
pGAD vectors with inserts were mated with each pGBDU. Yeast were allowed to             
mate for 48 h at 30 ºC. YPD plates were replica plated onto SD-leu, -ura plates and                 
incubated at 30°C for 48 hours. Using a blunt-ended sterile cocktail stick, grown             
yeast from cross-sections were mixed into sterile water and 5 µl pipetted onto new              
SD-leu -ura plates and incubated at 30 °C for 48 hours. SD-leu -ura plates were               
replica plated onto SD-leu -ura -ade and incubated at 30 °C until growth observed.  
 
2.2.18 SDS PAGE 
 
Laemmli sample buffer (3X stock: 188 mM Tris pH 6.8, 6% (w/v) SDS, 30% (v/v)               
glycerol, 0.03% (w/v) Bromophenol blue, ​10% (v/v) β-mercaptoethanol) was added          
to 20 µl lysate samples followed by incubation at 95 °C for 5 minutes. Samples were                
resolved by gel electrophoresis using discontinuous polyacrylamide gels during         
which samples move through a stacking gel initially and are separated on a lower              
resolving gel, using the Bio-Rad minigel apparatus. Resolving gels were made with            
7% (v/v) acrylamide (Protogel, National Diagnostics) using 2.5 ml resolving gel           
buffer (final concentration 0.375 M Tris-HCl ph 8.8, 0.2% (w/v) SDS), 6.1 ml ddH​2​O,              
50 µl 10% (w/v) ammonium persulfate (APS) and 5 µl TEMED. Gels were sealed              
with isopropanol. Stacking gels were made with 4% (v/v) acrylamide, 2.5 ml stacking             
gel buffer (final concentration 0.125 M Tris-HCl Ph 6.8, 0.2% (w/v) SDS), 50 µl 10%               
(w/v) APS and 10 µl TEMED. A protein ladder (Precision Plus Kaleidoscope ladder,             
Bio-Rad) was added to the gel along with samples and gel electrophoresis was             
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 performed at 200 V in SDS running buffer (25 mM Tris, 0.1% (w/v) SDS, 192 mM                
glycine) until bromophenol dye had eluted from the gel.  
 
2.2.19 Western Blotting 
 
Proteins were transferred onto nitrocellulose membranes using the iBlot system          
(Invitrogen) as per manufacturer’s instructions. Membranes were blocked in 5%          
(w/v) semi-skimmed milk in TBS-Tween (TBST) (100 mM NaCl, to mM Tris-HCl pH             
7.4, 0.1% (v/v) Tween-20), 30 minutes with agitation. Membranes were incubated           
with primary antibodies in 5% (w/v) milk TBST, 1 hour with agitation, followed by 3 x                
5 minute TBST washes. Membranes were incubated with horseradish peroxidase          
conjugated secondary antibodies in 5% (w/v) milk TBST, 30 minutes with agitation.            
TBST washes were repeated and proteins were visualised using ECL reagent           
(Amersham).  
 
2.2.20 Mass Spectrometry Sample Preparation 
 
Samples were dried in a vacuum concentrator then solubilised in NuPAGE LDS            
sample buffer (Life Technologies) with heating at 70 °C for 10 minutes before             
running into a 7 cm NuPAGE Novex 10% (w/v) Bis-Tris gel (Life Technologies) at              
200 V for 6 minutes. Gels were stained with SafeBLUE protein stain (NBS             
Biologicals) for 1 hour before destaining with ultrapure water for 1 hour. In-gel tryptic              
digestion was performed after reduction with dithioerythritol and        
S-carbamidomethylation with iodoacetamide. Gel pieces were washed two times         
with aqueous 50% (v/v) acetonitrile containing 25 mM ammonium bicarbonate, then           
once with acetonitrile and dried in a vacuum concentrator for 20 minutes. Gel             
pieces were rehydrated by adding 0.5 μg of sequencing-grade, modified porcine           
trypsin (Promega) in 200 μl of aqueous 25 mM ammonium bicarbonate. Digests            
were incubated overnight at 37 °C. Peptides were extracted by washing three times             
with aqueous 50% (v/v) acetonitrile containing 0.1% (v/v) trifluoroacetic acid, before           
drying in a vacuum concentrator and reconstituting in aqueous 0.1% (v/v)           
trifluoroacetic acid.  
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 2.2.21 Liquid Chromatography Mass Spectrometry  
 
Samples were loaded onto an UltiMate 3000 RSLCnano HPLC system (Thermo)           
equipped with a PepMap 100 Å C18, 5 µm trap column (300 µm x 5 mm Thermo)                 
and a PepMap, 2 µm, 100 Å, C18 EasyNano nanocapillary column (75 μm x 150               
mm, Thermo). The trap wash solvent was aqueous 0.05% (v/v) trifluoroacetic acid            
and the trapping flow rate was 15 µl/minute. The trap was washed for 3 minutes               
before switching flow to the capillary column. Separation used gradient elution of            
two solvents: solvent A, aqueous 1% (v/v) formic acid; solvent B, aqueous 80% (v/v)              
acetonitrile containing 1% (v/v) formic acid. The flow rate for the capillary column             
was 300 nl/minute. Column temperature was 40 °C and the gradient profile was:             
linear 3-10% B over 15 minutes, linear 10-35% B over 108 minutes, linear 35-65% B               
over 30 minutes, linear 65-99% B over 7 minutes then proceeded to wash with 99%               
solvent B for 4 minutes. The column was returned to initial conditions and             
re-equilibrated for 15 minutes before subsequent injections. The nanoLC system          
was interfaced with an Orbitrap Fusion hybrid mass spectrometer (Thermo) with an            
EasyNano ionisation source (Thermo). Positive ESI-MS and MS2 spectra were          
acquired using Xcalibur software (version 4.0, Thermo). Instrument source settings          
were: ion spray voltage, 1,900 V; sweep gas, 0 Arb; ion transfer tube temperature;              
275 °C. MS1 spectra were acquired in the Orbitrap with: 120 K resolution, scan              
range: m/z 375-1,500; AGC target, 4e5; maximum fill time, 100 ms. Data dependent             
acquisition was performed in top speed mode using a 1 s cycle, selecting the most               
intense precursors with charge states +2 to +5. Dynamic exclusion was performed            
for 50 s post precursor selection and a minimum threshold for fragmentation was set              
at 5e3. MS2 spectra were acquired in the linear ion trap with: scan rate, turbo;               
quadrupole isolation, 1.6 m/z; activation type, HCD; activation energy: 32%; AGC           
target, 5e3; first mass, 110 m/z; maximum fill time, 100 ms. Acquisitions were             
arranged by Xcalibur to inject ions for all available parallelizable time. 
 
2.2.22 Mass Spectrometry Data Analysis 
 
Peak lists were converted from .raw to .mgf format using Mascot Distiller (version 5,              
Matrix science), stipulating a minimum signal to noise ratio of 2 and correlation             
(Rho) of 0.6, before submitting to a locally-running copy of the Mascot program             
using Mascot Daemon (version 2.5.1, Matrix Science). Data were searched against           
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 the ​Rattus norvegicus subset of the UniProt database (21,353 entries, date           
20160909) specifying: Enzyme, trypsin; Max missed cleavages, 2; Fixed         
modifications, Carbamidomethyl (C); Variable modifications, Oxidation (M),       
Deamidated (NQ); Peptide tolerance, 5 ppm; MS/MS tolerance, 0.5 Da; Instrument,           
ESI-TRAP. Peak Lists were also searched against the same database using X!            
Tandem (The GPM, thegpm.org; version CYCLONE (2010.12.01.1)), with specified         
variable modifications increased to include: Glu/Gln->pyro-Glu (N-term) and        
ammonia-loss (N-term). Search results were combined and validated using Scaffold          
(version 4.8.4, Proteome Software Inc.). Protein identifications were accepted if they           
could be established at >99.0% probability to achieve a FDR <1.0% and contained             
at least 2 identified peptides. Protein probabilities were assigned by the Protein            
Prophet algorithm (Nesvizhskii ​et al. 2003). Proteins containing similar peptides that           
could not be differentiated based on MS2 analysis alone were grouped to satisfy the              
principles of parsimony. Proteins sharing significant peptide evidence were grouped          
into clusters. Proteins were annotated with GO terms from goa_uniprot_all.gaf          
(downloaded 12-Oct-2016) (Ashburner ​et al. 2000). Relative protein quantification         
was performed by spectral counting analogous to (Dowle, A et al. J. Prot. Res.              
2016; 15, 3550−3562). Significant differences were calculated using Fisher’s exact          
test with Hochberg and Benjamini multiple test correction applied. 
 
2.2.23 Immunofluorescence 
 
Cells were rinsed with PBS and fixed: 
 
Methanol fixation: cells were incubated in ice-cold methanol at -20 °C for 5 minutes              
before methanol aspiration. 
Formaldehyde fixation: cells were incubated in 4% (v/v) paraformaldehyde in PBS,           
20 minutes at RT, followed by paraformaldehyde aspiration and incubation in 50 mM             
NH​4​Cl in PBS, 10 minutes, before aspiration. Cells were permeabilised in 0.2% (w/v)             
BSA, 0.05% (v/v) saponin in PBS, 10 minutes; all following washes and antibody             
dilutions were performed in BSA-Saponin-PBS (BSP). For cytosol extraction before          
fixation, cells were rinsed with cytosol extraction buffer (CEB) (25 mM HEPES-KOH            
pH 7.4, 25 mM KCl, 2.5 mM magnesium acetate, 5 mM EGTA (sodium free), 150               
mM potassium glutamate) and incubated in CEB 0.05% (w/v) saponin, 1 minute,            
followed by paraformaldehyde fixation.  
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Coverslips were incubated in primary antibody diluted in BSP, 1 hour at RT followed              
by 3 x 5 minute BSP washes. Coverslips were incubated in Alexa            
fluorophore-conjugated secondary antibodies in BSP, 30 minutes at RT followed by           
3 x 5 minute BSP washes. Coverslips were rinsed in ddH​2​O and mounted onto              
slides with MOVIOL 4-88.  
 
 
Slides were imaged using Zeiss LSM 880 Axio Observer.Z1 inverted confocal laser            
microscope, 63x lens running Zen version 2.3 software. Image processing was           
completed using FIJI software (Schindelin ​et al.​ 2012).  
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 Chapter 3: Identifying and Characterising WDR98  
 
3.1 Introduction  
 
To begin this study, all relevant publications and databases were mined for current             
information on WDR98. Commercially available reagents were assessed and a          
variety of constructs and cell lines produced to develop the tools necessary to begin              
establishing the characteristics of WDR98. Pre-existing data was accumulated,         
including identification of WDR98 as lysosomal in a large scale human placental            
proteomic analysis (Schroder ​et al. 2007); as a regulator of autophagy whereby            
WDR98 knockdown increased autophagic flux (Lipinski ​et al. 2010), and reportedly           
interacting with RAB5 (Gillingham ​et al. 2014) and FYCO1 (Behrends ​et al. 2010),             
both of which are involved in the lysosomal-autophagy systems. Considering this, it            
seemed to suggest that the Pryor lab pilot data, which indicated WDR98 interacted             
with CCZ1 and MON1B, was plausible. Furthermore, HHPred protein structural          
prediction software (Soding ​et al. 2005) was used to identify proteins with similar             
structures based on amino acid sequence. The outcomes of this analysis were high             
degrees of structural similarity between WDR98 and the N-terminal domain of           
clathrin heavy chain (92.6%) and vacuolar sorting proteins VPS11 (91.64%), VPS41           
(91.11%) and VPS18 (90.86%). These three particular VPS proteins have all been            
shown to interact with MON1B ​(Poteryaev et al. 2010)​. This information again            
suggested that looking to characterise WDR98 in the context of lysosome biology            
was a worthwhile avenue of exploration.  
 
In order to achieve the project aims of characterising WDR98 and to begin to              
understand its function a variety of constructs were produced. This included           
GFP-WDR98, for immunoprecipitations and immunofluorescence microscopy,      
WDR98-HIS for Rab pulldowns and GST-WDR98 for antibody production. The latter           
being deemed necessary following commercial antibody characterisation which        
revealed no WDR98-appropriate results, as will be discussed later in this chapter.  
 
Cell lines were also produced in an attempt to generate permanent tools to study              
the inducible overexpression of WDR98 in a stable line. The generation and            
characterisation of these cell lines will also be discussed.  
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 CRISPR/Cas9 was also utilised extensively with the aim of obtaining a           
WDR98-knockout NRK cell line, however, the best result was a heterozygous           
knockout which displayed no distinct phenotype from wild type NRK cells.  
 
Phylogenetic analysis of the conservation of WDR98 amino acid sequences          
between a wide range of species, both animal and plant, was carried out to              
determine the extent to which WDR98 was conserved, and from this to infer whether              
function was likely similar and how important it was biologically.  
 
Overall, this chapter will discuss the attempts made to generate useful experimental            
tools and their characterisation, and the compilation of data already available. This            
will both inform later experiments and begin to build a picture of the role of WDR98                
in the cell.  
 
3.2 Methods  
 
3.2.1 Phylogenetic Analysis  
 
NCBI BLAST (protein-protein BLAST algorithm, Altschul ​et al. 1990) searches were           
performed using the human WDR98 full-length and unique MIC-domain amino acid           
sequences and subsequently identified sequences from species of decreasing         
complexity. Cladograms were compiled using Clustal X (Larkin ​et al. 2007) to align             
the sequences found across varying species and prepare phylogenetic trees.          
FigTree was used in their manipulation and Figure production.  
 
3.2.2 Commercial Antibody Characterisation  
 
Commercially-available antibodies to WDR98 were characterised using both NRK         
and HeLa cell lysates, with and without GFP-WDR98 transfections, by western           
blotting (Methods 2.2.18-19).  
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 3.2.3 DNA Construct Production  
 
After it was decided to use NRK as the main experimental model, all constructs              
produced (unless otherwise stated) were done so using the ​Rattus norvegicus           
WDR98 DNA sequence.  
 
3.2.4 Antibody Production and Characterisation  
 
GST-WDR98 protein was produced and purified as described in Methods 2.2.6. This            
protein was then sent to Eurogentec for antibody production using their 87-Day            
Classical Custom Polyclonal Antibody programme.  
 
These commissioned antibodies were characterised via western blotting (Methods         
2.2.18-19) and immunofluorescence (Methods 2.2.23). In some instances,        
antibodies (1:1000) were incubated with 10 ​μg ​GST-WDR98 protein prior to           
antibody incubation with the blot, with the aim of saturating the antibody and             
determining the identity of consistently strong bands.  
 
3.2.5 Cell Line Production  
 
Relevant constructs, pMEP4-MYC-GFP-WDR98 and pcDNA5-GFP-humanWDR98,     
were transfected into NRK cells and Flp-In-HeLa cells, respectively, and selected           
using G418 (pMEP4) and Hygromycin B (pcDNA5) to produce cell lines with            
inducible GFP-WDR98 expression. Expression induction was initiated using        
cadmium (ΔpMEP4) and doxycycline (pcDNA5). The efficacy of these cell lines was            
then assessed by immunofluorescence microscopy (Methods 2.2.23-24).  
 
3.2.6 CRISPR/Cas9  
 
An NRK CRISPR/Cas9 knockout protocol was optimised to the following:          
DharmaFect solution (DFS) was produced with 10 µl DharmaFect (Dharmacon) and           
490 µl Dulbecco’s serum-free media (SFM) (Gibco), incubated at room temperature           
(RT) for 5 minutes. The transfection mixture contained: 210 µl SFM, 3 x 5 µl crRNA                
with distinct targeting sites (Dharmacon), 15 µl trRNA (Dharmacon), 3 µg Cas9            
plasmid (Dharmacon) and 300 µl DFS, incubated at room temperature for 20            
36 
 minutes before being added to cells containing 2.4 ml DMEM per well of a 6-well               
plate and cells at ~60% confluency, passaged the day prior.  
 
Cells were incubated overnight at 37 °C in 5% CO​2 before seeding into larger dishes               
for selection of single colonies. The following day puromycin was added to a final              
concentration of 50 µg/ml. Once single colonies were established, cells were           
washed with PBS and colonies isolated with sterile pipette tips following           
trypsinisation. These were then transferred to a 24-well plate containing DMEM and            
puromycin and cultured for analyses.  
 
Once confluent, cells were transferred to T25 culture flasks and then once            
confluency was achieved again, these cells were lysed and the DNA extracted using             
the Promega Wizard Miniprep kit as per the manufacturer’s instructions. 
 
DNA was sent to either Source Bioscience or Eurofins GATC for sequencing around             
the CRISPR-target sites (appendix A ix). 
 
3.3 Results 
 
3.3.1 Evolutionary Conservation  
 
WDR98 appears very well conserved with 90.68 - 100 % identity match among             
mammals and 24.27 % identity match between ​Homo sapiens ​and ​Arabidopsis           
thaliana​. The source of this commonality lies in the C-terminal MIC domains, which             
appears consistently in all species identified. The range of species in which WDR98             
orthologs have been found is presented in a non-exhaustive cladogram (Figure 4)            
intended to represent the level of WDR98 conservation. Efforts were made to            
identify orthologs in yeast and bacteria, through mining bioinformatics databases,          
without success.  
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Figure 4: Evolutionary History of WDR98 
NCBI blast (protein-protein BLAST algorithm) searches were performed using the human 
WDR98 full-length and C-terminal MIC-domain amino acid sequences and subsequently 
identified sequences from varying species. This cladogram was compiled using Clustal X to 
align sequences and prepare phylogenetic trees using data from a small proportion of the 
sequences found across diverse organisms. FigTree was used to manipulate and organise 
the trees into cladograms such as that presented here.  
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 3.3.2 Commercial Antibody Testing  
 
Five commercially available antibodies to WDR98 (listed in Table 1) were tested via             
western blotting to check their specificity, in both wild type NRK lysates (except             
where stated) and lysates with GFP-WDR98 (100 kDa) transfection (Figure 5).           
Abcam ab137276 was later tested on HeLa lysates (5E) following a publication            
which claimed to have found specificity by western blotting in human cells (Pontano             
Vaites ​et al.​ 2017) though we were unable to replicate this result.  
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Figure 5: Commercial Antibodies Fail to Recognise WDR98 by Western Blotting 
Commercial antibodies to WDR98 (75 kDa) were assessed for specificity via western            
blotting, using both NRK wild type lysates (or HeLa lysates in E) and lysates from cells which                 
had been transfected with GFP-WDR98 (100 kDa). A - Abcam ab78596, B - SantaCruz              
sc-390305, C - Proteintech 20111-1-AP, D - Abcam ab137276, E - Abcam ab137276.  
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 3.3.3 DNA Constructs  
 
The following DNA constructs were successfully produced and verified by DNA           
sequencing (Appendices A i - A xiii):  
- GST-WDR98 
- WDR98-HIS 
- GFP-WDR98 
- GFP-WD40 
- GFP-MIC 
- ΔpMEP4-MYC-GFP-WDR98 
- pcDNA5-GFP-humanWDR98 
- pGAD-WDR98 
- pGBDU-WDR98  
- GST-RAB5A 
- GST-RAB7A 
 
3.3.4 Commissioned Antibody Testing  
 
In order to assess whether the antibodies from two rabbits raised against            
GST-WDR98 were indeed specific to WDR98, they were first tested on NRK lysates             
from cells which had been transfected with GFP-WDR98 (100 kDa) (Figure 6A).            
This did not produce bands at either the endogenous molecular weight of 75 kDa,              
nor the weight of the overexpressed protein attached to GFP. There were, however,             
strong bands at 55 kDa from both antibodies which were consistently present when             
testing on NRK lysates. This led to the incubation of antibody ‘A’ with 10 ​μg               
GST-WDR98 pure protein in an attempt to saturate the antibody. The aim of this              
was to reduce binding to endogenous WDR98 in case it was running much lower              
than expected at 55 kDa. In Figure 6B, both lanes contain wild type NRK lysate, the                
first lane was treated with the original antibody without protein incubation, whilst the             
second lane was treated with the antibody that had been incubated with            
GST-WDR98. There was no evidence of the 55 kDa band intensity decreasing, nor             
the intensity of any other bands.  
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Figure 6: Commissioned GST-WDR98 Antibodies Fail to Recognise WDR98 by          
Western Blotting or Immunofluorescence 
GST-WDR98 protein was produced and sent to Eurogentec for the production of antibodies             
using two rabbits. Antibodies were characterised by western blotting and          
immunofluorescence. (A) Both antibodies were tested on NRK lysates from cells transfected            
with GFP-WDR98, antibody ‘A’ was used in the first lane, and antibody ‘B’ in the second. ​(B)                 
Using NRK lysates, the original antibody ‘A’ was used in the first lane and antibody               
incubated with GST-WDR98 was used in the second lane. (C) Antibody ‘A’ was also tested               
using immunofluorescence, NRK cells were transfected with GFP-WDR98 and cells were           
assessed for GFP-WDR98-antibody colocalisation. Pearson correlation coefficient R = 0.07.          
Scale = 20 ​μm.  
 
Finally, antibody ‘A’ was also tested via immunofluorescence, again using NRK cells            
which had been transfected with GFP-WDR98 (Figure 6C). ​Complete colocalisation          
would be expected for a WDR98-specific antibody, however the Pearson correlation           
coefficient produced an R value of 0.07, suggesting a lack of WDR98 specificity.             
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 There were no points of colocalisation and this, combined with the western blotting             
results, led to the conclusion that these antibodies were not specific to WDR98.  
 
As the first attempt at immunising rabbits against GST-WDR98 was unsuccessful,           
trial protein productions of GST-WDR98 and WDR98-His were performed, to          
determine the protein with which we could expect success, with both 4 hour (37 °C)               
and overnight (21 °C) inductions using IPTG, analysed by western blotting. The            
GST protein (anti-GST) exhibited large amounts of degradation in both conditions           
compared to the HIS (anti-HIS) protein (Figure 7), which had the least amount of              
degradation when induced overnight. WDR98-HIS protein was produced with         
induction overnight and sent to Eurogentec for new antibody production.  
 
 
Figure 7: WDR98-HIS Exhibits Less Protein Degradation than GST-WDR98 
GST-WDR98 and WDR98-HIS protein was produced.. Tests were performed with both 4 
hour (37°C) and overnight (O/N, 21 °C) inductions using IPTG, separated by western 
blotting, stained with anti-GST and anti-HIS.  
 
Extensive testing has yet to be carried out, but preliminary tests of the new 
antibodies raised against WDR98-HIS show potential viability with a band matching 
to that seen with anti-HIS at around 70 kDa, which becomes cleaner after antibody 
affinity purification (Figure 8).  
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Figure 8: Commissioned WDR98-HIS Antibody may show WDR98 Specificity 
Initial tests of the latest WDR98-HIS (75 kDa) antibodies (44 and 45) on WDR98-HIS pure 
protein compared  with anti-HIS on WDR98-HIS pure protein. Blots before (left) and after 
(right) antibody affinity purification.  
 
The HIS and WDR98 antibody staining does not match up perfectly, so it is possible 
that there has been some protein degradation. Further optimisation and testing for 
function in immunofluorescence staining is needed.  
 
3.3.5 Cell Line Characterisation  
 
Cell lines NRK ΔpMEP4-MYC-GFP-WDR98 and HeLa      
pcDNA5-GFP-humanWDR98 were induced and protein expression assessed by        
immunofluorescence. The induced expression gave a weaker signal than transiently          
transfected GFP-WDR98 and over multiple passages, and after resurrection from          
liquid nitrogen storage, the expression weakened further (data not shown). As such,            
the decision was made to use transient transfections for all experiments to gain a              
consistent and higher level of expression.  
 
3.3.6 CRISPR/Cas9 Knockout Characterisation  
 
CRISPR/Cas9 has been employed extensively with the aim of generating a viable            
WDR98 knockout cell line, however, here we had little success. Due to the lack of a                
functional WDR98 antibody, cell line characterisation requires gDNA extraction,         
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 PCR and DNA sequencing. Exons 1, 8, 9 and 10 of WDR98’s 20 (appendix A viii)                
have been targeted, with the final trials hitting NRK cells with guide RNAs specific to               
all four target exons. This yielded one cell line with unusual sequencing in exon 9,               
including up to three nucleotides identified per base (Figure 9 Panel A). Suspecting             
a mixed population, cells were further subcloned and exon 9 resequenced, which            
revealed up to two nucleotides present per base - indicating either a mixed             
population or a heterozygote. Subcloning was conducted again, with absolute          
certainty only to clone from single cells, and the results were consistent with             
previous findings. It is most likely to be a heterozygote cell line, with only one               
chromosome being affected by the Cas9, as wild type sequence can be identified             
within the nucleotides reported (Figure 9 Panel B).  
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Figure 9: WDR98 CRISPR/Cas9 Chromatograms 
Exon 9 sequencing of WDR98 CRISPR/Cas9 knockout attempts in NRK cells, targeting            
directly after the blue highlighted sequence ‘TAAAT’, up to and including which is WT. Panel               
A: initial attempt. Panel B: subclone.  
 
The WDR98 Cas9 heterozygote cell line has been characterised, with studies           
looking at lysosome size and distribution displaying no strong visible difference from            
wild type (data not shown). Growth rates were also compared, but again there was              
no notable difference between that of the Cas9 clones or wild type (data not shown).  
 
3.4 Discussion  
 
3.4.1 Assessment of Methods  
 
When characterising antibodies, both commercial and those produced for this          
project, initial tests on NRK lysates failed to display bands of appropriate molecular             
weight. The inclusion of GFP-WDR98-transfected cell lysates negated the possibility          
that this was due to trace amounts of endogenous protein present within the cell,              
however, this did not improve the results and all antibodies to WDR98 tested failed              
to show evidence of protein-specificity and therefore useful functionality. Western          
blotting protocols were adapted to include semi-dry manual as well as iBlot transfers             
and different membranes were used, including nitrocellulose and PVDF.         
Unfortunately, none of these methods were successful in improving the antibody           
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 performance and as such, this project has been carried out in the absence of an               
antibody to WDR98.  
 
All CRISPR/Cas9 resultant cell lines were sequenced as either wild type, with silent             
mutations or as heterozygous knockouts. Given the numerous and extensive          
attempts to generate a WDR98 knockout using CRISPR/Cas9; optimisation of the           
transfection protocol using GFP and the use of a variety and multiple Cas9             
guideRNA targets; it was considered that WDR98 complete knockouts were          
potentially unviable. This was later supported by Pontano Vaites ​et al. (2017) who             
also struggled to generate a knockout. They instead found success using transient            
siRNA knockdowns, identifying enlarged endosomal/lysosomal structures using both        
immunofluorescence and TEM analysis, and accumulation of P62 - indicating a           
reduction in autophagic flux. RAB7 was also less inclined to localise lysosomally.  
 
A recent publication also supports this, reporting a similar phenotype using a            
CRISPRi knockdown HeLa cell line. In the absence of WDR98, they observed that             
early endosomes and lysosomes were enlarged, EEA1 and LAMP1 staining was           
increased, and EGF and EGFR trafficking to the lysosome was impaired (Tsui ​et al.              
2019). Their data supports the theory that WDR98 plays a role in endosomal             
maturation in concert with MON1B and CCZ1, and its transient nature adds weight             
to the likelihood that it is not possible to make viable, stable WDR98 knockout cell               
lines.  
 
3.4.2 Contribution to the Project  
 
The discovery that WDR98 and its unique MIC domain are so well conserved adds              
weight to the theory that WDR98 performs a fundamental, necessary function and            
shows that the work carried out during this project to characterise this protein was              
relevant. The inability to identify an ortholog in yeast using bioinformatics is            
intriguing, but its complete absence is unlikely. It is more plausible that an ortholog              
exists which has yet to be identified, perhaps due to quite different amino acid              
sequences, or the function of a single/group of proteins in yeast may have since              
evolved to impose distinct functions. Despite this, the phylogenetic findings are           
interesting, and have yet to be discussed in any other publications.  
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It was logical to test all available WDR98 antibodies and upon finding none of them               
suitable, to produce a protein construct with which to attempt to generate our own. It               
is unfortunate that this too was proven non-specific to WDR98, and this lack of              
antibody certainly made the overall project more difficult. With hindsight, a GST-tag            
was perhaps not the best purification tag to use given its large size and inherent               
immunogenicity. It was considered that the antibody may be specific to GST itself,             
but western blots containing GST-WDR98 pure protein again did not reveal           
antigen-specificity (data not shown). If GST had induced a high level of immune             
response, it is possible the serum received from Eurogentec was a combination of             
many different antibodies; though these should have been cleared during antibody           
affinity purification.  
 
Following the unsuccessful antibody trials, the production of several DNA constructs           
became invaluable. GFP-WDR98 was most commonly used and was used to obtain            
data from immunoprecipitation and immunofluorescence experiments. Further to        
this, the generation of GFP-WD40 and GFP-MIC truncated proteins also produced           
some exciting and novel, results which will be discussed later on in Chapters 4 and               
5. GST-RAB constructs and WDR98-HIS were instrumental in conducting the          
pulldown experiment in the absence of an antibody and the pGAD and pGBDU             
constructs were used to perform yeast 2 hybrid experiments.  
 
The inducible cell lines did not greatly contribute to the overall project, but did help               
establish that GFP-WDR98 is not well expressed within cells, through either           
inducible expression or transient transfection, though the latter yielded higher          
expression levels and was the method of choice for all experiments discussed.  
 
Similarly, the CRISPR/Cas9 attempts unfortunately did not contribute any data to           
the project, but the attempts were valid and worthwhile given the breadth of data              
that stands to be gained from a resource such as a WDR98 knockout. Pontano              
Vaites ​et al. ​(2017) and Tsui ​et al. (2019) exemplified this via the data obtained from                
their knockdowns. WDR98 knockouts could be further exploited to determine the           
phenotype with regard to expression levels and distribution of MON1B and CCZ1 in             
the absence of WDR98. This could help elucidate the functionality of this protein             
complex, how much they rely on each other and whether there is a feedback loop               
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 present or if WDR98 has a role in regulating the expression or function of either of                
the endosomal maturation proteins it binds to. Finally, given the high level of             
conservation of WDR98, there are many options for attempting to create mutant            
organisms to further help understand the function of the protein ​in vivo​, as none              
currently exist, according to publications.  
 
3.4.3 Future Directions  
 
In order to advance research in this field and speed up the acquisition of data, a                
suitable WDR98 antibody would be invaluable. Further testing of the new           
WDR98-HIS antibody will hopefully reveal WDR98-specificity. 
 
Increased time spent exploiting bioinformatics techniques and mining sequence         
databases could eventually lead to the discovery of a yeast WDR98 ortholog, which             
would also be a highly suitable and cheap research model with which to generate              
data rapidly.  
 
Finally, siRNA could be a good alternative to generate WDR98 knockdowns and            
subsequently assess the effect of its reduction in the cell on the endosomal             
maturation proteins, further elucidating the function of WDR98.  
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Chapter 4: WDR98 Protein-Protein Interactions 
 
4.1 Introduction  
 
With the aim of uncovering more detail about a possible function for WDR98, a              
variety of methods were employed to identify its protein binding partners with            
varying success. Methods selected included yeast 2 hybrid, pulldowns and GFP           
immunoprecipitations, with further assessment by western blotting and liquid         
chromatography mass spectrometry in order to maximise the potential to obtain data            
in the absence of a WDR98 antibody. The two main protein domains of WDR98              
were also individually assessed by GFP immunoprecipitation: WD40 and MIC          
(Figure 3). According to Uniprot databases and JPred predictions, WDR98 has a            
β-sheet rich propeller-like N terminal ‘WD40’ domain. Such domains are highly           
abundant and have well-defined roles in functioning as protein-protein or          
protein-DNA interaction platforms (Xu and Min 2011). WDR98 also has a highly            
conserved C terminal α-helical ‘MIC’ domain of unknown function, which appears to            
be unique to WDR98 and WDR98-related proteins, of which there are seven            
isoforms of varying lengths in humans. It has been consistently found that WDR98             
interacts with CCZ1 and MON1B (Pontano Vaites ​et al. ​2017) and that the WD40              
domain is sufficient to elicit binding to these proteins, albeit not as strongly as the               
full-length protein.  
 
4.2 Methods 
 
4.2.1 Yeast 2 Hybrid Interactions 
 
In addition to existing yeast 2 hybrid pGBDU (bait) and pGAD (prey) vectors             
containing MON1B, CCZ1, RAB5, and RAB7 that were previously generated by the            
Pryor lab; pGBDU- and pGAD-WDR98 were created to check for interactions with            
the aforementioned endosomal proteins. QuickChange PCR was also used to          
generate RAB constructs locked into the conformation of GDP-bound, GTP-bound          
and nucleotide free as well as the original wild type construct. SP6 was included as               
part of a different project and is not relevant to WDR98.  
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 Yeast strains were plated out onto selective synthetic defined (SD)-leucine (pGAD)           
and SD-uracil (pGBDU) plates (without leucine or uracil in the agar media            
respectively) and grown individually before mating on YPD (complete amino acids)           
plates. Plates were later replicated onto SD-leu/-ura plates (no leucine and no uracil             
combined) and allowed to grow for 48 hours at 30 ºC. Yeast from mated              
cross-sections were mixed with sterile water and pipetted onto new SD-leu/-ura           
plates and incubated at 30 ºC for another 48 hours before replica plating onto SD               
-leu/-ura/-adenine, the loss of the latter being negated by a successful bait-prey            
interaction, enabling the production of the missing amino acids and therefore,           
growth (Figure 10). 
 
Figure 10: Yeast 2 Hybrid Method 
Yeast 2 hybrid utilises the GAL4 transcription factor system which is divided into a binding               
domain (BD) and activation domain (AD), both of which are required in order to initiate               
transcription. When this interaction is mediated by the additional interaction of a set of              
proteins (bait and prey) to which they are fused, transcription is only enabled if there is the                 
ability of the bait and prey proteins to bind. In this instance, transcriptional control was over                
the genes responsible for producing leucine, uracil and adenine - which were absent from              
the final yeast plates, and as such, essential for growth. As such, visible yeast growth               
indicates a positive interaction between the bait and prey proteins. Figure adapted from Lin              
and Lai (2017).  
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4.3 Results  
 
4.3.1 Yeast 2 Hybrid Interactions 
 
Yeast 2 hybrid was utilised to assess the potential interactions among proteins            
involved in the endosomal-lysosomal systems, including WDR98 (Figure 11).  
 
 
Figure 11: MON1B and CCZ1 Interact via Yeast 2 Hybrid 
Yeast 2 hybrid with pGBDU (bait) and pGAD (prey) constructs expressing proteins involved             
in the endosomal and lysosomal systems, and RABs 5 and 7 locked into different states of                
nucleotide binding conformations. SP6 was included as part of a different project and is not               
relevant to WDR98. Yeast were plated out onto selective SD-leucine (pGAD) and SD-uracil             
(pGBDU) plates and grown individually before mating on YPD plates. Plates were later             
replicated onto SD-leu/-ura plates and allowed to grow for 48 hours at 30 ºC. Yeast from                
mated cross-sections were pipetted onto new SD-leu/-ura plates and incubated for another            
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 48 hours at 30 ºC before replica plating onto SD -leu/-ura/-adenine. Evidence of positive              
interactions circled red and autoactivation outlined blue. Image taken on day 30.  
 
Following 30 days of incubation for replicate three, the only evidence of positive             
interactions and resultant growth were between MON1B and CCZ1, with CCZ1 as            
the bait. Autoactivation also occurred in the pGBDU-SP6 and some of the            
pGBDU-RAB5 strains. There was no binding evident from any of the WDR98 yeast             
matings in either direction, though this does not indicate the interactions are not             
possible, simply that they were not detected via yeast 2 hybrid.  
 
4.3.2 WDR98 and WD40 Domain Interacts with CCZ1 and MON1B  
 
To confirm the interaction between WDR98 and CCZ1 (as indicated by the pilot             
large scale IP from the Pryor lab), and to examine whether either the WD40 or MIC                
domain were sufficient for the interaction, an IP was performed using Aminolink            
beads coupled to an anti-GFP-nanobody and NRK cells transiently transfected with           
GFP, GFP-WD40, GFP-MIC or GFP-WDR98. The GFP was then         
immunoprecipitated from lysates. Resultant lysates and immunoprecipitations were        
separated using SDS PAGE and lysates were blotted for GFP to show levels of              
GFP-protein expression in lysates pre- and post-IP (Figure 12A, B). Lysates and            
eluates were also blotted for CCZ1. Data shows consistent CCZ1 bands           
(SantaCruz) in pre-IP samples (Figure 12C). CCZ1 (55 kDa) was also present in             
post-IP samples: strongly in full-length GFP-WDR98 and much weaker, but evident,           
in GFP-WD40 (Figure 12D), suggesting this domain alone is sufficient for a low level              
of CCZ1-binding.  
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Figure 12: WDR98 and WD40 Domain Interacts with CCZ1 and MON1B  
Into NRK cells, GFP, GFP-WD40, GFP-MIC (the two domains of WDR98) and full-length             
GFP-WDR98 were transfected and GFP immunoprecipitated (IP) and lysates analysed for           
the presence of CCZ1 and MYC-MON1B (using a MYC-MON1B-inducible cell line). (A)            
Pre-IP lysates analysed using anti-GFP. . (B) Lysates post-IP. (C) Lysates pre-IP following             
transfections. (D) Post-IP eluate analysis for the presence of CCZ1 (55 kDa). (E) Post-IP              
eluate analysis for the presence of MYC-MON1B (59 kDa). GFP (27 kDa), GFP-WD40 (70              
kDa), GFP-MIC (47 kDa), GFP-WDR98 (100 kDa). 
 
To confirm the interaction between WDR98 and MON1B (again as indicated by the             
pilot IP from the Pryor lab) Flp-In HeLa cells with inducible MYC-MON1B expression             
were transfected with GFP, GFP-WD40, GFP-MIC or GFP-WDR98 and the          
MYC-MON1B expression induced. This was necessary due to the lack of a suitable             
MON1B or WDR98 antibody. As done previously, the GFP was then           
immunoprecipitated from lysates, resultant lysates and immunoprecipitations were        
analysed using SDS PAGE, and lysates were blotted for GFP and MYC.            
Replicating the data from CCZ1 interaction experiments, MYC-MON1B (59kDa) was          
present in post-IP samples: strongly in full-length GFP-WDR98 and weaker, but           
evident, in GFP-WD40 (Figure 12E), again suggesting the WD40 domain is           
sufficient for binding to MON1B.  
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4.3.3 Alternative Immunoprecipitation Interactions  
 
Using data compiled from the BIOGRID database (Oughtred ​et al. 2019) and the             
Pryor lab large scale IP pilot, a protein interaction network was produced to display              
significant proteins (in terms of function, localisation and disease) which may           
potentially bind to WDR98, MON1 and CCZ1 (Figure 13). This was used to identify              
proteins to investigate further in terms of an interaction with WDR98. 
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 Figure 13: WDR98 Potential Protein Interactions Network 
Data compiled from the BIOGRID database and preliminary Pryor lab data was used to              
produce a potential protein interaction network.  
 
Using specific antibodies, further immunoprecipitations were conducted to look for          
confirmation of interactions between full-length WDR98 and proteins identified on          
the potential protein interactions network. Given previous results (figure 12), CCZ1           
was used as a positive control. Antibodies against HDAC6, HSP90, STUB1 (Figure            
14A), APP and Beta-Amyloid (Figure 14B) were tested on pre-IP lysates and post-IP             
eluates.  
 
 
Figure 14: WDR98 does not Interact with HDAC6, HSP90, STUB1 or APP  
GFP and GFP-WDR98 were produced in transiently transfected NRK cells and GFP was             
immunoprecipitated (IP), then lysates analysed for the presence of a variety of proteins             
involved in trafficking. (A) Lysates analysed using anti-HDAC6, HSP90, CCZ1 and STUB1.            
(B) Pre-IP lysates analysed using anti-APP, CCZ1 and Beta-Amyloid. 
 
There were no new WDR98 protein interactions identified through these IPs, which            
can be considered true negatives due to the positive antibody signal in pre-IP             
lysates and absence of signal in post-IP eluates, in the presence of a positive signal               
indicating the interaction between GFP-WDR98 and CCZ1.  
 
4.3.4 RAB Pulldowns  
 
To clarify previously reported RAB and WDR98 interactions (Gillingham ​et al. 2014,            
Pontano Vaites ​et al. 2017), recombinant GST-RAB5 and GST-RAB7 were          
produced and loaded with nucleotides (GMPPNP, GDP and GTP) before incubation           
with recombinant WDR98-HIS in the presence of glutathione sepharose beads. GST           
57 
 bound to glutathione sepharose beads as indicated in Figure 15 and a weak amount              
of WDR98-HIS was detected in all conditions, including the GST-absent control,           
suggesting a weak ability to bind directly to the beads themselves. As the level of               
WDR98-HIS did not increase in any of the GST-RAB conditions compared to the             
negative control, and smudging in the GST-RAB5 lane was proven to be nonspecific             
through repetition, this is evidence that there is not a direct interaction between             
WDR98 or any nucleotide conformation RAB5/7 protein when in isolation ​in vitro​.  
 
 
Figure 15: WDR98 does not Directly Interact with RAB5/7 ​in vitro  
WDR98-HIS (75 kDa) was incubated with GST-RABs 5 (49 kDa) and 7 (48 kDa) in varying                
nucleotide-locked conformations (with nucleotides present) to test for protein-protein         
interactions via pulldown with glutathione beads in a wide range of different buffers             
(representative example blot shown).  
 
4.3.5 Immunoprecipitation Liquid Chromatography Mass Spectrometry  
 
Immunoprecipitations were conducted again as previously described but on a much           
larger scale and with liquid chromatography mass spectrometry (LC-MS/MS)         
analysis of eluates for GFP, GFP-WDR98 and GFP-MON1A, the latter included to            
aid identification of binding partners specific to WDR98, as trial analysis by            
LC-MS/MS revealed common interactors for both proteins. Triplicate repeats and          
Fisher’s exact test and Benjamini-Hochberg multiple test correction statistical         
analysis revealed statistical confidence (p < 0.00071) in GFP-WDR98 binding to           
only a handful of proteins, including MON1B (Table 3).  
 
Table 3: MON1B and Structural Proteins are Binding Partners of WDR98 
GFP and GFP-WDR98 were produced in transiently transfected NRK cells and GFP was             
immunoprecipitated, then eluates analysed via liquid chromatography mass spectrometry.         
GFP-WDR98 positive results from three replicates were compared to results from the GFP             
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 control analysis, and statistical analysis (Fisher’s Exact Test and Benjamini-Hochberg          
multiple test correction) revealed the proteins displayed in this table were able to bind to               
GFP-WDR98 with significant statistical confidence (p < 0.00071). 
 
GFP-WDR98 Binding Partners  Fisher’s Exact Test p =  
MON1B 0.0001 
PSMC5 0.0001 
VIMENTIN CLUSTER 0.0001 
MYOSIN CLUSTER 0.0001 
FIBRONECTIN 0.0001 
CYTOSPIN A 0.0001 
PSMC2 0.00014 
CLATHRIN HEAVY CHAIN 1 0.00028 
HISTONE H2B CLUSTER 0.0003 
PLASTIN CLUSTER 0.00036 
FLOTILLIN 2  0.00063 
 
The proteins identified mainly included cell-structural and transport proteins, notably          
clathrin heavy chain 1 which is required for clathrin-coated vesicles in protein            
trafficking, and two proteins (PSMC5 and PSMC2) of the 26S proteasome           
regulatory subunit. 
 
MON1B was the only repeat protein that we had previously confirmed interacted            
with WDR98 to be deemed significant in these experiments. CCZ1 was present in             
the analysis but not to a high enough level to be considered a significant binding               
partner following multiple test corrections (p = 0.0016).  
 
 
 
 
 
4.4 Discussion  
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4.4.1 Confirmation of Interactions  
 
Overall, the main results obtained from these protein-protein interaction studies are           
confirmation of the interactions between WDR98 and CCZ1 and MON1B of the            
endosomal maturation complex. Whilst this has since been replicated and published           
in new literature (Pontano Vaites ​et al. 2017), we have also discovered that the              
WD40 domain is sufficient to bind to CCZ1 and MON1B, albeit with apparent             
weaker affinity than the full-length protein, whereas the MIC domain alone does not             
exhibit any CCZ1 or MON1B binding. The beta-propeller structure predicted to exist            
in the WD40 domain often acts as a protein-protein or protein-DNA binding platform             
in other proteins (Xu and Min 2011), which would appear to also be the case in                
WDR98. This may leave the unique helical MIC domain free to perform an             
alternative function to the binding of the WD40 domain. These findings localise            
WDR98 to maturing endosomes and lysosomes within the cell, and also suggest            
cross-species conservation as the rat-derived WDR98 protein was observed to bind           
both rat (large-scale IP LC-MS/MS) and human (IP western blotting) MON1B           
orthologs. Analysis via LC-MS/MS also supports a highly specific role for WDR98 in             
supporting endosomal maturation and trafficking to the lysosome as very few           
proteins were found to bind significantly to WDR98 using this method, including            
MON1B, structural proteins and members of the 26S proteasome regulatory          
subunit. The significance of the proteasome regulatory subunit-binding again         
highlights a well-defined role for WDR98 in helping to regulate protein trafficking and             
degradation. As does the clathrin heavy chain, which is essential for           
receptor-mediated endocytosis and vesicular structure. However, these two latter         
interactions have only been identified using this method, and further validation using            
other approaches would be required to achieve confirmation.  
 
MON1 and CCZ1 have been shown to bind to both RAB5 and RAB7 in              
Caenorhabditis elegans ​(Poteryaev et al. 2010) and ​Drosophila ​melanogaster         
(Yousefian et al. 2013​, ​Hegedűs et al. 2016)​. Drosophila melanogaster WDR98           
(CG8270) has previously been shown to bind to RAB5 (Q to L mutant that stabilises               
GTP bound RABs) ​(Gillingham et al., 2014)​, whereas Pontano Vaites et al. (2017)             
detected WDR98 binding to RAB7 (T to N mutant that stabilises GDP bound RABs).              
However, RAB mutants such as T22N can cause RAB instability, which promotes            
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 non-specific interactions (personal communication with Miguel Seabra, Imperial        
College, London). Our data suggests there may not be a direct interaction between             
WDR98 and RAB5 or RAB7. This is plausible as published data from Gillingham ​et              
al. (2014) and Pontano Vaites ​et al. (2017) cannot rule out indirect interactions via              
linker proteins. The presence of additional proteins, for example MON1B and/or           
CCZ1, may be required to enable an interaction between WDR98 and RABs, or they              
may simply work together as part of the same protein complex, for example during              
the RAB5 - RAB7 switch in endosomal maturation process. Regardless, this is the             
first ​in vitro interaction study of RAB5 and 7 with WDR98 ​in isolation. Following              
rigorous testing of differing protein concentrations, different types of cross-linking          
beads and a wide variety of buffers, our conclusion is that they are unable to interact                
directly ​in vitro​.  
 
4.4.2 Assessment of Methods  
 
Yeast 2 hybrid was a relatively quick and economical way to test for interactions              
between multiple different proteins at the same time, with a visual positive/negative            
result. However, this method is not without its limitations. Most often, protein-protein            
interactions are not displayed as positive in both bait-prey directions, as seen here             
between the well-established interactors MON1B and CCZ1. Their positive         
interaction was only displayed using CCZ1 as the bait and MON1B as the prey, not               
the other way around, meaning it is necessary to try both conformations to check for               
false negatives. There is also the possibility of false positives, as also shown in this               
study. Autoactivation occurred in the pGBDU-SP6 and some of the pGBDU-RAB5           
strains, which is a common limitation for some protein fragments within pGBDU            
vectors (Galletta and Rusan 2015). Whilst this rarely occurs in both pGBDU and             
pGAD vectors containing the same protein, it does restrict the data that can be              
collected, as true positives, only occurring in one bait-prey direction, may be            
masked by the false positives. For WDR98, there was no autoactivation or evidence             
of binding from any of the yeast matings in either direction. This does not indicate               
the interactions are not possible, simply that they are not detected in this yeast 2               
hybrid approach.  
 
The use of GFP immunoprecipitation has proven invaluable and can provide data            
using a variety of different analyses. For known targets, western blotting analysis is             
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 quick and relatively economical once the relevant antibodies are acquired, and there            
are methods to circumnavigate the lack of a suitable antibody including the            
generation of inducible-expression cell lines and transfection of tagged DNA          
constructs, though it is a more lengthy and difficult process to produce the             
additional molecular constructs required. LC-MS/MS analysis completely removes        
the need for protein-specific antibodies and also allows proteome-wide,         
non-targeted forward screening. Here, this was able to illuminate WDR98          
interactions with cell structural proteins and proteasome subunits which may          
otherwise not have been identified. The statistical analysis used, Fisher’s Exact Test            
with Benjamini-Hochberg multiple test corrections are highly stringent, (p <          
0.00071), however they may be so stringent that we are also dismissing other             
positive results as not significant, including CCZ1 which had a p value of 0.0016,              
despite displaying a clear positive result from many IPs with western blotting            
analysis. Further repeats of these experiments would be useful, however it is costly             
given the amount of transfection reagent and volume of consumables required to            
achieve the level of sample necessary for the complex LC-MS/MS analysis, in            
addition to the costs of the MS itself.  
 
Whilst isolated pulldown experiments can also do away with the requirement for            
protein-specific antibodies, they too are not without their limitations. Despite trying           
many different conditions to detect a WDR98-RAB5/7 interaction ​in vitro​, it is            
possible that the optimal condition simply was not found in order to facilitate an              
interaction, highlighting the inherent difficulties behind ​in vitro studies. Many different           
replicates were carried out until the decision was made to conclude that we could              
not find evidence of a direct WDR98-RAB5/7 interaction ​in vitro​. A further problem is              
finding suitable cross-linking beads, because all beads tested (including Ni-NTA          
agarose) were found to exhibit some level of nonspecific binding to either            
GST-RAB5/7 or WDR98-HIS. An increase in western blotting band intensity could           
have been taken as a positive result compared to nonspecific binding in the             
negative control, however this did not occur within our experiments and the            
conclusion remains that WDR98 is unable to directly interact with RAB5/7, in any             
nucleotide conformation, ​in vitro​.  
 
4.4.3 Future Directions  
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 It would be very helpful to have an atomic-resolution structure of WDR98 to             
visualise the distinct domains, thus enabling a model of how the interactions with             
MON1B and CCZ1 might take place to be created. Atomic-resolution structures of            
WD40-type domains already exist and this is a domain which is relatively well             
researched (Zhang ​et al. 2019); the truncated WDR98 WD40 construct could be            
used for protein crystallisation studies. A crystal structure would also help with the             
investigation of the secondary structure of the central part of the protein, which is              
currently unknown. Current understanding is that a complex of both MON1B and            
CCZ1 dimers are required to form the endosomal maturation complex (Kiontke ​et al.             
2017) and a crystal structure may help elucidate how WDR98 fits into that complex.              
Further studies such as analytical size-exclusion chromatography or analytical         
ultracentrifugation could determine whether WDR98 too is required in duplicate.          
Potential obstacles to this include the fact that WDR98 is a rather unstable protein              
that tends to be insoluble, with attempts to produce high amounts of protein             
rendering relatively low yields (data not shown).  
 
Repetition of the IPs with LC/MS-MS analysis would be costly but useful to check for               
any positive results which may have been missed, given that CCZ1 was determined             
to be a non-statistically significant binding partner.  
 
Finally, as with all studies of this nature, development of a suitable antibody would              
be invaluable, as would generation of a WDR98 knockout or knockdown model. The             
model cell line could be used to analyse the effects on the levels and behaviour of                
MON1B and CCZ1, and the overall effect on endosomal maturation and lysosomal            
trafficking.  
 
 
 
 
 
 
Chapter 5: WDR98 Subcellular Localisation  
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 5.1 Introduction 
 
To further characterise WDR98 and understand its likely function, addressing the           
final experimental objective, immunofluorescence was utilised to establish where         
WDR98 localised to within the cell. Due to the lack of an appropriate antibody, this               
was achieved through transient transfection of a GFP-WDR98 encoding vector into           
NRK cells (unless otherwise stated) and analysis using confocal microscopy. Given           
the previous literature claim that WDR98 localised to the lysosome (Schroder ​et al.             
2007) we expected to find it colocalising with lysosomal membrane protein LGP120            
and checked other cellular locations thereafter. CCZ1 was studied following the           
results of the pilot immunoprecipitation trial by the Pryor lab which suggested that             
CCZ1 and WDR98 interacted. Again due to the lack of an antibody to MON1B, a               
GFP-WDR98 encoding vector was transiently transfected into HeLa cells with          
inducible expression of MYC-MON1B. Other proteins analysed for colocalisation         
include RAB5, RAB7 and LC3. The localisation of the distinct protein domains,            
WD40 and MIC, were also studied using GFP tagged constructs. These were also             
observed to localise individually to the lysosome. It is important to note that as              
transfections were required to collect all of this data, thus the WDR98 subcellular             
localisation and distributions are that of cell lines overexpressing the target protein            
and may differ from endogenous WDR98 protein.  
 
5.2 Methods  
 
5.2.1 WDR98 Overexpression  
 
Following the production of the DNA constructs, GFP-WDR98, GFP-WD40 and          
GFP-MIC, these were transformed into bacteria for replication and DNA extracted           
via Midiprep (Methods 2.2.5). The DNA was then transfected into NRK cells which             
were incubated for 24 hours prior to fixation and staining (Methods 2.2.23).  
 
 
 
 
5.2.2 Transfection Optimisation  
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 In order to obtain optimal transfections, and as such the highest level possible of              
protein expression, the transfection protocol was rigorously tested prior to          
experimentation. Two reagents were assessed: X-tremeGENE HP and Genecellin.         
Differing ratios of transfection reagent to DNA were trialled, ranging from 1:1 to 4:1              
with varying cell confluency levels. The conditions with the brightest GFP signal by             
microscopy were X-tremeGENE HP 2:1 DNA with cells at 80-90% confluency at the             
time of transfection.  
 
5.2.3 Image Analysis 
 
Images were acquired using a Zeiss LSM 880 Axio Observer.Z1 inverted confocal            
laser microscope running Zen software version 2.3. Images were collected as           
Z-stacks and compressed into maximum intensity projections. Further processing         
was completed using FIJI software (Rueden et al. 2017, Schindelin et al. 2012), and              
analysis for colocalisation was completed using the Coloc2 plugin. Pearson’s          
correlation coefficient was calculated using images of at least 30 separate cells from             
at least three replicate experiments and determining the average R value of each. R              
= -1 would indicate localisation at opposite sites, R = 0 would indicate no              
relationship, negative or positive, between signals, and R = 1 would indicate perfect             
colocalisation. 
 
5.3 Results  
 
5.3.1 WDR98 Subcellular Localisation  
 
The subcellular location and distribution of WDR98 was characterised, in the           
absence of a suitable antibody, by overexpression of GFP-WDR98 using transiently           
transfected NRK cells. This was assessed against a range of organelle markers,            
including LGP120 (lysosome), CCZ1 and MON1B (endosomes and lysosomes),         
RAB5 (early endosomes), RAB7 (late endosomes) and LC3 (autophagosomes).         
Colocalisation has been qualified both visually (Figure 16) and semi-quantitatively          
using Pearson’s correlation coefficient analysis (Table 4). A GFP antibody was used            
to supplement the GFP construct transfections due to difficulties in expression and a             
weak signal.  
 
65 
  
66 
  
Figure 16: WDR98 Colocalises with LGP120, CCZ1, MON1B, RAB5 and RAB7 
GFP-WDR98 was transiently transfected into NRK cells using X-tremeGENE HP. This was            
assessed against a range of organelle markers, including LGP120 (A, lysosome), CCZ1 (B)             
and MON1B (C, endosomes and lysosomes), RAB5 (D, early endosomes), RAB7 (E, late             
endosomes) and LC3 (F, autophagosomes). Images were acquired using a Zeiss LSM 880             
Axio Observer.Z1 inverted laser scanning confocal microscope. Images were collected as           
Z-stacks and compressed into maximum intensity projections. Further processing was          
completed using FIJI software and analysis for colocalisation was completed using the            
Coloc2 plugin. Scale bar = 20  µm. 
 
 
67 
 Table 4: Pearson Correlation Coefficients of GFP-WDR98 Subcellular Colocalisation  
Immunofluorescence images of WDR98 subcellular localisation were acquired by transiently          
transfecting a GFP-WDR98 encoding vector into NRK cells (with the exception of            
MYC-MON1B inducible expression HeLa cells) and counterstaining with a range of markers            
for endosomal and lysosomal systems. Images were captured using a Zeiss LSM 880 Axio              
Observer.Z1 inverted laser scanning confocal microscope. Images were collected as          
Z-stacks and compressed into maximum intensity projections. Further processing was          
completed using FIJI software and analysis for colocalisation was completed using the            
Coloc2 plugin. A minimum of 30 cells were assessed per condition with the average Pearson               
correlation coefficient calculated as a quantification of colocalisation between markers. 
 
Organelle Marker Pearson Coefficient R =  
Lysosome LGP120 0.55 
Endosome and 
Lysosome 
CCZ1 0.85 
Endosome and 
Lysosome 
MON1B 0.83 
Early Endosome RAB5 0.51 
Late Endosome RAB7 0.78 
Autophagosome LC3 0.16 
 
GFP-WDR98 was able to localise to lysosomes, specifically those surrounding the           
nuclear periphery (Figure 16A) and reported a moderate association score of 0.55.            
CCZ1 and MON1B (MYC-MON1B induced expression in HeLa cells) consistently          
displayed GFP-WDR98 colocalisation (Figure 16B and 16C), with strong correlation          
coefficients of 0.85 and 0.83 respectively, placing WDR98 at both endosomes and            
lysosomes. GFP-WDR98 was also observed to colocalise with both RABs 5 and 7             
(Figure 16D and 16E), though less so with the former at early endosomes (R = 0.51)                
and more so with RAB7 at late endosomes (R = 0.78). Finally, there appears to be                
little to no association of WDR98 with LC3 at autophagosomes (Figure 16F) with a              
Pearson correlation coefficient score of 0.16.  
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 5.3.2 WDR98 Truncated Domains Subcellular Localisation  
 
The subcellular location and distribution of the individual WDR98 domains,          
GFP-WD40 and GFP-MIC, were also characterised in a lysosomal context (Figure           
17) and Pearson correlation coefficient values were calculated (Table 5).  
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Figure 17: WDR98 and its Domains Localise to the Lysosome 
The subcellular location and distribution of GFP, GFP-WD40, GFP-MIC and GFP-WDR98           
were characterised by transient transfection of NRK cells with the relevant expression vector             
using X-tremeGENE HP. This was assessed against LGP120, a lysosomal membrane           
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 protein and marker. Images were acquired using a Zeiss LSM 880 Axio Observer.Z1             
inverted laser scanning confocal microscope. Images were collected as Z-stacks and           
compressed into maximum intensity projections. Further processing was completed using          
FIJI software and analysis for colocalisation was completed using the Coloc2 plugin. Scale             
bar = 20  µm. 
 
Table 5: Pearson Correlation Coefficients of GFP-WDR98 Truncated Constructs at the           
Lysosome  
Immunofluorescence images of GFP, GFP-WD40, GFP-MIC and GFP-WDR98 subcellular         
localisation were acquired by transient transfection and counterstaining for LGP120 to           
identify the lysosome. Images were captured using a Zeiss LSM 880 Axio Observer.Z1             
inverted laser scanning confocal microscope. Images were collected as Z-stacks and           
compressed into maximum intensity projections. Further processing was completed using          
FIJI software and analysis for colocalisation was completed using the Coloc2 plugin. A             
minimum of 30 cells were assessed per condition with the average Pearson correlation             
coefficient calculated as a quantification of colocalisation between two markers. 
 
Transfected Construct LGP120 Colocalisation Pearson 
Coefficient R =  
GFP 0.35 
GFP-WD40 0.57 
GFP-MIC 0.54 
GFP-WDR98 0.55 
 
Both GFP-WD40 and GFP-MIC individually localised to the lysosome (Figure 15B           
and 17C), with a similar association level to the full length protein (Figure 17D) and               
slightly more so than GFP alone (Figure 17A). The GFP control transfection            
obtained a Pearson score of 0.35 in contrast to the WDR98 domain scores of 0.57               
for GFP-WD40 and 0.54 for GFP-MIC.  
 
5.3.3 WDR98 Overexpression Phenotype  
 
The approximate number, size and distribution of lysosomes in NRK cells with and             
without GFP or GFP-WDR98 expression was quantified to check whether          
transfections or increased expression of this protein affected lysosome morphology.          
Though there appeared to be no significant perturbations in terms of number of             
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 lysosomes, there were clear differences between untransfected NRK controls and          
transfected cells, with both GFP- and GFP-WDR98-transfected cells displaying         
notable lysosomal swelling (Figure 18).  
 
 
Figure 18: Transfection of GFP-Constructs causes Lysosomal Swelling 
The effects of transfection using X-tremeGENE HP to insert GFP-sequences into NRK cells             
was assessed in terms of lysosomal phenotype using LGP120 as a lysosomal marker.             
Untransfected controls (Zoom A). Transfected cells (Zoom B). Images were acquired using a             
Zeiss LSM 880 Axio Observer.Z1 inverted laser scanning confocal microscope. Images were            
collected as Z-stacks and compressed into maximum intensity projections. Scale bar = 20             
µm. 4x Zoom. 
 
5.4 Discussion  
 
5.4.1 Confirmation of Localisation 
 
Data from this study and also from Pontano Vaites ​et al. (2017) and Tsui ​et al.                
(2019) confirm the localisation of WDR98 to the endosomal and lysosomal systems            
within the cell. The immunofluorescence images published by Tsui ​et al. (2019) also             
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 indicate a preference for WDR98 to colocalise at lysosomes close to the nuclear             
periphery, which have been suggested to contain a lower pH and be the more active               
set of lysosomes, compared to those around the cell membrane (Johnson ​et al.             
2016). It is both novel and intriguing that the two separate protein domains, WD40              
and MIC, also localised to the lysosome in a manner that was similar to the full                
length protein. This could mean that either domain is responsible for anchoring the             
protein to the lysosomal membrane - potentially the MIC domain as the WD40             
domain has the capability to bind to MON1B and CCZ1, whereas MIC does not.  
 
There is now an increasing body of evidence that WDR98 functions within the             
endosomal-lysosomal system, which has been added to by these         
immunofluorescence studies.  
 
5.4.2 Assessment of Methods  
 
The biggest caveat of the methods used to assess WDR98 localisation is that it is               
only detectable within a cell line overexpressing the target protein. This requires the             
use of a transfection reagent, which itself imposes an atypical phenotype on the cell,              
as suggested by the results in Figure 18. Not only are there a large number of                
differentially expressed mRNA transcripts, which is induced by transfection alone          
(Jacobsen ​et al. 2009), but the transfection process itself is likely to result in              
lysosomal stress as the cell enters survival mode. This is partially backed up by the               
increased lysosomal swelling observed in all transfected cells.  
 
The use of the large GFP tag may also affect the folding and trafficking of WDR98                
as it increases the molecular weight from 75 kDa to 100 kDa. With hindsight, a               
smaller tag would have been preferable, as due to the difficulty getting NRK cells to               
express GFP-WDR98 it meant an additional GFP antibody was required, negating           
the reasons for selecting a GFP-tag initially (although it appears localisation was not             
affected, as Pontano Vaites ​et al. ​(2017) found the same localisation using the             
smaller FLAG-HA tag). Furthermore, there is increasing evidence that GFP itself is            
harmful to cells, increasing the level of cellular stress in the experimental conditions             
(Ansari ​et al. 2016). Indeed, our NRK cells when transfected with GFP constructs             
were only viable for roughly 48 - 72 hours maximum before there was considerable              
cell death.  
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 5.4.3 Future Directions  
 
Once a suitable antibody has been produced, it would be very worthwhile to repeat              
all experiments in this chapter in true wild-type conditions, without the need for             
transfection, overexpression of target proteins, or the introduction of cytotoxic          
GFP-tagged constructs.  
 
The distribution of endogenous WDR98 in altered metabolic conditions (e.g.          
starvation to increase autophagic flux and endocytosis inhibition to decrease          
trafficking to the lysosome) could be analysed to further elucidate its function and             
potential regulatory role.  
 
Immunofluorescence would also be a great tool for the analysis of a WDR98             
knockout/knockdown cell line to probe the effects on the endosomal-lysosomal          
system, and to determine whether it is possible to rescue some or all wild-type              
functionality with either the WD40 or MIC domain alone.  
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 Chapter 6: Conclusions and Future Directions  
 
6.1 Characterisation of WDR98  
 
Progress has been made in the characterisation of WDR98, in terms of compiling             
available data from journal articles and databases, and of conducting new research            
into its protein binding partners and subcellular location. WDR98 has been shown,            
via immunoprecipitation and immunofluorescence, to interact, and colocalise, with         
MON1B and CCZ1. These interactions also occur with the WD40 domain alone.            
WDR98 and both of its domains in isolation localise to the lysosome, in particular              
those surrounding the nuclear periphery, which have been reported to be the most             
active (Johnson ​et al. 2016). We cannot find any evidence of a direct interaction ​in               
vitro between WDR98 and either RAB5 or RAB7 in any nucleotide-bound           
conformation.  
 
6.2 Corroboration with Publications  
 
Pontano Vaites ​et al. (2017) were the first to publish a paper with a significant focus                
on WDR98 (termed RMC1 by the Harvard lab) and their data reflected many, but              
not all, of my findings. They too identified the ability of WDR98 to interact with               
CCZ1, MON1A and MON1B as well as its localisation to the lysosome. However,             
Pontano Vaites ​et al. (2017) predicted the helical structure of the MIC domain to be               
responsible for binding other proteins, based on structural data alone. In contrast,            
we have consistently shown that the WD40 domain is sufficient to bind to CCZ1 and               
MON1B, whereas the MIC domain alone does not exhibit any CCZ1 or MON1B             
binding. The WD40 domain β-propeller structure in other proteins often acts as a             
protein-protein or protein-DNA binding platform (Xu and Min 2011), which would           
appear to also be the case in WDR98.  
 
Drosophila melanogaster WDR98 (CG8270) has been shown to bind to RAB5 (in Q             
to L mutant that stabilises GTP bound Rabs) ​(Gillingham ​et al. 2014) and Pontano              
Vaites ​et al. (2017) found WDR98 binding RAB7 (in a T to N mutant that stabilises                
GDP bound Rabs). Our data suggests there may not be a direct interaction between              
WDR98 and RAB5 or RAB7. We argue this is plausible because published data             
from Gillingham ​et al. (2014) and Pontano Vaites ​et al. (2017) cannot rule out              
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 indirect interactions. Pontano Vaites in particular, based their claim on the mere            
presence of both WDR98 and RAB7 in the same size exclusion chromatography            
fractions, which could be coincidence and would require much more explicit           
demonstration to truly demonstrate an interaction. We conclude that the presence of            
additional proteins, such as MON1B/CCZ1, may be required to enable an interaction            
between WDR98 and RABs.  
 
Following unsuccessful attempts to produce a WDR98 knockout cell line using 
CRISPR/Cas9, we considered whether a WDR98 mutation could be 
homozygous-lethal. Pontano Vaites ​et al.​ (2017) also suggested that it was not 
possible after several failed attempts. Tsui ​et al.​ (2019) used transient CRISPRi 
HeLa cells to observe that in the absence of WDR98, early endosomes and 
lysosomes were enlarged, EEA1 and LAMP1 staining was increased and EGF and 
EGFR trafficking to the lysosome was impaired. This corroborates findings from 
Pontano Vaites ​et al.​, whose knockdown exhibited swollen endosomes and 
lysosomes and accumulation of p62, indicating disrupted autophagy; and also 
supports our theory that WDR98 knockout cell lines are not viable, as there have 
been no publications of their creation or use. More importantly, their data adds 
weight to the theory that WDR98 plays a role in endosomal and lysosomal 
maturation and trafficking.  
 
6.3 WDR98 in Context  
 
6.3.1 WDR98 in Health 
 
As more research groups move to studying WDR98, its full characterisation in terms             
of its properties and biological function cannot be far away. There is growing interest              
in this previously uncharacterised protein and given the significance of the proteins it             
interacts with and the crucial systems it is involved with, it is exciting to think that we                 
could soon have an established, proven function for WDR98. What we know so far              
is that this function will most likely centre around the regulation of endosomal             
maturation and lysosomal trafficking. The mechanism by which this is achieved           
remains unclear. 
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 6.3.2 WDR98 in Disease  
 
Various groups have found WDR98 to be mutated in different cancers, including            
colorectal ​(Jones et al. 2016)​, thyroid, pancreatic ​(Kimmelman et al. 2008)​, ovarian,            
liver, bladder, endometrial, lung, ovarian, prostate, oesophageal, kidney and         
melanoma ​(Delgado et al. 2014)​. Therefore, there is cause to study this protein in              
disease as well as in health. As discussed in the introduction, ​Kimmelman et al.              
(2008) managed to knockdown WDR98 in a pancreatic cancer cell line and            
intriguingly observed reduced ability to form colonies ​in vitro​. Once further           
understanding of the role of WDR98 has been established, this will more            
appropriately inform disease-related research. Potential starting points include more         
knockdowns of WDR98 in different cancer cell lines to see whether they affect cell              
growth and overexpression in cancer cells, with experiments focusing on growth           
rates, viability and apoptotic assays.  
 
Recently, a significant body of literature has focused on the roles of endocytosis,             
autophagy and the lysosome in cancer. Developments in this area included           
evidence showing that Ras-mutant tumours are able to upregulate RAB5-dependent          
endocytosis (Balaji ​et al. 2012) and overexpression of LAMP1/2 in metastatic           
colorectal tissue (Furuta ​et al. 2001). These mutations can benefit cancer cells by             
facilitating the destruction of adherens and tight junctions by cadherin degradation,           
which in turn promotes epithelial-mesenchymal transition and eventually metastasis         
(Mellman and Yarden 2013) and increased activation of vacuolar ATPase promoting           
an acidic tumour microenvironment and destruction of the extracellular matrix, also           
enabling tumour progression (Hernandez ​et al. ​2012). The lysosome is an emerging            
cancer therapeutic target and managing the interactions between the lysosome and           
cancer cells has been identified as a possible strategy to overcoming cancer drug             
resistance. There are numerous lysosome-targeting cancer drugs at the preclinical          
stage. Drugs targeting HSP70, a protein which protects the integrity of the            
lysosomal membrane, block autophagy and lead to apoptosis (Piao and Amaravadi           
2016). Chloroquine and hydroxychloroquine also inhibit autophagic flux and are          
drugs already approved for the treatment of malaria and these drugs could be used              
in combination with other anti-cancer therapies to circumvent the pro-survival effects           
of autophagy that can pertain to cancer drug resistance (Verbaanderd ​et al. 2017).             
Considering the likely integral-lysosomal status of WDR98 and its reported          
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 overexpression in certain cancers, this is a protein worth studying and           
characterising, both in health and disease.  
 
6.4 Future Directions  
 
It would be interesting to investigate further whether there is a WDR98 ortholog             
present in yeast. This could be achieved by either a bioinformatics or wet lab              
approach, to identify proteins with homology and to see if their manipulation            
matches the phenotype of parallel WDR98 manipulation. Given the level of           
conservation and the seemingly important role played by WDR98, it would be            
unlikely for yeast to be missing a protein performing that role if there is no ortholog.  
 
The development of an antibody would be invaluable to assess the subcellular            
localisation of endogenous WDR98 in a variety of cells and tissues across different             
organisms if the epitope allowed. It could also be used to study the response of               
WDR98 to environments affecting lysosomal trafficking, such as starvation and          
endocytosis inhibition. 
 
It would be worthwhile to further develop and analyse WDR98 knockout or            
knockdown models to establish its exact function in the cell. Not only would this be               
valuable to our understanding at a cellular level, but it would be interesting to see if                
a whole organism would be viable in the absence of WDR98. The use of rescue               
constructs containing full length WDR98, as well as domains WD40 and MIC            
individually, could confirm function and help to determine the role each domain            
plays.  
 
Visualisation of a crystal structure for WDR98 in complex with MON1B and CCZ1             
would inform about protein-protein interactions and how the proteins complex          
together, and whether altered conformations are necessary for different         
functionality.  
 
Finally, based on the collective results of ​Delgado et al. (2014)​, ​Jones ​et al. (2016)               
and ​Kimmelman et al. (2008)​, it is worth pursuing further understanding of WDR98             
in a disease context. Given the emerging understanding of the role of the lysosome              
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 in cancer, it is also worthwhile studying the organelle as a whole and scrutinising the               
viability of lysosomal proteins as cancer drug targets.  
Appendices  
 
A. DNA Construct Coding Sequences  
(All sequences are from rat unless otherwise stated) 
 
i. GST-WDR98 
 
ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCTT
TTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATAAA
TGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATTGAT
GGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCACAAC
ATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGGTTTTG
GATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTCAAAGTT
GATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATGTCATAAA
ACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACGCTCTTGAT
GTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTTTGTTTTAAA
AAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAAGTATATAGCA
TGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTCCAAAATCGGAT
CTGGTTCCGGATCCCGGGGCCCGGTACCGCGGCCGCTAGCATGCAGTCGACTAGT ​ATGGG
CAGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCCAGTGCAGTTCGAGAAGGCGAACCC
GGTTAACTGCGTGTTCTTCGACGAGGCCAACAAGCAGGTTTTTGCTGTTCGGTCAGGTGG
AGCTACAGGAGTGGTCGTTAAAGGTCCAGATGATAGGAATCCCATCTCTTTTAGAATGGA
CGACAGAGGAGAAGTGAAGTGCATTAAGTTTTCTCTAGAAAATAAGATACTGGCTGTCCA
GAGGACTTCGAAGGCCGTGGACTTTTGTAATTTTATTCCAGATAACTCTCAACTGGAGTA
CACACAAGAGTGCAAGACCAAGAATGCCAACATACTAGGATTCTGCTGGACCAGTTCTAC
CGAAATTGTCTTCATAACGGATCAAGGCATCGAATTTTACCAGGTGTTGCCTGAGAAGCG
AAGCCTCAAACTCCTGAAGAGCCACAACATCAATGTGAACTGGCACATGTACTGTCCCGA
GAGCTCGGTGATCCTGCTGTCCACGACAGTCCTTGAGAATGTCCTGCAGCCTTTTTACTT
TAAGGCTGGCACCATGTCGAAGCTTCCCAAGTTTGAGATTGAGTTACCAGCTGCACCGAA
GTCAACTAAACTTAGCCTCTCAGAACGAGACATTGCGATGGCGACCATATACGGGCAGCT
CTACGTCCTCTTCCTGCGGCATCATTCCCGGACCTCCAATAGCACAGGAGCGGAGGTGGT
GCTGTACCATCTCCCACGAGAGGGTGCGTGTAAGAAGATGCACATACTGAAGTTGAATAG
GACGGGAAAGTTTGCTCTAAATGTAGTGGACAACCTGGTAGTTGTCCACCATCAGGACAC
AGAGACGTCAGTGATATTTGACATCAGGTTACGGGGAGAGTTCGACGGCACAGTCACCTT
CCATCATCCTGTGCTTCCAGCGAGATCAATTCAGCCTTACCAGATCCCCTTGGCAGGTCC
TGCTGCTGTAACCAACCAGTCTCCCGTCCCCTGTAAACTCTATTCCTCCTCGTGGATCGT
CTTCCAACCAGACATCATCATCAGTGCAAGCCAAGGTTACCTCTGGAACCTGCAGGTGAA
ACTTCAGCCCATAGTGAATCTCTTGCCAGATAAAGGAAGACTGATGGACTTTCTCCTCCA
GAGGAAGGAGTGTAAAGCCGTCGTTCTGTCTGTCTGTTCACAGATGCTGAGTGAGTCAGA
CAGAGCCACGCTGCCTGTGATAGCCACTGTTTTCGATAAACTCAACCATGAGTACAAGAA
GTACTTGGATGCTGAACAGAGCTACACAATGGCAGTAGAAGCAGGGCAAAGCCGGAGCAA
CCCACCTCTCAAAAGGCCAGTGAGGACCCAAGCCGTGGTAGACCAGTCTGATGTGTACAC
ACACGTGCTGTCACCATTTGTGGAAAACAAGGAGACGCCACCCAAGTTTGTGATAGCTGT
GCTGATGGAATACATCCGTTCTCTGAACCAGTTTCAGATCCCAGTGCAGCATTACTTACA
CGAACTTGTCATCAAGACACTTGTCCAGCACAACCTATTTTACATGCTCCACCAGTTTCT
79 
 GCAGTACCATGTGCTCAGCGACTCCAAGCCTCTGGCTTGCTTGTTGCTGTCCCTAGAAAG
CTTTTATCCTCCCGCCCACCAGCTGTCTCTGGACATGTTGAAGAGACTTTCAACAGCAAA
TGATGAGATCGTAGAAGTGCTTCTGTCTAAGCACCAGGTGCTGGCTGCCCTAAGGTTCAT
CCGGGGTATTGGCGGCCATGACAACATTTCCGCACGAAAATTCTTAGATGCTGCTAAGCA
GACTGATGATGTCATGCTCTTCTATACCATATTCCGCTTCTTTGAACAGCGAAACCAGCG
TTTGCGAGGGAACCCTAACTTCACACCAGGAGAACACTGTGAGGAACACGTAGCCTTTTT
CAAGCAGGCTTTTGGAGAACAAGCTCTAATGAGGCCTACAACATTCTGA 
 
 
ii. WDR98-HIS 
 
ATGGGCAGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCCAGTGCAGTTCGAGAAGG
CGAACCCGGTTAACTGCGTGTTCTTCGACGAGGCCAACAAGCAGGTTTTTGCTGTTCG
GTCAGGTGGAGCTACAGGAGTGGTCGTTAAAGGTCCAGATGATAGGAATCCCATCTCT
TTTAGAATGGACGACAGAGGAGAAGTGAAGTGCATTAAGTTTTCTCTAGAAAATAAGA
TACTGGCTGTCCAGAGGACTTCGAAGGCCGTGGACTTTTGTAATTTTATTCCAGATAA
CTCTCAACTGGAGTACACACAAGAGTGCAAGACCAAGAATGCCAACATACTAGGATTC
TGCTGGACCAGTTCTACCGAAATTGTCTTCATAACGGATCAAGGCATCGAATTTTACC
AGGTGTTGCCTGAGAAGCGAAGCCTCAAACTCCTGAAGAGCCACAACATCAATGTGAA
CTGGCACATGTACTGTCCCGAGAGCTCGGTGATCCTGCTGTCCACGACAGTCCTTGAG
AATGTCCTGCAGCCTTTTTACTTTAAGGCTGGCACCATGTCGAAGCTTCCCAAGTTTG
AGATTGAGTTACCAGCTGCACCGAAGTCAACTAAACTTAGCCTCTCAGAACGAGACAT
TGCGATGGCGACCATATACGGGCAGCTCTACGTCCTCTTCCTGCGGCATCATTCCCGG
ACCTCCAATAGCACAGGAGCGGAGGTGGTGCTGTACCATCTCCCACGAGAGGGTGCGT
GTAAGAAGATGCACATACTGAAGTTGAATAGGACGGGAAAGTTTGCTCTAAATGTAGT
GGACAACCTGGTAGTTGTCCACCATCAGGACACAGAGACGTCAGTGATATTTGACATC
AGGTTACGGGGAGAGTTCGACGGCACAGTCACCTTCCATCATCCTGTGCTTCCAGCGA
GATCAATTCAGCCTTACCAGATCCCCTTGGCAGGTCCTGCTGCTGTAACCAACCAGTC
TCCCGTCCCCTGTAAACTCTATTCCTCCTCGTGGATCGTCTTCCAACCAGACATCATC
ATCAGTGCAAGCCAAGGTTACCTCTGGAACCTGCAGGTGAAACTTCAGCCCATAGTGA
ATCTCTTGCCAGATAAAGGAAGACTGATGGACTTTCTCCTCCAGAGGAAGGAGTGTAA
AGCCGTCGTTCTGTCTGTCTGTTCACAGATGCTGAGTGAGTCAGACAGAGCCACGCTG
CCTGTGATAGCCACTGTTTTCGATAAACTCAACCATGAGTACAAGAAGTACTTGGATG
CTGAACAGAGCTACACAATGGCAGTAGAAGCAGGGCAAAGCCGGAGCAACCCACCTCT
CAAAAGGCCAGTGAGGACCCAAGCCGTGGTAGACCAGTCTGATGTGTACACACACGTG
CTGTCACCATTTGTGGAAAACAAGGAGACGCCACCCAAGTTTGTGATAGCTGTGCTGA
TGGAATACATCCGTTCTCTGAACCAGTTTCAGATCCCAGTGCAGCATTACTTACACGA
ACTTGTCATCAAGACACTTGTCCAGCACAACCTATTTTACATGCTCCACCAGTTTCTG
CAGTACCATGTGCTCAGCGACTCCAAGCCTCTGGCTTGCTTGTTGCTGTCCCTAGAAA
GCTTTTATCCTCCCGCCCACCAGCTGTCTCTGGACATGTTGAAGAGACTTTCAACAGC
AAATGATGAGATCGTAGAAGTGCTTCTGTCTAAGCACCAGGTGCTGGCTGCCCTAAGG
TTCATCCGGGGTATTGGCGGCCATGACAACATTTCCGCACGAAAATTCTTAGATGCTG
CTAAGCAGACTGATGATGTCATGCTCTTCTATACCATATTCCGCTTCTTTGAACAGCG
AAACCAGCGTTTGCGAGGGAACCCTAACTTCACACCAGGAGAACACTGTGAGGAACAC
80 
 GTAGCCTTTTTCAAGCAGGCTTTTGGAGAACAAGCTCTAATGAGGCCTACAACATTCC
ATCATCACCATCACCAC 
 
 
 
 
iii. GFP-WDR98  
 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGG
ACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCAC
CTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGG
CCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACC
ACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCG
CACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAG
GGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGC
CGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGAC
GGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCG
TGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAA
CGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTC
GGCATGGACGAGCTGTACAAG ​TTACTCAGATCTCGAGCTCAAGCTTCGAATTATGGGC
AGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCCAGTGCAGTTCGAGAAGGCGAACC
CGGTTAACTGCGTGTTCTTCGACGAGGCCAACAAGCAGGTTTTTGCTGTTCGGTCAGG
TGGAGCTACAGGAGTGGTCGTTAAAGGTCCAGATGATAGGAATCCCATCTCTTTTAGA
ATGGACGACAGAGGAGAAGTGAAGTGCATTAAGTTTTCTCTAGAAAATAAGATACTGG
CTGTCCAGAGGACTTCGAAGGCCGTGGACTTTTGTAATTTTATTCCAGATAACTCTCA
ACTGGAGTACACACAAGAGTGCAAGACCAAGAATGCCAACATACTAGGATTCTGCTGG
ACCAGTTCTACCGAAATTGTCTTCATAACGGATCAAGGCATCGAATTTTACCAGGTGT
TGCCTGAGAAGCGAAGCCTCAAACTCCTGAAGAGCCACAACATCAATGTGAACTGGCA
CATGTACTGTCCCGAGAGCTCGGTGATCCTGCTGTCCACGACAGTCCTTGAGAATGTC
CTGCAGCCTTTTTACTTTAAGGCTGGCACCATGTCGAAGCTTCCCAAGTTTGAGATTG
AGTTACCAGCTGCACCGAAGTCAACTAAACTTAGCCTCTCAGAACGAGACATTGCGAT
GGCGACCATATACGGGCAGCTCTACGTCCTCTTCCTGCGGCATCATTCCCGGACCTCC
AATAGCACAGGAGCGGAGGTGGTGCTGTACCATCTCCCACGAGAGGGTGCGTGTAAGA
AGATGCACATACTGAAGTTGAATAGGACGGGAAAGTTTGCTCTAAATGTAGTGGACAA
CCTGGTAGTTGTCCACCATCAGGACACAGAGACGTCAGTGATATTTGACATCAGGTTA
CGGGGAGAGTTCGACGGCACAGTCACCTTCCATCATCCTGTGCTTCCAGCGAGATCAA
TTCAGCCTTACCAGATCCCCTTGGCAGGTCCTGCTGCTGTAACCAACCAGTCTCCCGT
CCCCTGTAAACTCTATTCCTCCTCGTGGATCGTCTTCCAACCAGACATCATCATCAGT
GCAAGCCAAGGTTACCTCTGGAACCTGCAGGTGAAACTTCAGCCCATAGTGAATCTCT
TGCCAGATAAAGGAAGACTGATGGACTTTCTCCTCCAGAGGAAGGAGTGTAAAGCCGT
CGTTCTGTCTGTCTGTTCACAGATGCTGAGTGAGTCAGACAGAGCCACGCTGCCTGTG
ATAGCCACTGTTTTCGATAAACTCAACCATGAGTACAAGAAGTACTTGGATGCTGAAC
AGAGCTACACAATGGCAGTAGAAGCAGGGCAAAGCCGGAGCAACCCACCTCTCAAAAG
GCCAGTGAGGACCCAAGCCGTGGTAGACCAGTCTGATGTGTACACACACGTGCTGTCA
81 
 CCATTTGTGGAAAACAAGGAGACGCCACCCAAGTTTGTGATAGCTGTGCTGATGGAAT
ACATCCGTTCTCTGAACCAGTTTCAGATCCCAGTGCAGCATTACTTACACGAACTTGT
CATCAAGACACTTGTCCAGCACAACCTATTTTACATGCTCCACCAGTTTCTGCAGTAC
CATGTGCTCAGCGACTCCAAGCCTCTGGCTTGCTTGTTGCTGTCCCTAGAAAGCTTTT
ATCCTCCCGCCCACCAGCTGTCTCTGGACATGTTGAAGAGACTTTCAACAGCAAATGA
TGAGATCGTAGAAGTGCTTCTGTCTAAGCACCAGGTGCTGGCTGCCCTAAGGTTCATC
CGGGGTATTGGCGGCCATGACAACATTTCCGCACGAAAATTCTTAGATGCTGCTAAGC
AGACTGATGATGTCATGCTCTTCTATACCATATTCCGCTTCTTTGAACAGCGAAACCA
GCGTTTGCGAGGGAACCCTAACTTCACACCAGGAGAACACTGTGAGGAACACGTAGCC
TTTTTCAAGCAGGCTTTTGGAGAACAAGCTCTAATGAGGCCTACAACATTCTGA 
 
iv. GFP-WD40 
 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGG
ACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCAC
CTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGG
CCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACC
ACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCG
CACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAG
GGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGC
CGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGAC
GGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCG
TGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAA
CGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTC
GGCATGGACGAGCTGTACAAG ​TTACTCAGATCTCGAGCTCAAGCTTCGAATTATGGGC
AGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCCAGTGCAGTTCGAGAAGGCGAACC
CGGTTAACTGCGTGTTCTTCGACGAGGCCAACAAGCAGGTTTTTGCTGTTCGGTCAGG
TGGAGCTACAGGAGTGGTCGTTAAAGGTCCAGATGATAGGAATCCCATCTCTTTTAGA
ATGGACGACAGAGGAGAAGTGAAGTGCATTAAGTTTTCTCTAGAAAATAAGATACTGG
CTGTCCAGAGGACTTCGAAGGCCGTGGACTTTTGTAATTTTATTCCAGATAACTCTCA
ACTGGAGTACACACAAGAGTGCAAGACCAAGAATGCCAACATACTAGGATTCTGCTGG
ACCAGTTCTACCGAAATTGTCTTCATAACGGATCAAGGCATCGAATTTTACCAGGTGT
TGCCTGAGAAGCGAAGCCTCAAACTCCTGAAGAGCCACAACATCAATGTGAACTGGCA
CATGTACTGTCCCGAGAGCTCGGTGATCCTGCTGTCCACGACAGTCCTTGAGAATGTC
CTGCAGCCTTTTTACTTTAAGGCTGGCACCATGTCGAAGCTTCCCAAGTTTGAGATTG
AGTTACCAGCTGCACCGAAGTCAACTAAACTTAGCCTCTCAGAACGAGACATTGCGAT
GGCGACCATATACGGGCAGCTCTACGTCCTCTTCCTGCGGCATCATTCCCGGACCTCC
AATAGCACAGGAGCGGAGGTGGTGCTGTACCATCTCCCACGAGAGGGTGCGTGTAAGA
AGATGCACATACTGAAGTTGAATAGGACGGGAAAGTTTGCTCTAAATGTAGTGGACAA
CCTGGTAGTTGTCCACCATCAGGACACAGAGACGTCAGTGATATTTGACATCAGGTTA
CGGGGAGAGTTCGACGGCACAGTCACCTTCCATCATCCTGTGCTTCCAGCGAGATCAA
TTCAGCCTTACCAGATCCCCTTGGCAGGTCCTGCTGCTGTAACCAACCAGTCTCCCGT
CCCCTGTAAACTCTATTCCTCCTCGTGGATCGTCTTCCAACCAGACATCATCATCAGT
82 
 GCAAGCCAAGGTTACCTCTGGAACCTGCAGGTGAAACTTCAGCCCATAGTGAATCTCT
TGCCAGATAAAGGAAGACTGATGGACTTTCTCCTCCAGAGGAAGTAA 
 
 
v. GFP-MIC  
 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGG
ACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCAC
CTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGG
CCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACC
ACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCG
CACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAG
GGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCA
ACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGC
CGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGAC
GGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCG
TGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAA
CGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTC
GGCATGGACGAGCTGTACAAG ​TTACTCAGATCTCGAGCTCAAGCTTCGAATTATGCCC
AAGTTTGTGATAGCTGTGCTGATGGAATACATCCGTTCTCTGAACCAGTTTCAGATCC
CAGTGCAGCATTACTTACACGAACTTGTCATCAAGACACTTGTCCAGCACAACCTATT
TTACATGCTCCACCAGTTTCTGCAGTACCATGTGCTCAGCGACTCCAAGCCTCTGGCT
TGCTTGTTGCTGTCCCTAGAAAGCTTTTATCCTCCCGCCCACCAGCTGTCTCTGGACA
TGTTGAAGAGACTTTCAACAGCAAATGATGAGATCGTAGAAGTGCTTCTGTCTAAGCA
CCAGGTGCTGGCTGCCCTAAGGTTCATCCGGGGTATTGGCGGCCATGACAACATTTCC
GCACGAAAATTCTTAGATGCTGCTAAGCAGACTGATGATGTCATGCTCTTCTATACCA
TATTCCGCTTCTTTGAACAGCGAAACCAGCGTTTGCGAGGGAACCCTAACTTCACACC
AGGA 
 
vi. ΔpMEP4-MYC-GFP-WDR98 
 
CGGCCTTGCCGGCCTCGAGCGGCCGCTTACAGAGTATGGTAATTTCGTTCTTTAGATTTG
CAGAATTTATAGAGAAAGAAAATTACAGCCTGCACACCCAAGACAAGGACGATTCCTCCA
ATGAAGCTGGCTGCATCAAAGGTGGACTTCCGCTCAGGCTGTGAGGTTGGAGTCACAGTG
GTATTTGTTGCACCTGCTGATGTGACAACTGAGGGAGTAGGTGTAGGAGAGGAAGGCCGA
GTTGTAGGCTTAGCTGTAGAATTGGTTGGCACTGGGGTGGTAGGTATTACAGAACAGGAG
TCAGTACTGGTCTTCTGGGTACAATTACTTACTAATTCACTTGAACAATAGGTCTTATTT
GCTTCATGGCAATCTAGCCAGACGCAGGTAATATTATTAGTCAAGGTGGCGTTGACACAG
GAAACACAGCTGTTGAAGCTCTCACAGGTTTCTGGCGGCTTGGTGGTGGTGAGCGTCGTC
GGGACCACTTTGCTGGTCGTGGTCGGCGGGTCAGTCACGTTGGGAGATGCGCTGCTGTTG
CTCTGCGCGGCCGACAGGCAGAGCGCGGCGAGGCAGGTGGCGGCCCAGAACAGTCCGCGG
GAGGCGCCCGACATCGTGTCCTCAGCCCGTCGGTCGACGCTAGCAGCTGGTAC ​GAACAAA
AACTCATCTCAGAAGAGGATCTGGCCACC ​ATGGTGAGCAAGGGCGAGGAGCTGTTCACCG
83 
 GGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGT
CCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCA
CCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGT
GCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCG
AAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCG
CCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACT
TCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACG
TCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACA
ACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCG
ACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAG
ACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCA
CTCTCGGCATGGACGAGCTGTACAAG ​TTACTCAGATCTCGAGCTCAAGCTTCGAATTATG
GGCAGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCCAGTGCAGTTCGAGAAGGCGAAC
CCGGTTAACTGCGTGTTCTTCGACGAGGCCAACAAGCAGGTTTTTGCTGTTCGGTCAGGT
GGAGCTACAGGAGTGGTCGTTAAAGGTCCAGATGATAGGAATCCCATCTCTTTTAGAATG
GACGACAGAGGAGAAGTGAAGTGCATTAAGTTTTCTCTAGAAAATAAGATACTGGCTGTC
CAGAGGACTTCGAAGGCCGTGGACTTTTGTAATTTTATTCCAGATAACTCTCAACTGGAG
TACACACAAGAGTGCAAGACCAAGAATGCCAACATACTAGGATTCTGCTGGACCAGTTCT
ACCGAAATTGTCTTCATAACGGATCAAGGCATCGAATTTTACCAGGTGTTGCCTGAGAAG
CGAAGCCTCAAACTCCTGAAGAGCCACAACATCAATGTGAACTGGCACATGTACTGTCCC
GAGAGCTCGGTGATCCTGCTGTCCACGACAGTCCTTGAGAATGTCCTGCAGCCTTTTTAC
TTTAAGGCTGGCACCATGTCGAAGCTTCCCAAGTTTGAGATTGAGTTACCAGCTGCACCG
AAGTCAACTAAACTTAGCCTCTCAGAACGAGACATTGCGATGGCGACCATATACGGGCAG
CTCTACGTCCTCTTCCTGCGGCATCATTCCCGGACCTCCAATAGCACAGGAGCGGAGGTG
GTGCTGTACCATCTCCCACGAGAGGGTGCGTGTAAGAAGATGCACATACTGAAGTTGAAT
AGGACGGGAAAGTTTGCTCTAAATGTAGTGGACAACCTGGTAGTTGTCCACCATCAGGAC
ACAGAGACGTCAGTGATATTTGACATCAGGTTACGGGGAGAGTTCGACGGCACAGTCACC
TTCCATCATCCTGTGCTTCCAGCGAGATCAATTCAGCCTTACCAGATCCCCTTGGCAGGT
CCTGCTGCTGTAACCAACCAGTCTCCCGTCCCCTGTAAACTCTATTCCTCCTCGTGGATC
GTCTTCCAACCAGACATCATCATCAGTGCAAGCCAAGGTTACCTCTGGAACCTGCAGGTG
AAACTTCAGCCCATAGTGAATCTCTTGCCAGATAAAGGAAGACTGATGGACTTTCTCCTC
CAGAGGAAGGAGTGTAAAGCCGTCGTTCTGTCTGTCTGTTCACAGATGCTGAGTGAGTCA
GACAGAGCCACGCTGCCTGTGATAGCCACTGTTTTCGATAAACTCAACCATGAGTACAAG
AAGTACTTGGATGCTGAACAGAGCTACACAATGGCAGTAGAAGCAGGGCAAAGCCGGAGC
AACCCACCTCTCAAAAGGCCAGTGAGGACCCAAGCCGTGGTAGACCAGTCTGATGTGTAC
ACACACGTGCTGTCACCATTTGTGGAAAACAAGGAGACGCCACCCAAGTTTGTGATAGCT
GTGCTGATGGAATACATCCGTTCTCTGAACCAGTTTCAGATCCCAGTGCAGCATTACTTA
CACGAACTTGTCATCAAGACACTTGTCCAGCACAACCTATTTTACATGCTCCACCAGTTT
CTGCAGTACCATGTGCTCAGCGACTCCAAGCCTCTGGCTTGCTTGTTGCTGTCCCTAGAA
AGCTTTTATCCTCCCGCCCACCAGCTGTCTCTGGACATGTTGAAGAGACTTTCAACAGCA
AATGATGAGATCGTAGAAGTGCTTCTGTCTAAGCACCAGGTGCTGGCTGCCCTAAGGTTC
ATCCGGGGTATTGGCGGCCATGACAACATTTCCGCACGAAAATTCTTAGATGCTGCTAAG
CAGACTGATGATGTCATGCTCTTCTATACCATATTCCGCTTCTTTGAACAGCGAAACCAG
CGTTTGCGAGGGAACCCTAACTTCACACCAGGAGAACACTGTGAGGAACACGTAGCCTTT
TTCAAGCAGGCTTTTGGAGAACAAGCTCTAATGAGGCCTACAACATTCTGA 
 
 
vii. pcDNA5-GFP-humanWDR98  
 
84 
 GACGGATCGGGAGATCTCCCGATCCCCTATGGTGCACTCTCAGTACAATCTGCTCTGATG
CCGCATAGTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCG
CGAGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTGC
TTAGGGTTAGGCGTTTTGCGCTGCTTCGCGATGTACGGGCCAGATATACGCGTTGACATT
GATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATA
TGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCC
ATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGT
ATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATT
ATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCA
TCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTG
ACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACC
AAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCG
GTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCCCTATCAGTGATAGAGATC
TCCCTATCAGTGATAGAGATCGTCGACGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGA
GACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGA
CTCTAGCGTTTAAACTT ​ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCA
TCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCG
AGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGC
CCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCT
ACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCC
AGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGT
TCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACG
GCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGG
CCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACG
GCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGC
TGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGA
AGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGG
ACGAGCTGTACAAG ​TTACTCAGATCTCGAGCTCAAGCTTCGAATTATGGGCGAGGAGGAC
TACTATCTGGAGCTGTGCGAGCGGCCGGTGCAGTTCGAGAAGGCGAACCCTGTCAACTGC
GTCTTCTTCGATGAGGCCAACAAGCAGGTTTTTGCTGTTCGATCTGGTGGAGCTACTGGC
GTGGTAGTTAAAGGCCCAGATGATAGGAATCCCATCTCATTTAGAATGGATGACAAAGGA
GAAGTGAAGTGCATTAAGTTTTCCTTAGAAAATAAGATATTGGCTGTTCAGAGGACCTCA
AAGACTGTGGATTTTTGTAATTTTATCCCTGATAATTCCCAGCTGGAATACACACAGGAG
TGCAAGACTAAGAATGCCAACATTCTAGGATTCTGCTGGACTAGTTCAACTGAAATTGTC
TTCATAACAGATCAAGGAATCGAATTTTACCAGGTATTACCAGAGAAACGGAGTCTGAAA
CTCTTGAAGAGCCACAATCTCAATGTGAATTGGTACATGTACTGCCCCGAGAGCGCCGTG
ATCTTGCTGTCTACCACGGTCCTGGAGAATGTCCTGCAGCCTTTTCACTTTAGGGCTGGC
ACTATGTCGAAGCTGCCCAAATTTGAGATTGAATTACCAGCTGCGCCTAAGTCAACTAAA
CCCAGCCTTTCCGAAAGAGACATCGCAATGGCTACCATATACGGGCAGCTGTATGTTCTC
TTCTTGAGGCATCATTCTCGGACCTCCAACAGCACAGGAGCGGAGGTGGTCCTCTATCAT
CTACCACGAGAAGGTGCCTGTAAAAAGATGCACATATTGAAGTTAAATAGGACGGGAAAG
TTTGCCCTGAACGTGGTGGACAACCTGGTAGTCGTGCATCATCAGGATACAGAGACATCG
GTAATATTCGATATCAAGTTACGGGGAGAGTTTGACGGCTCCGTTACCTTCCACCACCCC
GTGCTTCCCGCTCGATCGATCCAGCCCTATCAGATCCCCATCACAGGTCCTGCTGCCGTG
ACCAGCCAGTCTCCTGTTCCATGTAAACTCTATTCTTCATCTTGGATTGTCTTTCAACCT
85 
 GACATCATTATCAGCGCAAGCCAAGGTTACCTCTGGAACCTCCAAGTGAAACTTGAGCCC
ATAGTAAATCTCTTACCAGACAAAGGAAGACTCATGGACTTTCTCCTCCAGAGAAAGGAA
TGCAAGATGGTCATCCTGTCTGTCTGTTCACAGATGTTAAGTGAGTCAGACAGAGCATCG
CTGCCCGTGATAGCCACTGTTTTTGATAAACTCAACCATGAGTATAAAAAGTACCTGGAT
GCCGAGCAGAGTTATGCGATGGCGGTGGAAGCAGGGCAGAGCCGAAGCAGCCCGCTCCTC
AAGAGGCCGGTGCGGACCCAGGCGGTGCTGGACCAGTCAGATGTGTACACCCATGTCCTG
TCAGCCTTTGTGGAAAAGAAGGAGATGCCTCATAAATTTGTGATAGCCGTGCTGATGGAA
TACATTCGTTCTCTTAACCAGTTTCAGATTGCAGTACAGCATTACCTACATGAACTTGTT
ATCAAAACCCTTGTCCAGCACAACCTCTTTTATATGCTGCATCAGTTCCTGCAGTACCAC
GTCCTCAGCGACTCCAAACCTTTGGCTTGTCTGCTGTTATCCCTAGAGAGTTTCTATCCT
CCTGCTCATCAGCTATCTCTGGACATGCTGAAGCGACTTTCAACAGCAAATGATGAAATA
GTAGAAGTTCTCCTTTCCAAACACCAAGTGTTAGCTGCCTTAAGGTTTATCCGGGGCATT
GGTGGCCATGACAACATTTCTGCACGAAAATTTTTAGATGCTGCAAAGCAGACTGAAGAC
AACATGCTTTTCTATACAATATTCCGCTTTTTTGAACAGCGAAACCAGCGTTTGCGAGGG
AGCCCCAATTTCACACCAGGGGAACACTGTGAAGAACATGTTGCTTTTTTCAAACAGATT
TTTGGAGACCAAGCTCTAATGAGGCCTACAACATTCTGAAATCACTTGCTGTTTTTTTAT
ATAAAAATGTGTACAAAGTTAATTTATTGCATTAATAAAGCTCTTTAAACTATAAAATGT
TATAAAGTGTATCTACAACCTC 
 
 
 
viii. WDR98 gDNA  
(Exons in bold) 
 
GAAATTTAATGCCCTAATCTCCCTTTATTTCCTCTTAAATAAAGGCGCCAGTCCCATTGG
CTTAGGGACCTACCTGATGCCTTCAGTTTTCCTTAATTTCCTTTGAAGCTTCAAGCACAT
TCTGAGATATTGGGGATTAAAACTTCAACACGTAAATTCTAGGGGAGGGGCGAAATCTAG
TCCCTAACATCCTAGCAGATCACAGTACTTGCCAGTATGGCTAAGGCAGACTGCTCAAAA
AATCAGTTTCTGGGGCTAAACACGGAATT ​CCGTTGAGTAATGTAGTTGCCTGG​CGTGAGGG
AGGTCCTGAGGTGAACACAGAAATCAATCCTGGCTCGTAGATCTTTGCTGCACGCTTACA
GTTAGCCTCCTGCCTCATCTCTCGACTAAACAGACAAGAACAGAACCCTGGGCGTAGGCG
ACGCAGAATGTCACCACCCGTAAGCAAATTAGAAACCAGGCTGTCCTCCCAGCAGCCCGC
AGGCTTCCGGGTCACGTGACCCGACCTCCTCCCTCCTACAAGGGGGCGTGTCTTCGGTGT
TGGGACCCTCCCCCGCTCACTGAGGCGCCGCTGGCCCGGTCACGTGGAGGGCGGGGCGG ​G
GCCTAGGGCTGCGGCCCAGCGGCGACCCGGTTCTTGGACTGCATCTTCTACGGACGAGCTCC
GCCGGTCCCAGCCATGGGCAGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCCAGTGCAGT
TCGAGAAGGCGAACCCGGTTAACTGCGTGTTCTTCGACGAGGCCAACAAGCAG​GTGAGCGG
CGGCCACGGCGGGGGCCGGGCGCCCAGACGCCGGAGTGTCTCTGCACCGGCGCCGAGAGT
GCGGGGTGTATTGTACCAGAGCTGAGACGCGAGTGAAAGTGCATGGGCGGTGTCAGTGTG
CGAGCTGGCTTTCAGACGGTCAGTCCCAGAGTCTGGCCTGCGGTCTTAAAATTCGTCTAA
GCATGTCCTGTTTGTTCGGATGAATCGAGGATGTGGTACGGTAGACATGATTCTTGAAAG
GCTGAGTCTAGGTCCTTATAAAGTCTGACCATTCATGTTGCCTCTTTTCCTCAG ​GTTTTT
GCTGTTCGGTCAGGTGGAGCTACAGGAGTGGTCGTTAAAGGTCCAGATGATAGGAATCCCAT
CTCTTTTAG​GTAATTTGCACTTTCAGAATAATACCCACATGTAAACACCGGCGGCTTTCT
AACTCAGAAAGTTGAATCATTTTGTCTCTAAG ​CGGCCTGTCGTGTCAGTAAG​AAAAAGCAG
86 
 TGGACATTTGCTAGTACAGTTTGGTTACAGCACAACTGTCAGAGTGAAATAGGGATTGCT
AGTTCAAGTGGGAACCAAAATCTCCTAGAGCACCCACTTCCTGGTACTTGAAGTTATCGA
GTCCGTGTGTTTTGCACTCATTTCTGCAGTGCGCAGTGCTGGACCTGGGGACTCATTGAC
GTTTATCCCAGCACTTCTAGAGTTTTTGCTGGGTGGTGGAAAATCCAGTGTTCTGGTGTA
ATGGAGAACAATCAGGGCTTCCACTGAGGTTGAAGTGACAGACCGGCTTTCCAAAGTATG
TAGGTTGACAATGTGATTGACATAGCAGTTCTTTTCATTTTTACAAGTCCCTCAGCACCT
TGGCAACAGGCCTATAATCCCAGCCCTCTGGGAAGCTAAGTAGCAAATAGCTTGCAGGTT
AGTGGCAGTGTAGCAAAACCCCGTTTTCAACAACAACGACGACAACAAAAATCTCAGAAA
AATAAATTGCATTTAATATGTGTCAGCTGTTTGAAGTAAAAAAAAAAAAACAGCCAACTT
TGTTTTCCTTTCTTTTCCTTTGTTACTTCTTCCTTTATTTTTTCATTTTTTTTTGAGACA
GGGTTTCTCAATGTAGCCCTGGCTGTCCTGTAACTTAATTCTGTAGACAGGCTGACCTTG
AACTCAGAGATCCTTCTGCTCCTGCCTCCTGAGTGCTGGAATTCAAGGTGTATTTGACAG
CTTGTCTTGCTTTCTTTTAATGGCCCTTGCTCAGCACATCCTGAAAGCAGCTTTAACTGG
AGAGAAGAGATTTAGCAAATACTGTTTGCCATGCTAAGCTCTATGCTAAAGCTCTGTTCA
TCGTGTGGGAACACTTAGGGGTGCAGCTTTGACATCAGTAATGGGGTTGAGTAAGGCCAC
AAGGTGGGAAGGGAGTGATTTCTGGTTGGAGTCGAGACCTAGATAACACCAGGAGCAAAG
GTGTGATGTTCTGGGGAGTCTCCTCCTTGTGTTTGGGACACTGTCTCACTGGCACATTAC
CATGGCAAGGGCTCCTTAAGGGCTTGCTTGCCTCTGTCTCCACAGCCCTGGAATTATAAG
GGATGGCACAGTGTTGAGATTTTTTTTTTTAAAACAGCTTTATTGAGTTAAAATTGGCTC
ATAAATTGCACATTTACTGTGCATTGATATATCTATACACCCAGGAAACTGTCACTACAA
CTAAGGTAATGAATGCAGCTTTATCCCACAAGATCTCCGGTAGTCTTCAGGTGACGTGTG
TGACCCCAAGTCTCCAACCACTTGGCTGTGTCATCTGTCCACCTCACTAGCAAGTCGTTG
CCTGTAGATTCTGGTCACAGCTTCAGAAATGCAATTCCTAACATTTGGCTCAGGGCTGCT
GCTTCCCAGAGTTCTGGCTTTTTGTCAGTGGGAGTAAGGACTAGAGTTGAGAGCGGCTTC
TCCCCTAACCGTGCTTTCTTCTTCAG ​AATGGACGACAGAGGAGAAGTGAAGTGCATTAAGT
TTTCTCTAGAAAATAAGATACTGGCTGTCCAGAGGACTTCGAAGGCCGTG​GTAAGACATAG
CTTAGAACAGCATCGGAAAGAGAGTGGGTGCTTGGAAGAGACAGAGTCTGAGTTCTGGCT
GTTTGCTCGTCCTCAGAGTCAGTGAAGTGGGGGCTCCTGAGAGCGTTTGCAGATAAGAGG
ACGAACGAGCTTACTTATCATTTGTCTGTCCTTAAAGGCAGTGTGTATTCATGATGCGAA
ATGCTGAGCCTCATCATGCCATTGTCATACGTGTTTATCGTGTCCTGTGATAATGTTCTG
CCCCATTGCCTTCTCCTGGCCCCCCTCCTGGACCCCTTCTGGCCTCCCCCCTCCTCTAAG
TGGCCCTTTTCTACTCTGATCATTTGTATGTGTGTGGATGTGTGTACCATGTGTGTGCAG
TACCTGAGGAGGCCAGAAGAGGGCACAGGATCCCCTGCAACAGGAACTACAGGCGGTTGG
GTGCTGACAATCGAAGCCGGCTGTTGAGCCAGCTCTCTATCCTCTATTTTGTTTAAGTAA
TTTGGATTATCATGCATCTTTATATTGCTTGTTAACTGGCAACATGGATTATGGGAGGTA
TATTTTGATTACTTGGTAAATGAATCGTATTTCAAGTCACTTCAGCATCTGGTTCTTTCT
CCACCAGATATGCTGGAGAATATTGGATTGGGATATCCAATGCTGGATTGGGTAGGAACA
GGCAGATGAACACAGTTGGGGAGTTTGCTGGTGCTTCATCTCTTGGACATCCTCACTATC
GCTTGCCTTGGGTTGGGATGCAGTGTGATTAGCCTAGCATGAGGAAATCACAGGTTTGCT
CCTAGTGTCTCATGTCAGTCATTATTCATCCCGTTCACTGCTGTCATCAGTAAAGTAGGA
AGGAGGTGGTGGGAAGACAGGCAGACAGCTGTGTTTGCTGCTGCTTTATTTCTCTGGATT
TCCAGGAAGCCTGGGGGAAGTGATGTCACCCATTTGAGGAATATATTTCTCCTTTCCTCC
CTCCTCCTTTCTTTCTGCTCCTTCTCTCTCCTTTCTCTCTATTTCCCGCTCCTTTTATGG
TCAAGGTTGACCTGGAATTTACTACATAGAACAAGTTGGTGTTGAACTTAAAGCAATCCT
CCAGTCTCAGCTTCTTGGGTGCTGAGATCCTAGGTATGAGCTGCCCACTTGGCTTGAGGA
ATGAGTTTTAGAAGTCTGTTCATGAGTTCCAACTGAGTGTTTAGGTGGACTCCTTTTAGT
87 
 TGACTGGTAAATCTGGTTTCATTTGATCCTAATTGTCTTTATATCTTTTCTCTGTGGGTG
TTTGTCCAGCTGTTTTTTAATCACTTTAAAAATCTGCTTGTCAGGCATAAGGGGACACAC
TCTTAATACCCCCTAGCACTCAGAAGGCAGAGGTAGGCAGCTCTCTCTGCCAGCACTTCC
TACTGAGACCCTGCCTCAGAACAAAAACAAAAAAGTTGTCCATTTTATTTCGTAGTAGGC
TATTTAATCTGATAATTTCCCTCTGTGTATTTTTTCTGTCTTTCAG ​GACTTTTGTAATTTT
ATTCCAGATAACTCTCAACTGGAGTACACACAAGAGTGCAAG​GTACACGGCTGGTGTGGGG
GAGGGGGCTTCATTCCTCACTGCAGTGTCCACTGTTGTTTGTGTGTGGAGAACAGGTTGG
GTAGTAGACACACATTGGAATCTCTGTCTGGGGAGGTGTCTGTGTTGACGGTGAGCTGTA
GAGGTTGGTTGGGGGTTCAGCTATGCCAGACAGTTTCACCCAGTTTTGTCTCTTAGCTAT
AAAGTGGAGGACTGATGGTAAAGGGTCACCGTCAAGGCTCCCTGGGGCTTCCTCACCGTG
CTTGCAGGCCTCTGTGTCTCAGGCTTGGATCCCACCTGCCCCATCTTGTAAGGTTCTCTG
AAGTGTTGTTTCCTCAATGAGTCTCCCTCCTGTATCCCTGCACCCTATGTAGGTATAGCC
CTAGTCTCTCTTAATTAGAATAGCTGGGTGTAGAAAATGAAGCTGGTGGGAGGGAGCTAT
GCCATGGTCAGCCCAGGGGCAGCTGGGAGAGTAACCACAGTTGTCAGTCGCAGGAGTAAC
TTTGGTGTACCTCATTGTTCTTGGTAAGTGGCACTCAAGATGGGGTCCTTATCTGTGAGA
GGAGACTCAGGACTTAACCAAACTCCTTCCAGCCCTACAGGTGCTCTAAAGGAACCGCTC
CTTGTCTGAGCCCTGCTTTGCCCCTTCTGTCTTTGAGCCACCCATTCTGTGGTCTCAGGC
CCTGGAACCCATCTTGGTTTGTGTTAACTGAAGAACTTTAGCCCTTGTATTATTGTAATG
ACTGTGAGAATGTTGCAGTTTGAGAGGCAGAAGTTGGAATTTCTGGCCTCTGGGTATTAT
CTTTCTATAAAATTTAGGCTTCTTTCTCTGTTCAGCAGGGTACAAGGATTCAGAATCTTT
GGTAGAAATGTTAGGACAAAAATCGGGAGAGCTGTGTTTAAGAGCGTTTGAATCTGGCAT
GGAAATGCTCCCCTGTAGCCCAGCATCTGGGCGGGTGCATCAGGAGAGTCCTGAGTCCAG
GCTGCCTGGGCTGTAGGGCTCCAGGCAGCCTTTGTCAGAGTGTGGGATGGAGCCTAATGA
GTGAGTGACCGTAACAGCCGAGCATTGAGGTTTTGAAGGGAGCTGCACAGCCTTCAAACC
AGAGCATTCACACTTGTTAGAGCTACAGTGTGTCCTTGATTTGTGTGTGGTGTAGGTACG
CCTGTCCTCACAGGTCAGTGGAGGATGTGGAGTGTCCTGCACTGTGACATTTTATCCCCT
TGAGGCAGGTCTCTTACTGAACCTGGAGATAGGCTAGTGGCCAGCAAGCCCAAGTCCCTC
CTCTCTGCTCCTCATGTCCCACACCAGCACTGTGATTATGGCCACTTGTGGCCATTTATG
TGGGTACTGGGGATTTGAACTCAAGTCCTCCTGCTGTGAGCAGGGGCTCTTACCCACAGG
GGCATCTCTCTAGCCCCTTGCTTTTTGTTAATTTTCACTTATTTATTTTTTTGGAGATAG
TGTTTCATGTCCAGACTGGCCTGCATCTTGAAATGTACCCATGGATGGCCTTGAATTCCC
AAATGCCCTGCCCTAGCCTCCTGGGTGCTGGGATTATAGACATCACAATCACAGCCAGCT
AAAAACCACCTTTTTTTGTAATTCTTCCAG ​ACCAAGAATGCCAACATACTAGGATTCTGCT
GGACCAGTTCTACCGAAATTGTCTTCATAACGGATCAAGGCATCGAATTTTACCAG​GTATTA
TATCAGTTATAGATTTGCTAGAGAAAGCAAAGGCAGTTCAGCAGCCTGTGTTGTATCAAA
AAGGTCCTGAAACCAACCTCTTAGTTGAGGAAACATTATACAAAAGTAAAAGTTCCTAAA
ATTGACTGTCAGCCCCAGTTTGTACATAGTTCAGTTTTCCTCTGGACACGTGCATTTATC
ATTGTTATTTTTATTTTTATTTTTTTTGCAGTGGGGCTCCTGCACATAAACTTGTGTGGT
GTAGGTTTTTCTTGCATAGCAGTATGCTTTGGGGGTTGTCCCCAGATTTCGTCCTGAGAA
TAGTTCTGCTCTGTGGACAATCTGCTGTTTGCCATGTCACTTCCTGTTACAAGATGTCTG
GCTTGATTTCACTCTTTATGGTTGGTTACTCCAGAAGTTCACGAGCCGTCTTACATGTTT
CTTCATGTTCATGGGCAAGCAGTTCTTGTAATTGCATAGATACAGACAGACACCATTACA
TTTTTCACAGATGTCCATGCTTTGAGAAATAGTGTGGGACTCTCTTGTCCACATTGCTGC
TGGGCCTGAATCTCATTGATCTGTAGACAGTTGCCTTCTCAGACGGGGAAAGATTCTCAC
TGTCCTCTTAGGACAGTGGGTCACAATCCCTATCACAAGGGTAACCTAAGACCATCAGAA
AACACAAATATTTGTAACCATGGGCTTTTTTTTTTTTACCTGCACCTCAGTTCCTAAATA
88 
 ATGACTCTGAGACTGAATTATTTATGAGTAAATGCCTAGGTCTTAGACTTGATCTTATTC
CCTGACCAGCCTTTAACTTAATTAACCCATTTATTCTATTCTGTGAGTGCCACAAGGCTG
GTTATCTCTCCTCAGATTCATGTCTGTCTCCTCAGAGTTCAGGGCAAATCTCTTCCTGAG
CCTGACTTTATCCCAGAGTCTCCTTTTCTGACGGGAACTCCCATATCCTATTTCCTGACT
CAGCATCATGGAGGAGCCTTGACAGCAGTGTAAAATCAAATAATGAGCATGAAGAGCACT
GTAAGTTTAAATCCATACACGGAGAAGGGATAGAGGACCCCGGAGGATAGAGGCCTCCCT
ACAGTCATTTTAAAAATATCTGTGCTGGTGCTTAAGAGCACTTTCAGGATCATAGTGGGT
CACAGACATCCGAACTTCAGTGCCAAGGTATTCAAAACCTCTTCTGACTTTCACAGGTGT
AAGACCTGCGCATAGTTCATATCATATTTTCCAACACACACACACACAAAACATTTATAT
ACATAAAACAAAATAACACTGGAAAAACACTCGGTTCTCTCTAGTGAGTAAGTATGTCAG
ATCCCCAAGACATGTTAGGGCTGGTGAGATGGGTCAGCACTTGTCACCCAGTCCTTGTGA
TCTGAGTTCCTTCTGTCATGAGAGAACTGTCACCCCGAAGACGTCTTCTGATTTCCATGT
GCACATTATGACATACTCGTGTCTCCATATACATAATAACAACAAAGAAATAGATTAAAA
AGAAAGAGAACTCCAGCATGCTTCTTTATGGCTCTCAGTGTGTGTGTCTGTGCCACAGTG
CACATGTGGAGGTCAGAGGAGAACTCTGTGGAGTCCCTTATTTCCCTCCGTCTTTTTGTG
GGTCCTGGGATCAGGTTAGGGCAGGCAGTCTTTACTTGCTGAGCCATCTTTCTGGCCGTG
TACGTTCTCATTTTGTGAGGCTTGGGTGAGGATGTTCATGCTTGGCCTTGATTTCCCTCG
TGGGGTGAGTGTTGGTATCTTGAGTCTGCAGTGTTCTTAGTGTGCCAGAATATGGAGAAT
AGATGTGCCTAGATTCTGAAGGGCTGCACTTGCAAGCGGTCTTACGAATAGTGGGGTTAG
GAAGAAGAAGCCTGGCCTGATCAGCCAGGTGGAGTGTAGAGAGAGCTGGTGGCTCTCATG
TTGTGCTGTCTCTCAGAGTGTAGGAAAGAGTAAATTAATGAGGGGTGGAAAGCGCCAGGC
ACACAGCGCCATAATAAATACAAGTAGCAGTTAGCTGTACGACCCTGGGCTGCATTGTTT
GGGTTTTGTGGTGGTGGTGGTGACTGAACTGGCTGGGCCTCCTGTTTCTTATGCAAGCTC
TTGTCCACTGGGTTTATCCCGACCTTGGTGGGCTTTCTGTGCTCTTTATTTACCTCACTT
GTCGTAGCAGTCTTTTAACGTGAAGATCCCTCTTCTTGACCTTCGTCCCAG ​GTGTTGCCT
GAGAAGCGAAGCCTCAAACTCCTGAAGAGCCACAACATCAATGTGAACTGGCACATGTACTG
TCCCGAGAGCTCGGTGATCCTGCTGTCCACGACAGTCCTTGAGAATGTCCTGCAGCCTTTTT
ACTTTAAG​GTGAGAGTGAGCCTCAGCCCCTTAAAATAACCTCTCTACCCAGCTCTAAAGC
TGGTCGGTCCTATGAATGCCGCCTCTCAGACCACTAGAGGGTGCCCTTCACCATCCCAGC
AGTCCAAGAATGTCCTGAGGGGGAGCATTGAAGACCTGTCTCCATTGCTTTCATGCCGGG
CAGGCTAAAACATGGAAGGAGTGCCCTAAATGTTCCTAAACTTCCCCCTAAACAG ​GCTGG
CACCATGTCGAAGCTTCCCAAGTTTGAGATTGAGTTACCAGCTGCACCGAAGTCAACTAAAC
TTAGCCTCTCAGAACGAGACATTGCGATGGCGACCAT​GTATGTCTGTCTTCAGAGGGTGCT
GTGTGTAACATGACACTTTTTTAAAAAGTTTTATTTTTCTGGGTATGCTTTATCTGTATG
TGTGTGCACCTCAGAGGCCATAGAGGGTGTCAAGTCCCCTGGAAATGGAATTACAGCTGC
CATGTGGGTGCTGGGAACTGAACCCGGGAGCTGAGGTGTGACTTATCACAGTAGAATGCA
CTTTCCTTCTTCTCTGTTCTCTGCTTGGCCACCCAGTTTAGGGAGTTGAAAAGTGACTGC
TTTTTTGGCTCAATTCTGGGTGGGGACTGGTAGGCGGGGCCAAGCTCATTGCTGGCACCC
AGTAGGTGACATCTGCTGTGGAGAGTGCCTGGCCCATCCTTCTGTTACGGCACATGTCCT
CGTTCTGTGAAAGGAAGCAGCTAGAAGGGAAATAACCAGTGGGTGTTGTGACTGTTGACC
TGTATTTCTTCCCTGCCTTGAATTGTGTGCTTGGCTGTAGTCAAACTGTATGTAGAGGAC
TCTTACTATCCCTGTAAGGCTGGGTTGGAACTTGTTCTGTAGTCAAGATGACTTGAACTT
CTGATCCTCCTGAGTGCTGAAATTCTGAACATAAGCCACCATACTCAGTTTATGGCATGA
AGGGGCTCAAGCCAGGCCTTTGTCCAGCTAGGTAAGCCTTACTCTAGCAGCTCAGTTACG
TACCCAGCGGAGAGAAAGGACTCTGGAATGGCCACGATGACTTCTCTCTCTCCGACTAG ​A
TACGGGfCAGCTCTACGTCCTCTTCCTGCGGCATCATTCCCGGACCTCCAATAGCACAGGAG
89 
 CGGAGGTGGTGCTGTACCATCTCCCACG​GTACGTCTGCCTCATGCCCTCTTCTCTCTTTGC
TTTTAAGTTGAACTGAGGTGTGCTGACCTCTTCCTCTGACTTCTGTGCTCTCTTACAG ​AG
AGGGTGCGTGTAAGAAGATGCACATACTGAAGTTGAATAGGACGGGAAAGTTTGCTCTAAAT
GTAGTGGACAACCTGGTAGTTGTCCACCATCAGGACACAGAG​GTAAAGTCTCCTGGGGAAG
CTGCGGTTGTCTGTGTGGGGCCCTTTGATAGGCTTTGTGAGAACCGGCAAACCTGACAAG
GGTGGGAAAGAGCGTAAGCTCAAAGGAGTTAAGTTTAACTGATTCTCTAACAGTTTATTA
AATAAAAATGATTCCAGTTTGGGGATGCAGTTTGCTAGGCAGAGGGCTTGCTTCATTCGT
CCCATCCCAGCTTTGCTTAAAGATCAGCTGTGATGGTGCACACCTGTTATCCCAGCACGC
GGGAGGAAGAGGCAGGAGGATGAGAAGTTCAAACAGTCGTTAGCTCTACAGTGGGTTGGA
GGGCAGCTTGGGCTACATGAGCTGCTGTCTCAAAAAACAAAACAAACAAAATAAAAAAAA
AACAAACCAAACAAAACAAAAAACTAAGGAAATTAAAAACTTTAAGAAGACATCATTTGA
TGTGATCTTTGTACTCTTGCTCAATCTTGGATTGATCCAGCTGAGCTGGGGCCTGCTGCA
GACCTGGGTGTGGGTGTGGATAGCAGTATCTGACCAGGGTGTTGGACACTGTCCTGCCCA
TCAGTCTGCAATAGGTCTTGCTTTTCCAAGTGGTTAGCTGAGCGCCTGGTGGTAGGCCAG
CCACACCTTTCCTCTACTTTGCTGAAGGGTCCTGCTGCTACGTCTCTAACTAATGGAGAT
GTTGTTTCAAGTTCAAGTGAAGTTTATATGCCTGTGTCTCTTTGAGATCTTACAAGGAAG
CAGGAAGCATTTGTGAAAGCAATAGCAGTGGGAAGGAGAGTGTGATGTGCATAGCCGTCC
TCTGAGGGAGAGCTGGGCTGGGGTGGCTGGGCACAGGCTTCCAGACCGGCAACAGGTGAT
GTGTTTGCTCCTACCGTAG ​ACGTCAGTGATATTTGACATCAGGTTACGGGGAGAGTTCGAC
GGCACAGTCACCTTCCATCATCCTGTGCTTCCAGCGAGATCAATTCAGCCTTACCAGATCCC
CTTGGCAG​GTAAGAGAAGTTCTGCGAAATGGCAGTGCTGTCTTTTCCCCACAGGGCCATA
TTCTTGTTAGAATCTTCTGGGGTCAGGCTCAGAATGGGACAGGGAACGAGGAGAATCCCC
AATCTGCTTTATTTTGCAGAGGAACATTTGTTTTCTTGTTTTGGGATGCTGGGGGATTAA
TTAACATTTTCTGTTTTCCTGTTTCTGTAACCCTGGGATTAAATTCAGCTGACTATGGCT
AAATAGTTTTATTGGGCTTACATGCCCCTGCATTTTCATACTCTGTGTTTGGTTTTTTGT
TTTTTTTTAGATTTGCTTTTTACGTATGTGTTTGTATGTGTCTGCATGTATGTATGAGCG
TGTGTGTTTGGGTGCTGTCAGAAGGCAGAAGAGGGTGCTGGAGTCCCTGGAGCTGGAGTT
ACATGTGGTTGTATCTTTGAGGATGAGGATGCTGGAGACTGAATTCAGGTCCTGTGTTAG
AGCAACAAGGACTTTTAACCACTGAGCCAGCTTGCCAAACCCTTGTTTGGTTATAGCAGA
TGTGGCCAATGGTTAGTCACAGTAACCCCACAGTCGGGGAGGAGGTCAGGAGAGTAGTAG
GTCAGTAGTTCAGAAAAGAAATAGTCCCATTCATAACAGGCCTCTAATAATACTGTTACT
GTAATTTTATAGGAGACTACAGTCCAGTTAGCTGGTTGTCTCTGTTTTGTTAGGAGACAT
ACATGTCAGCTGGCCTGTGGCAGTTCTCAGCCTCTGATTTCCTTGTGCTTTTGTGGAGAC
AGTTGAGAGCCACGCTCTAGGTGGTAGATTGGTCAGCAGGCGCTCAGCCTCGAGTAGCTG
GCTCATCTTACAGGCTCAGAAAATGTCCAGTGGCATCTGGCTTTTCCTGGATAACATTAG
CAGTAAGCAACGGATGAGAGCAAATTTTTGACATGGGTAAAACCACTGTAAACATGTAAA
ACCCTCAATTTTGATCCAGTAATAAAGGAGCAATAAACAGGCTGTTTGCTTGAGCAAGGT
GCAAATTGAAGTGGATCAGATTAGTCTAGGAAGGACTGTCCAACATTCTTTTATTCTGGC
AGTAATTACGTAGCAAGCCTAGTTGTCTAGAAAGGTCACTCCTGACTTACGAAAATAATG
AAAATAAACTATTGCCGAGAGGGCAGGAATACATGGGTTGCTGGGGTTTTAGGCAGTCTG
GGCAGGTAGAGCATGCCTTCCCTTTGTGTTTCCTGCTGCACATGGGCCCCTGGGATATCT
GAGACTAATGTGCCCACCTGGCACCGGTTGGGTGGGCATGTACCCATAAGCTGATTGTGA
ACGCATTGGTTTTGTCTTGCTGAACAGGTAGGTGGCTTGTGTTTGACTGTGTTAGGAACA
CCAGGGGTCTCTGGAGATTGAAATGCCCATGCTCTCCTGAGGCCCACGATAGGCAATGGA
ATTTTCCTCTTCAGTGAGCCAGTGCTTCGCTGAAGCTTGAGTGACTGCACGGCCATCATT
TGGATGTGGACTGTGTTAGATGGCTGTCTTACCTATGCAGCTAGGCAACACGGCCTTCTG
90 
 ATTGTAGTTGGCCAGGTGGCACAGAATGGGAACCCTGCTTAGCTTGAGGAGTGCTCTCAT
TCCCCAGGCTGCAGGACAGCCAGCAGAACTGGTTGAATGAGGCTCTGCCATGAGAGGGTG
TGCTGCTTAGGTTGGCCCTCTTAGGCCTAGATCTGTTCAGTGCAGCACAGAGGGTAGGGA
AGCTCACTGTTCAGCAATTGCCCACAAGCCGGCTTCATTCGACCCATCAGTGAATCTGGG
TAGTATTTTTGAGATATCTGGGTCAATTTCTCAGGGGTTTAATGTGCACATTTAAACGGT
GATTCTTCATTTCTGGTTAAAAACAAGCTCAGGGCAGAGACGTGGCTTATGGTGAAGAGC
ACTTGCCGAGCCTGCAGAGGACCTGGGTTTGGTCTCTGGTACCCGTGTGGTGGTGGACAA
CTATCTGTAACTCCTCTCTTGGCCTCTTCAGGCACCGGACTTGGATGTGGAACGAGTGCA
CACACTCGTGCGCGCACGCACACACACACACATACACACACACACACACACAAACACACA
CACACACACACACACACACACACACACACACCCATAAAACATTTAAAATTAAACCTTAAA
ACCAACTTCTGTGTGGGAAGCTTTGACAAATTTCCTCTTCCTGGAGACACATTTTCATGC
CAGTGCTGACACCCTCCCTCTTGTTGCTCAGAGGTGTCATTAATGAGGAGGGTCTCCCCC
CTCCCCCTCCCCTCCTCCCTCCCCCGCCCCTTCCTCTCCCCCCACCTCGCCCTAACTACA
GGTCAAGTCCTGCTGCTGGAGCCCATTATAAAGTCTGTCTTTACTGTCATCAAGACAAAA
CGGCAACCAACAGTTGGGTAAAAGATCTTTACCAATCCTACAACAAGATAGAGGCTACAA
TATCCAAATATACCCAAGAACTCAAGAAGTGAGACTCCAGAGAGCCAAATCACCCTATTA
AAAAAGGGTACAAAGATAAACAAAACATTCTCAGCTGAGGATTATCGAATGGCAAAAAGC
ACCTAAAGAAATGTTCAACGATCTTAGTCATCATGGGAAATGCAAATCCAAAACAACCCT
GAGATTGTCACCCTCACACCAGTCAGAATGGGCTAAGATCAAAAACTCAGGTGACAGCAG
ATGTGGCGAGGATGTGGAGAAAGAGGGAACACTCCTCCATTGTTTGGTGGGATTGCAGAC
TGGGTAACAACCACTCTGAAAATCAGTCTGGAGGTTCCTCAGAAAATTGGACATTACATT
ACCTGAGGATCCAGCTAATACCTCTCTTGGGCATATACCCAAAAAGATGCTCCACCTACA
AACAAAGACACGTGCTCCACTATGTTTCATAGCAGCCTTATTTATAATAGCCAGAAGCTG
GAAAGAACCCAGATGCCCTTCAACAGAGGAATGGATTAAAAAAATGTGGTACATCTACAC
AATGGAATACTACTCAGCTATCAAAAACAATGACTTCGTTTTTGATATTCATATCAAACT
ATGAAATTCATAGGCAAATGGAATGAACTAGAAAATATCATCCTGAGTGAGGTTACCCAA
TCACAGAAAAACACACTTGGTATGCACTCCTTGATAAGTGGATATTAGCCAAAAAGCTCA
AATTACCCAAGATGCAATCCACAGACCACAGGAAGCTCAAGAAGAAGGATGACCAAAATG
CAGATGCTCCCACTCCTTCTTAAAAGGGGGAAAATATCATAGAAGGGGATATGGAAGCAA
AGTTTAGAGCAGCGACTCAAGGAATGGCCATTCAGAGCCTGACACACATGTGGCCCATAT
ATATACAGCCACCAAAACTAGATAAGATTGATGAAGCTAAAAAAATGCATGCAGAAAGGG
ACTCTTCTGAGAAACACATCCAGATTATGTCCAATACAGAGGTCAATGCTAGCAGCAAAC
CACTGAACTGAGAATAGGACCCCCTTGGGGTAATTAGAGGAAGAGTTGAAGGAGCTTGCA
ACCCCATAAGAACAACAATGCCAACCAACCAGAGCTTCCAGGGACTAAACCACTGCTGAA
AGACTATACATGGACTGACCCAGGGCTCCAACTGCATATGTAGCAGAGAATAGCCTTGTT
GGGGCACCAGTGGAAGGGGAAGCCCTTGGTCTTGCCAAGATTGGACCCCCAGTGTAGGGG
AATATGGGGGAGGGCAATAAGGGGGATTTATAGGGGGAACACCTGTATGGGGGAAGGGAG
GGAATGGGGGCTTGGACAGGAAACCAGAAAGGGGAATAACTTTTGAAATGTAAGTAAAGA
AATATATAATAAAAATTAAAAAAAAGAAAAATAATAATAAAAAAATACCTAAAAACAAAA
CAAAATCTGTCTTTGCTCGGCTCGGTTCTCCTTCTAGCAGGCTCCCTGACTGCCTCCTCA
CACTTTGGTTTTCTGTTTGCAG ​GTCCTGCTGCTGTAACCAACCAGTCTCCCGTCCCCTGTA
AACTCT​GTATCCTCACGAAGGTGGTGGCGCTGTGCACACAGGGCAGTCTCCCTGCCCCAC
TGCTGGAGCTGCTCTGGGGAGGCAGGCCTTCTGTGACCTCAAACGTGGGGGTTGGGCAAG
TGAATGGGGCTTCCCTTTTATCACCCAATGTTCCCAGTGTGGACTTTCCTTTAACGTACA
G ​ATTCCTCCTCGTGGATCGTCTTCCAACCAGACATCATCATCAGTGCAAGCCAAG​GTAGGT
CTGGGGGCCATTGCCTACTTTAGTCCTGCCAGAGTGACTTCAGTATGAGTCTTTGAGGTG
91 
 ACTGACCCTCCCCTCAGCCTTGAAAGTGGGACTGCGTTTCATCCTATACCCTCCTCTGCA
AGGGTTTTTCCATGAGCATGTATGATTCTTATAGCTAAAGTGACTAAGAATGGCCAATCC
CAGTTTGATTCCCACGGCCATTTCAGAAAGCTGCCTATGGTGAGTGGTCTGCATTCTCAT
TCTCTAGCCCCACTCCCTGTGTTCCTGCCCAAGACCCCTGCCCTTCACCTTTCCAGCAGA
CAGCTCCTCAGCCTGCTGTCTCTCCCTGGGTAACGGCCTGCGGCATTGCACTTGAGAACT
TCCCACCAGTTTCCATGGTTTTGAGTGTCCAGCCTCACCCTCTGGGGTTCTTAGGTAGAC
ACCCACTGTATATAGTGAGTGCTTCTCTTCTGTATACTGACAGTAGGGCCAGCTCTTGGA
AACTGAGAAAGGCGTCACTTTTTTTTTTTTTTTTTGATGTGACCTCTGGTGGCACCAGCT
TGCCTGTTAGCACTCAAATAGGCCGATGAGTGGGTGGGTATTTCACTGATAGCCTATGGG
GTTACCTCCTGCACCCATGAGCTAGTACAGCAAAAACACAAGTACCTGGTACACAGCCAA
TGAGGGGGCTAGCACGTTAGAGGGGAAGGAGTCCTCTGGATTGAGCTGCTGTCCTTGGAG
ACAACCGTGAGAGTGACTCTTAGTGCAATTCTTCACGCATTAGAAATCAGCTAAGTTTTC
TGATAGTGTGACTGTCAGGTCTTCCACAGTCAGCCTCCTTCCTGGACATCCTAGCTCCTT
GTTGGTCGGGAAGGAAGGGCTGTTAACTGTATTTGCAGTCCTTAACCTGGGGCAGTTGGG
ACATTCTTTGTTGGGTTTGGTTCTGGCTAGCGCACACTGATGAACATGCTACCTCTTAAC
ATCCAG ​GTTACCTCTGGAACCTGCAGGTGAAACTTCAGCCCATAGTGAATCTCTTGCCAGAT
AAAGGAAGACTGATGGACTTTCTCCTCCAGAGGAAGGAGTGTAAAGCCGTCGTTCTGTCTGT
CTGTTCACAGA​GTAAGTGCACTGACCCTTTCCCACTGTCTGTGGAAAAGCACCATCTCTT
TATTTAATTATGCCTTGCGGCCTGTGCTTAGTACCTGCTGAGCCTCCTTCCAGGGTGCCC
AACCCCACCTTACAACTGGGAATTGAACATGCCTTTCACACTCAGGCCGGCACACTTGAA
GGATGGATTCTTAACCTCATAGGAAAGACTGGGAGATAAACACAGGACTTGTAGACTGAC
AGAAACCCACCAGTAGGCAGAAAGCTGATTACATCCTCTGGTGCCACTGGTCCTGACTGA
TTTTAACATTTCCTTGAAGGTCCTCAAGGCAGGGTTTGCATGGGTCACCCTCTGAGACTG
CCATGTCACCAGCACGTGGGGATCCTGATTACAGTGGGTCTGACCGTGTGCATTGTACTT
TCCAG ​TGCTGAGTGAGTCAGACAGAGCCACGCTGCCTGTGATAGCCACTGTTTTCGATAAAC
TCAACCATGAGTACAAGAAGTACTTGGATGCTGAACAGAGCTACACAATG​GTAAGACAGAC
TGTATTGGAGAGTCCTGCAGTGTGATGTGGTCATACAGCGTAACAGCTGAGGGCACCGTG
ACAGTGGCAAGCCAGAGTGCATCTGGCTCAAGGCTTCACTGTTCTGCTTTTTAAAATCTG
TTTGTGCTTTTGTTTGGTTATGTTGTAGAAAGACAATCAGCCGTGGCTTTTAACAGAGCA
AATTAGAGATGTGATTTCTTTCCACTGGTGCTTGCCTTTCTCCTTTGCAAATATTTAGAA
ATATCAGGTTATCTAGAGGGACATTTGGGCAGGGCGTGTCCAACATGCAACACGTACTTG
TATGAAACCTAAAAGTAAATTCTAAAAGATGGTTATTTCAAGTAAGAATAGACGAATGTG
TGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTATCCCCCACCCCCACCCCCAG
CTGAGAACCAAACCCAGGGCCTTGTGCTTGCTAGGCAAGCACTCTACCACTGAGCTAAAT
CCCCAACCCCTTGTGGTTTTTTTTTTTTTGTTTTGTTTTGTTTTTGTTTTAAAGACAGGG
TTTCTCTATGTTGCTGTCCAGGTTGGTCTTGAACTCAGAGGTCCACCTGTCTCCTGAGTG
CTGGGATTAAAGCCTTGTTTTTTTTAGAGTCTCACTGTGTACCTCTACCTCTGGCTGGCC
TGGAACTTGGTTATAGAGAGTCCTCCTAAGTATTAGGCATGTGACACGACACCTGGCCAA
AATTTTATTGGTGAAATGTGTCCTTTGACAATTTCCTGTACGTCTGCAGCGTTGTTTCCT
CACTTCCCGGTCATCCCTCCTACCTGTGTCTCCCCTCCTGCCCCTTACTCCTCTTTCCTG
TTACGATGGCTTTGTTTTATGACCCACTGATTTTAATGAGGACTGTCTAATAAGCACAGA
TTTGCAAAAGTCCCTTGGAGCCTGGTTGGGATCACTATTGGGTACTCAACCGGAAGGCCA
TGGCTGTCTCTTCCCAGACAGTTCAGCAGGGAAATTTAGGGTCCCATGAGCCCCTCCAGA
TCCACGGCTGACGGCCAGTGCAGTGCAGTTGTGTGAGATGTCTGTGTCAAGCTTATGGGT
GGTATTTTGTAGCCCTTTCTTGGTCTTCTGGCGTTTACATTCTTTGTGATGTTCTCTGAA
TCTCAGAAGGGGCTGAATATTCAACATTTATCCTCAGCATCTGGGCAGACACACAGATAT
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 CCTAGGACAAGTACCCTGTGAGCCACTGGTTAAGTACCAGCACCATGCATTTCAGTTAAT
AGACAGCACGTGTTCAGTGAAAGGTAGGGAAAAAGTTACTGTGGCTTATTACTAGGTACG
AAACTTAGTTCTTCCACTTTTCTAAAGCGTGAAAGAAACTTGGGACAAGTGGGAGAAATT
ATTTCAAGGACATGCTTAGCAACAGTGGACACTGTTTTAAGCAACAAACTGAGACCCCCA
CTTTGCATGGCTATTTGAGGTTAGTGAGTCCTGGGCCACTGAAGGGCAGGCTGCCTACAT
TACCTCTCCTTGTTCTGTGTCAGCCGTCTGGCTGTGCCTCCTTCCTCCTCTTGGTCCTTC
TGGTGGTGTCCTGGGCTGAGGGCTTGAGCCCAGTGGCAGACTCTGGGCTATGCCAGACTG
CTTATCAGCTGTCAGGAAGCAGAGGTCTGCACTGAGCTGCTGCTCACTAGAGATCAAACA
GCTGGCACAGCTCACAGCTCTGTCGTCTGAATAATTCCCATTACACTGGCCTGTGGCTGT
AACTTGGTGGTAGAAATGTAGATTGGTGAAGCTCTGGATCCATTTCAAGGACTACAGAAT
GAATTCTAAAATGACAGCATAGAGCTTTTACTGTCTGGCAGAACTTCATGAATGAGGGCG
CAGCTGGCCAGGAGAGTCAGGTCAGTTCAATCTTCAGAAGTTGGGAAAAACATGACTGGC
TTTATTTGATTGCAGTCTCCCACAAACACTGGAGTGTCTGGCTTGTGTCTAGAAACTTAA
GTCTTGAGCTAAGTATAGTGGGTACCATTTCTGTGGAAGATGACTAAGGTCACAAGTTGT
CCCTCTTTAG ​GCAGTAGAAGCAGGGCAAAGCCGGAGCAACCCACCTCTCAAAAGGCCAGTG
AGGACCCAAGCCGTGGTAGACCAGTCTGATGTGTACACACACGTGCTGTCACCATTTGTGGA
AAACAAG​GTATGTAATGGTTTCTGGTCTCCCAAGTGGGTTACTGAGAGGGCAGCAACAGA
ATCCACACTATGGTTAAATTAAGTGGTATTGCCCTGGGAGAGGGTCTTGGGCCATGAGGC
TGGCTTCTAGTAGACTTATACTTGGTCACTAGGACGTACGGTCCATAAGGATTTGTCTAC
ACCAGCAGACAGGATCAGTGGGCTGCCTGTAACTCCTTTTGCAACTCACATTACAAGACC
CCCTTCTTCCTCCACAG ​GAGACGCCACCCAAGTTTGTGATAGCTGTGCTGATGGAATACAT
CCGTTCTCTGAACCAGTTTCAGATCCCAGTGCAG​GTACCTTCAGAGGGCTGCTTGCCATCC
TGAGTTAGAGGAAGGAGGTCAGAAGAGATGGCTGAAAAATCCGCAGACCCCGGGGTGATG
TTAACATGTCAGTCATCAGTGGGGATGGGGAATCTGGTTGAGAATGCTTTGTTACAGCTA
AATTATGGGAATGTGGCCAGTCACATAGTCCGGCCACTCAGCGATGTTATTTACCTTCTT
CCTGTGTCCCCAG ​CATTACTTACACGAACTTGTCATCAAGACACTTGTCCAGCACAACCTA
TTTTACATGCTCCACCAGTTTCTGCAGTACCATGTGCTCAGCGACTCCAAGCCTCTG​GTCTG
TATCATTGGATGTCCATTCTGTAGTCTCTAAACCTCCCCGTGGGAACCTTCCAACTGAGG
CCGGCTGAAACCCTGTCTTTCAG ​GCTTGCTTGTTGCTGTCCCTAGAAAGCTTTTATCCTCC
CGCCCACCAGCTGTCTCTGGACATGTTGAAG​GTACCCGCCCTGCCCAGCTTCAGGTCGCCA
GCGTTCTCTCCTGTGCTTGCCCTGACTGCTGTCTTCCTCACTTTCAG ​AGACTTTCAACAGC
AAATGATGAGATCGTAGAAGTGCTTCTGTCTAAGCACCAGGTGCTGGCTGCCCTAAGGTTCA
TCCGGGGTATTGGCGGCCATGACAACATTTCCGCACGAAAATTCTTAGATGCTGCTAAGCAG
ACTGATGATGTCATGCTCTTCTATACCATATTCCGCTTCTTTGAACAGCGAAACCAGCGTTT
GCGAGGGAACCCTAACTTCACACCAG​GTAAGGGAAGGCCCAGGGTGACCTCAGGCAACGGG
GGGGGGGGGGGGGGGCTTTCAAGAAGTTCAGGGTGGAATTTAGGCTTCTGGGGCATATTC
TATATCTGGCCTTGGAATCTCTATATGGACGAATCAGGGACAGGAGTGCCTCAGTTTTAA
ATGGTGATAAAACAGGATGCAGGAGAGGAGCTTATGCTGTGTGTACACAGTACAGGTGGC
CTGAGTGACAGGTCAGGGATGCCCTGGTCTGACAAGGATGTAAGCCGTGACTGCTGAAGG
TACGAGTTCTGCAACAGACCTCAAAATGTAGGAGGGATTTTATTAAAGAAAAATAAGTTA
AAACCCAGCATACAACCCATGAGCATTGTCTGCACTCCGTCTTCCTGTGCCACAACCAGC
TGGCACCTAAGCTACATTTTTCCTGCAG ​GAGAACACTGTGAGGAACACGTAGCCTTTTTCA
AGCAGGCTTTTGGAGAACAAGCTCTAATGAGGCCTACAACATTCTGAAGTCCCTCAACGGTT
TTAATATAAAAATGTACAAAGTTAATTTATTGCATTAATAAAGCTCTTTAAACTACAAAAGT
GTTGTAATAAAGTACCTACAGCATCCTCAAATGTTGCTGACTCCCAAAACAGGAGAGAGCAT
GTGGGCTGGCTTTTCAGAATTGGGGATCAGGTCACAGTTGTAGCCACCACCTGTGAAGT​GGA
93 
 CAGTCAGTTGTGTTGGTGTTTTGCTGGGGCAGACACAGGTGAAAGGCTAAGGCAGACTTG
TGAAGGACTGTTTCCCTAAAGCAAGCACGTGAAAGGACATGAATGACTGGCATGTATTGC
TTGGTCTGCCTTACATTGCGTAGCTGAGCTCTGTTTGTTGGGACTCCACAGAGAAGGAAA
TAGAGAGCTAAGCTGTGGAACATTTGTTGGGTCTTGAGTCTTCGCTGTGAGAGGCTCAGC
AGAGAGCATCGAGAGTTCCTGTTGGCCCCGCCCCTCCTGCTGATGGCCATTCAGCCGAGG
CCTGGCCACTGCTGCTGCCATCCCGATACTATTGAACTGGACAGCTGATGTATCCGTGAG
GTGTTTGAGTGATCGAGTTGCTGACCTATGAACTGAACTGCTGATTTCCTGACAACACAG
ATAGGATATGCTGCAAAGAACCTTTCTTAACACATCCACTTCCCACTCTCTGGTGGGTGT
TGGACTAGAAGGGGTTAAAGTTTTAATGATGGTTTGATAGCCATCATTAAAAGTAGGCAT
TGAAAGAATGAAAGTTGTAGAACTGCCCTTCCTTGTGCCCAAGATGAGGTTTCTTAG 
ix. CRISPR/Cas9 Target Sequences  
1. Exon 1 
GTTAACTGCGTGTTCTTCGA 
2. Exon 8 
CTCTCTCTCCGACTAGATAC 
3. Exon 9 
GGTAGTTGTCCACCATCAGG 
4. Exon 10 
GTGCTTCCAGCGAGATCAAT 
 
x. pGAD-WDR98 
 
TGCATGCCTGCAGGTCGAGATCCGGGATCGAAGAAATGATGGTAAATGAAATAGGAAA
TCAAGGAGCATGAAGGCAAAAGACAAATATAAGGGTCGAACGAAAAATAAAGTGAAAA
GTGTTGATATGATGTATTTGGCTTTGCGGCGCCGAAAAAACGAGTTTACGCAATTGCA
CAATCATGCTGACTCTGTGGCGGACCCGCGCTCTTGCCGGCCCGGCGATAACGCTGGG
CGTGAGGCTGTGCCCGGCGGAGTTTTTTGCGCCTGCATTTTCCAAGGTTTACCCTGCG
CTAAGGGGCGAGATTGGAGAAGCAATAAGAATGCCGGTTGGGGTTGCGATGATGACGA
CCACGACAACTGGTGTCATTATTTAAGTTGCCGAAAGAACCTGAGTGCATTTGCAACA
TGAGTATACTAGAAGAATGAGCCAAGACTTGCGAGACGCGAGTTTGCCGGTGGTGCGA
ACAATAGAGCGACCATGACCTTGAAGGTGAGACGCGCATAACCGCTAGAGTACTTTGA
AGAGGAAACAGCAATAGGGTTGCTACCAGTATAAATAGACAGGTACATACAACACTGG
AAATGGTTGTCTGTTTGAGTACGCTTTCAATTCATTTGGGTGTGCACTTTATTATGTT
ACAATATGGAAGGGAACTTTACACTTCTCCTATGCACATATATTAATTAAAGTCCAAT
GCTAGTAGAGAAGGGGGGTAACACCCCTCCGCGCTCTTTTCCGATTTTTTTCTAAACC
GTGGAATATTTCGGATATCCTTTTGTTGTTTCCGGGTGTACAATATGGACTTCCTCTT
TTCTGGCAACCAAACCCATACATCGGGATTCCTATAATACCTTCGTTGGTCTCCCTAA
CATGTAGGTGGCGGAGGGGAGATATACAATAGAACAGATACCAGACAAGACATAATGG
GCTAAACAAGACTACACCAATTACACTGCCTCATTGATGGTGGTACATAACGAACTAA
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 TACTGTAGCCCTAGACTTGATAGCCATCATCATATCGAAGTTTCACTACCCTTTTTCC
ATTTGCCATCTATTGAAGTAATAATAGGCGCATGCAACTTCTTTTCTTTTTTTTTCTT
TTCTCTCTCCCCCGTTGTTGTCTCACCATATCCGCAATGACAAAAAAAATGATGGAAG
ACACTAAAGGAAAAAATTAACGACAAAGACAGCACCAACAGATGTCGTTGTTCCAGAG
CTGATGAGGGGTATCTCGAAGCACACGAAACTTTTTCCTTCCTTCATTCACGCACACT
ACTCTCTAATGAGCAACGGTATACGGCCTTCCTTCCAGTTACTTGAATTTGAAATAAA
AAAAAGTTTGCTGTCTTGCTATCAAGTATAAATAGACCTGCAATTATTAATCTTTTGT
TTCCTCGTCATTGTTCTCGTTCCCTTTCTTCCTTGTTTCTTTTTCTGCACAATATTTC
AAGCTATACCAAGCATACAATCAACTCCAAGCTTTGCAAAGATGGATAAAGCGGAATT
AATTCCCGAGCCTCCAAAAAAGAAGAGAAAGGTCGAATTGGGTACCGCCGCCAATTTT
AATCAAAGTGGGAATATTGCTGATAGCTCATTGTCCTTCACTTTCACTAACAGTAGCA
ACGGTCCGAACCTCATAACAACTCAAACAAATTCTCAAGCGCTTTCACAACCAATTGC
CTCCTCTAACGTTCATGATAACTTCATGAATAATGAAATCACGGCTAGTAAAATTGAT
GATGGTAATAATTCAAAACCACTGTCACCTGGTTGGACGGACCAAACTGCGTATAACG
CGTTTGGAATCACTACAGGGATGTTTAATACCACTACAATGGATGATGTATATAACTA
TCTATTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGAGATCTTTAATACGACT
CACTATAGGGCGAGCGCCGCCATGGAGTACCCATACGACGTACCAGATTACGCTCATA
TGGCCATGGAGGCCAGTATGGGCAGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCC
AGTGCAGTTCGAGAAGGCGAACCCGGTTAACTGCGTGTTCTTCGACGAGGCCAACAAG
CAGGTTTTTGCTGTTCGGTCAGGTGGAGCTACAGGAGTGGTCGTTAAAGGTCCAGATG
ATAGGAATCCCATCTCTTTTAGAATGGACGACAGAGGAGAAGTGAAGTGCATTAAGTT
TTCTCTAGAAAATAAGATACTGGCTGTCCAGAGGACTTCGAAGGCCGTGGACTTTTGT
AATTTTATTCCAGATAACTCTCAACTGGAGTACACACAAGAGTGCAAGACCAAGAATG
CCAACATACTAGGATTCTGCTGGACCAGTTCTACCGAAATTGTCTTCATAACGGATCA
AGGCATCGAATTTTACCAGGTGTTGCCTGAGAAGCGAAGCCTCAAACTCCTGAAGAGC
CACAACATCAATGTGAACTGGCACATGTACTGTCCCGAGAGCTCGGTGATCCTGCTGT
CCACGACAGTCCTTGAGAATGTCCTGCAGCCTTTTTACTTTAAGGCTGGCACCATGTC
GAAGCTTCCCAAGTTTGAGATTGAGTTACCAGCTGCACCGAAGTCAACTAAACTTAGC
CTCTCAGAACGAGACATTGCGATGGCGACCATATACGGGCAGCTCTACGTCCTCTTCC
TGCGGCATCATTCCCGGACCTCCAATAGCACAGGAGCGGAGGTGGTGCTGTACCATCT
CCCACGAGAGGGTGCGTGTAAGAAGATGCACATACTGAAGTTGAATAGGACGGGAAAG
TTTGCTCTAAATGTAGTGGACAACCTGGTAGTTGTCCACCATCAGGACACAGAGACGT
CAGTGATATTTGACATCAGGTTACGGGGAGAGTTCGACGGCACAGTCACCTTCCATCA
TCCTGTGCTTCCAGCGAGATCAATTCAGCCTTACCAGATCCCCTTGGCAGGTCCTGCT
GCTGTAACCAACCAGTCTCCCGTCCCCTGTAAACTCTATTCCTCCTCGTGGATCGTCT
TCCAACCAGACATCATCATCAGTGCAAGCCAAGGTTACCTCTGGAACCTGCAGGTGAA
ACTTCAGCCCATAGTGAATCTCTTGCCAGATAAAGGAAGACTGATGGACTTTCTCCTC
CAGAGGAAGGAGTGTAAAGCCGTCGTTCTGTCTGTCTGTTCACAGATGCTGAGTGAGT
CAGACAGAGCCACGCTGCCTGTGATAGCCACTGTTTTCGATAAACTCAACCATGAGTA
CAAGAAGTACTTGGATGCTGAACAGAGCTACACAATGGCAGTAGAAGCAGGGCAAAGC
CGGAGCAACCCACCTCTCAAAAGGCCAGTGAGGACCCAAGCCGTGGTAGACCAGTCTG
ATGTGTACACACACGTGCTGTCACCATTTGTGGAAAACAAGGAGACGCCACCCAAGTT
TGTGATAGCTGTGCTGATGGAATACATCCGTTCTCTGAACCAGTTTCAGATCCCAGTG
CAGCATTACTTACACGAACTTGTCATCAAGACACTTGTCCAGCACAACCTATTTTACA
TGCTCCACCAGTTTCTGCAGTACCATGTGCTCAGCGACTCCAAGCCTCTGGCTTGCTT
GTTGCTGTCCCTAGAAAGCTTTTATCCTCCCGCCCACCAGCTGTCTCTGGACATGTTG
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 AAGAGACTTTCAACAGCAAATGATGAGATCGTAGAAGTGCTTCTGTCTAAGCACCAGG
TGCTGGCTGCCCTAAGGTTCATCCGGGGTATTGGCGGCCATGACAACATTTCCGCACG
AAAATTCTTAGATGCTGCTAAGCAGACTGATGATGTCATGCTCTTCTATACCATATTC
CGCTTCTTTGAACAGCGAAACCAGCGTTTGCGAGGGAACCCTAACTTCACACCAGGAG
AACACTGTGAGGAACACGTAGCCTTTTTCAAGCAGGCTTTTGGAGAACAAGCTCTAAT
GAGGCCTACAACATTCTGA 
 
xi. pGBDU-WDR98  
 
TGATGGAAGACACTAAAGGAAAAAATTAACGACAAAGACAGCACCAACAGATGTCGTT
GTTCCAGAGCTGATGAGGGGTATCTCGAAGCACACGAAACTTTTTCCTTCCTTCATTC
ACGCACACTACTCTCTAATGAGCAACGGTATACGGCCTTCCTTCCAGTTACTTGAATT
TGAAATAAAAAAAAGTTTGCTGTCTTGCTATCAAGTATAAATAGACCTGCAATTATTA
ATCTTTTGTTTCCTCGTCATTGTTCTCGTTCCCTTTCTTCCTTGTTTCTTTTTCTGCA
CAATATTTCAAGCTATACCAAGCATACAATCAACTCCAAGCTTGAAGCAAGCCTCCTG
AAAGATGAAGCTACTGTCTTCTATCGAACAAGCATGCGATATTTGCCGACTTAAAAAG
CTCAAGTGCTCCAAAGAAAAACCGAAGTGCGCCAAGTGTCTGAAGAACAACTGGGAGT
GTCGCTACTCTCCCAAAACCAAAAGGTCTCCGCTGACTAGGGCACATCTGACAGAAGT
GGAATCAAGGCTAGAAAGACTGGAACAGCTATTTCTACTGATTTTTCCTCGAGAAGAC
CTTGACATGATTTTGAAAATGGATTCTTTACAGGATATAAAAGCATTGTTAACAGGAT
TATTTGTACAAGATAATGTGAATAAAGATGCCGTCACAGATAGATTGGCTTCAGTGGA
GACTGATATGCCTCTAACATTGAGACAGCATAGAATAAGTGCGACATCATCATCGGAA
GAGAGTAGTAACAAAGGTCAAAGACAGTTGACTGTATCGCCGGAATTCCCCGGGATGG
GCAGCGAGGACTACTACCTGGAGCTGTGCGAGCGGCCAGTGCAGTTCGAGAAGGCGAA
CCCGGTTAACTGCGTGTTCTTCGACGAGGCCAACAAGCAGGTTTTTGCTGTTCGGTCA
GGTGGAGCTACAGGAGTGGTCGTTAAAGGTCCAGATGATAGGAATCCCATCTCTTTTA
GAATGGACGACAGAGGAGAAGTGAAGTGCATTAAGTTTTCTCTAGAAAATAAGATACT
GGCTGTCCAGAGGACTTCGAAGGCCGTGGACTTTTGTAATTTTATTCCAGATAACTCT
CAACTGGAGTACACACAAGAGTGCAAGACCAAGAATGCCAACATACTAGGATTCTGCT
GGACCAGTTCTACCGAAATTGTCTTCATAACGGATCAAGGCATCGAATTTTACCAGGT
GTTGCCTGAGAAGCGAAGCCTCAAACTCCTGAAGAGCCACAACATCAATGTGAACTGG
CACATGTACTGTCCCGAGAGCTCGGTGATCCTGCTGTCCACGACAGTCCTTGAGAATG
TCCTGCAGCCTTTTTACTTTAAGGCTGGCACCATGTCGAAGCTTCCCAAGTTTGAGAT
TGAGTTACCAGCTGCACCGAAGTCAACTAAACTTAGCCTCTCAGAACGAGACATTGCG
ATGGCGACCATATACGGGCAGCTCTACGTCCTCTTCCTGCGGCATCATTCCCGGACCT
CCAATAGCACAGGAGCGGAGGTGGTGCTGTACCATCTCCCACGAGAGGGTGCGTGTAA
GAAGATGCACATACTGAAGTTGAATAGGACGGGAAAGTTTGCTCTAAATGTAGTGGAC
AACCTGGTAGTTGTCCACCATCAGGACACAGAGACGTCAGTGATATTTGACATCAGGT
TACGGGGAGAGTTCGACGGCACAGTCACCTTCCATCATCCTGTGCTTCCAGCGAGATC
AATTCAGCCTTACCAGATCCCCTTGGCAGGTCCTGCTGCTGTAACCAACCAGTCTCCC
GTCCCCTGTAAACTCTATTCCTCCTCGTGGATCGTCTTCCAACCAGACATCATCATCA
GTGCAAGCCAAGGTTACCTCTGGAACCTGCAGGTGAAACTTCAGCCCATAGTGAATCT
CTTGCCAGATAAAGGAAGACTGATGGACTTTCTCCTCCAGAGGAAGGAGTGTAAAGCC
GTCGTTCTGTCTGTCTGTTCACAGATGCTGAGTGAGTCAGACAGAGCCACGCTGCCTG
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 TGATAGCCACTGTTTTCGATAAACTCAACCATGAGTACAAGAAGTACTTGGATGCTGA
ACAGAGCTACACAATGGCAGTAGAAGCAGGGCAAAGCCGGAGCAACCCACCTCTCAAA
AGGCCAGTGAGGACCCAAGCCGTGGTAGACCAGTCTGATGTGTACACACACGTGCTGT
CACCATTTGTGGAAAACAAGGAGACGCCACCCAAGTTTGTGATAGCTGTGCTGATGGA
ATACATCCGTTCTCTGAACCAGTTTCAGATCCCAGTGCAGCATTACTTACACGAACTT
GTCATCAAGACACTTGTCCAGCACAACCTATTTTACATGCTCCACCAGTTTCTGCAGT
ACCATGTGCTCAGCGACTCCAAGCCTCTGGCTTGCTTGTTGCTGTCCCTAGAAAGCTT
TTATCCTCCCGCCCACCAGCTGTCTCTGGACATGTTGAAGAGACTTTCAACAGCAAAT
GATGAGATCGTAGAAGTGCTTCTGTCTAAGCACCAGGTGCTGGCTGCCCTAAGGTTCA
TCCGGGGTATTGGCGGCCATGACAACATTTCCGCACGAAAATTCTTAGATGCTGCTAA
GCAGACTGATGATGTCATGCTCTTCTATACCATATTCCGCTTCTTTGAACAGCGAAAC
CAGCGTTTGCGAGGGAACCCTAACTTCACACCAGGAGAACACTGTGAGGAACACGTAG
CCTTTTTCAAGCAGGCTTTTGGAGAACAAGCTCTAATGAGGCCTACAACATTCTGA 
 
xii. GST-RAB5A 
 
ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTC
TTTTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGA
TAAATGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTAT
ATTGATGGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACA
AGCACAACATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGG
AGCGGTTTTGGATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAA
ACTCTCAAAGTTGATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATC
GTTTATGTCATAAAACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTT
GTATGACGCTCTTGATGTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCA
AAATTAGTTTGTTTTAAAAAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGA
AATCCAGCAAGTATATAGCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGG
CGACCATCCTCCAAAATCGGATCTGGTTCCGGATCCCGGGGCCCGGTACCGCGGCCGC
TAGCATGCAGTCGACTAGT ​ATGGCTAGTCGAGGCGCAACAAGACCCAACGGCCCAAAT
ACTGGAAATAAAATATGCCAGTTCAAACTAGTACTTCTGGGAGAGTCCGCTGTTGGCA
AATCAAGCCTAGTGCTTCGTTTTGTGAAAGGCCAATTTCATGAATTTCAAGAGAGTAC
CATTGGGGCTGCTTTTCTAACCCAAACTGTATGTCTTGATGACACTACAGTAAAGTTT
GAAATCTGGGATACAGCTGGTCAAGAAGGATACCATAGCCTAGCACCAATGTACTACA
GAGGAGCACAAGCAGCCATAGTTGTATATGATATCACAAATGAGGAGTCCTTTGCAAG
AGCAAAAAATTGGGTTAAAGAACTTCAGAGGCAAGCAAGTCCTAACATTGTAATAGCT
TTATCGGGAAACAAGGCCGACCTAGCAAATAAAAGAGCAGTAGATTTCCAGGAAGCAC
AGTCCTATGCAGATGACAATAGTTTATTATTCATGGAGACATCCGCTAAAACATCAAT
GAATGTAAATGAAATATTCATGGCAATAGCTAAAAAATTGCCAAAGAATGAACCACAA
AATCCAGGAGCAAATTCTGCCAGAGGAGGAGGAGTAGACCTTACCGAACCCACACAAC
CAACCAGGAATCAGTGTTGTAGTAACTAAACCTCTAGTTTGAAC 
 
xiii. GST-RAB7A 
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 ATGTCCCCTATACTAGGTTATTGGAAAATTAAGGGCCTTGTGCAACCCACTCGACTTCT
TTTGGAATATCTTGAAGAAAAATATGAAGAGCATTTGTATGAGCGCGATGAAGGTGATA
AATGGCGAAACAAAAAGTTTGAATTGGGTTTGGAGTTTCCCAATCTTCCTTATTATATT
GATGGTGATGTTAAATTAACACAGTCTATGGCCATCATACGTTATATAGCTGACAAGCA
CAACATGTTGGGTGGTTGTCCAAAAGAGCGTGCAGAGATTTCAATGCTTGAAGGAGCGG
TTTTGGATATTAGATACGGTGTTTCGAGAATTGCATATAGTAAAGACTTTGAAACTCTC
AAAGTTGATTTTCTTAGCAAGCTACCTGAAATGCTGAAAATGTTCGAAGATCGTTTATG
TCATAAAACATATTTAAATGGTGATCATGTAACCCATCCTGACTTCATGTTGTATGACG
CTCTTGATGTTGTTTTATACATGGACCCAATGTGCCTGGATGCGTTCCCAAAATTAGTT
TGTTTTAAAAAACGTATTGAAGCTATCCCACAAATTGATAAGTACTTGAAATCCAGCAA
GTATATAGCATGGCCTTTGCAGGGCTGGCAAGCCACGTTTGGTGGTGGCGACCATCCTC
CAAAATCGGATCTGGTTCCGGATCCCGGGGCCCGGTACCGCGGCCGCTAGCATGCAGTC
GACTAGT ​ATGACCTCTAGGAAGAAAGTGTTGCTGAAGGTTATCATCCTGGGAGATTCTG
GAGT ​C ​GGGAAGACATCACTCATGAACC ​A ​GTA ​T ​GT ​G ​A ​A ​TAAG ​A ​AATTCAG ​C ​A ​A ​TCA ​G ​TAC
AAA ​G ​CCAC ​A ​ATAGGAGCTGACTTTCTGACCAAGGAGGTG ​A ​T ​GGT ​G ​GATGACAGGC ​T ​A ​GT
CACAATGCAG ​A ​T ​A ​TGGGAC ​A ​CAGCAGGACAG ​G ​AA ​C ​GGTTCCA ​G ​TCTCT ​C ​GGTGTGG ​C ​C ​T
T ​C ​TACAGAGGTGC ​A ​GA ​C ​TGCTG ​C ​G ​T ​T ​CTG ​G ​TATTTGA ​T ​GT ​G ​ACTG ​C ​C ​C ​CCAACACATT ​C
AAAA ​C ​C ​CT ​A ​GA ​T ​A ​G ​C ​TGGA ​G ​AGATGA ​G ​TTTCT ​C ​ATCCAGGC ​C ​AGTC ​C ​C ​C ​G ​AGATCCTGA
AAACTT ​C ​CCATTTGTTGT ​G ​TT ​G ​GGAAACAAGATTGAC ​C ​T ​C ​G ​AAAA ​C ​AGACAAGTG ​G ​C ​C ​A
CAAAGCG ​G ​G ​CACAG ​G ​C ​C ​TGGTG ​C ​T ​A ​CAG ​C ​AAAAACAACATT ​C ​C ​C ​T ​A ​C ​TTTGAGA ​C ​CAGT
GCCAA ​G ​GA ​G ​GCCATC ​A ​A ​C ​G ​TGGA ​G ​CAGG ​C ​G ​TT ​C ​CAG ​A ​C ​G ​A ​T ​T ​G ​C ​A ​C ​GG ​A ​A ​T ​GCACTTAA
GCA ​G ​GAAA ​C ​G ​GAG ​G ​T ​GGA ​G ​C ​TGTA ​C ​A ​A ​C ​G ​AATTTCCTGA ​A ​CCT ​A ​TCAAACTG ​G ​A ​CA ​A ​G ​A
ATGAC ​C ​G ​G ​G ​C ​C ​A ​A ​G ​G ​CCT ​C ​G ​GCAGAAAG ​C ​TGCAGTTG ​C ​TGA 
 
 
List of Abbreviations 
 
ADE - adenine  
AF - Alexa Fluor 
AGC - automatic gain control  
APP - amyloid precursor protein 
APS - ammonium persulphate  
BCA - ​bicinchoninic acid assay 
BLAST - ​Basic Local Alignment Search Tool  
BSA - bovine serum albumin 
BSP - BSA-saponin-PBS 
CEB - cytosol extraction buffer  
CMA - chaperone mediated autophagy 
CRISPR - ​clustered regularly interspaced short palindromic repeats 
ddH​2​O - double distilled water 
DFS - ​DharmaFect solution 
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 DMEM - Dulbecco’s modified eagle medium  
DNase - ​deoxyribonuclease 
EDTA - ethylenediaminetetraacetic acid 
EEA1 - early endosome antigen 1 
EGF - epidermal growth factor 
EGFR - epidermal growth factor receptor 
ESI - electrospray ionisation  
FDR - false discovery rate 
GDI - guanine dissociation inhibitor  
GDP - guanosine diphosphate  
GEF - guanine nucleotide exchange factor  
GFP - green fluorescent protein 
GLU - glutamic acid 
GLN - glutamine  
GMPPNP - ​5'-guanylyl imidodiphosphate  
GST - glutathione s-transferase  
GTP - guanosine triphosphate  
HCD - ​higher-energy collisional dissociation 
HDAC6 - histone deacetylase 6 
HeLa - Henrietta Lacks 
HIS - histidine  
HRP - horseradish peroxidase  
HSP90 - heat shock protein 90 
IF - immunofluorescence  
IgG - immunoglobulin G 
IP - immunoprecipitation  
KDA - kilodaltons  
LAMP - lysosomal associated membrane protein  
LC-MS - liquid chromatography mass spectrometry  
LDS - ​lithium dodecyl sulfate 
LEU - leucine 
LGP120 - lysosomal membrane glycoprotein 120 
LSM - laser scanning microscope 
NCBI -​ National Center for Biotechnology Information 
NRK - normal rat kidney 
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 OD - optical density  
PAGE - ​polyacrylamide gel electrophoresis 
PBS - phosphate buffered saline  
PCR - polymerase chain reaction  
PEG - ​polyethylene glycol  
PVDF - ​polyvinylidene fluoride 
RMC1 - regulator of MON1-CCZ1 complex  
RT - room temperature  
SD - synthetic defined  
SDS - ​Sodium dodecyl sulfate 
SFM - serum free media  
SOC - ​super optimal broth with catabolite repression 
STUB1 - ​STIP1 homology and U-Box containing protein 1 
TAE - ​tris-acetate-EDTA 
TBS - tris buffered saline 
TBST - tris buffered saline TWEEN 20 
TEMED - ​tetramethylethylenediamine 
URA - uracil  
V/V - volume/volume  
WB - western blot 
WDR98 - WD40 repeat 98  
WT - wild type  
W/V - weight/volume  
YPD - ​yeast extract–peptone–dextrose 
Y2H - yeast two hybrid  
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